Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CD200R1L	"CD200R2, CD200RLa"	ENSG00000206531	"CD200 receptor 1 like"	Q6Q8B3	3	112815709-112846856	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	85	"blood: 31.3;testis: 7.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;CACO-2: 3.5;CAPAN-2: 1.3;RPMI-8226: 1.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	304	"basophil: 31.3"	"Lineage enriched"	"Detected in single"	313	"granulocytes: 31.3"																					"unprognostic (3.80e-1)"				"unprognostic (1.88e-1)"		"unprognostic (2.37e-2)"		"unprognostic (1.55e-1)"				"unprognostic (1.16e-2)"	"unprognostic (1.78e-1)"		"unprognostic (1.40e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.8			0.0		0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM64	"C11orf28, TRIM64A"	ENSG00000204450	"Tripartite motif containing 64"	A6NGJ6	11	89968502-89975228	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	65	"blood: 8.6;placenta: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	86	"basophil: 8.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.6"									HPA045370	Approved									"HPA045370: AB_2679298"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		4.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"blood: 175.9"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	22	"basophil: 175.9;eosinophil: 152.0"	"Lineage enriched"	"Detected in many"	92	"granulocytes: 175.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB003795	Uncertain									"CAB003795: AB_562259"	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.6	0.2	0.3	2.9	1.1	0.4	0.3	0.2	0.8	0.3	1.3	0.2	0.2	2.9	0.8	0.2	0.4	0.5	1.3	0.3	0.2	0.2	0.5	1.2	5.8	0.6	0.3	0.2	0.2	0.3	0.0	0.3	7.0	0.7	1.0	1.4	0.9	2.4	0.2	3.2	3.6	5.1	1.6	0.5	2.7	2.2	0.4	0.2	0.6	1.8	2.8	0.6	4.0	0.3	0.0	0.2	175.9	0.0	0.0	1.9	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.7	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.1	0.3	0.1	0.0	0.2	0.0	24.9	0.0	2.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.1	2.7	2.1	0.0	0.0	0.5	0.0	175.9	0.0	152.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.2	1.9	0.3	0.3	1.1	0.2	0.8	0.2	0.2	0.3	0.2	0.7	0.2
TRIM64B		ENSG00000189253	"Tripartite motif containing 64B"	A6NI03	11	89869282-89876017	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	24	"blood: 22.3;placenta: 7.0"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	223	"basophil: 22.3"	"Lineage enriched"	"Detected in single"	223	"granulocytes: 22.3"									HPA045370	Approved									"HPA045370: AB_2679298"															"unprognostic (2.08e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	7.0		0.0	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.6			0.2		0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.4	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HIST1H2BH	"H2B/j, H2BFJ"	ENSG00000275713	"Histone cluster 1 H2B family member h"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 220.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 17.7"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: "	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.9	0.6	0.0	25.6	0.0	3.1	2.1	0.0	0.0	0.9	5.5	0.0	0.9	7.8	1.0	2.4	8.4	1.5	4.0	1.8	0.0		0.7	0.0	2.2	11.3	0.0	0.0	0.4	0.1	0.0	0.0	4.9	0.0	1.2	2.2	0.0	1.8	0.1	0.0	0.6	8.1	0.1	0.0	9.6	1.6	3.3	0.0	220.5	0.4	9.5	23.3	1.4	0.0	1.0	0.9	4.7	0.4	1.0	0.7	9.3	1.8	0.1	7.3	0.0	0.0	0.1	1.2	0.9	0.4	1.3	0.6	2.4	1.1	0.0	1.8	0.1	3.6	0.0	0.6	1.8	0.9	0.1	1.3	5.5	0.4	0.0	0.0	4.2	0.3	0.3	0.5	0.5	0.3	2.6	6.5	0.1	2.0	3.8	2.7	1.7	1.9	4.0	0.0	0.9	0.0	2.8	3.4	3.0	4.3	1.4	0.6	2.1	3.3	0.0	0.6	0.0	0.8	3.2	17.7	4.4	0.0	0.5	1.5	3.9	3.5	0.4	0.7	0.5	0.0	0.2	1.0	0.3	0.7	0.9	0.6	0.1	0.2	4.7	1.0	0.2	0.4	0.7	9.3										
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"blood: 19.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 2.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	199	"basophil: 19.8"	"Lineage enriched"	"Detected in single"	199	"granulocytes: 19.8"																																					0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"blood: 494.6"	"Cell line enriched"	"Detected in some"	94	"HEL: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 494.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 494.6"					"Low region specificity"	"Detected in all"			"CAB022102, HPA036051, CAB055526"	Approved									"CAB022102: , CAB055526: , HPA036051: "	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	5.8	1.4	1.6	3.6	0.8	6.0	9.2	0.9	1.3	8.0	3.4	1.1	3.4	3.2	10.6	5.6	12.1	2.0	25.4	4.1	4.3	1.3	3.6	2.4	27.8	0.6	1.0	5.3	1.5	2.6	0.5	1.9	0.5	2.7	9.4	5.4	6.5	5.9	4.7	1.2	17.9	4.1	6.0	2.8	3.5	2.3	1.5	6.8	2.4	2.5	19.7	16.2	3.8	4.9	0.0	75.4	494.6	0.3	0.4	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	494.6	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	75.4	0.0	0.0	0.1	0.4	0.4	0.2	10.4	0.0	3.0	1.6	0.8	0.9	1.3	4.3	1.3	1.0	5.3	2.7	6.8
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682676	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	16	"blood: 73.8"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	679	"basophil: 73.8"	"Lineage enriched"	"Detected in single"	679	"granulocytes: 73.8"					"Low region specificity"	"Detected in many"			HPA072995	Approved				"Secreted to blood"					"HPA072995: AB_2732215"	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.4	1.2	0.3	1.1	0.3	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	1.1	0.3	0.7	0.8	0.8	0.3	0.3	0.1	0.5	0.3	4.6	1.1	0.3	0.3	0.3	0.3	3.7	1.4	0.3	0.3	0.4	0.0	0.3	0.4	0.3	0.3	1.6	1.0	0.3	0.3	0.7	0.2	1.0	0.3	1.3	0.8	0.3	0.3	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3
BX088645.1		ENSG00000283378			9	61330717-61453030	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 21.7;bone marrow: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 21.0;SiHa: 4.6;TIME: 6.6;WM-115: 18.5"									"Cell type enriched"	"Detected in some"	13	"neutrophil: 21.7"	"Lineage enriched"	"Detected in single"	182	"granulocytes: 21.7"																																					0.1	0.0		0.0		14.1	0.0		0.5	0.1	0.0			0.0	0.0	0.0	0.2	0.0	0.0	1.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.1		0.3	0.0	0.5			0.1		0.0	0.0		0.1	0.0	21.7	0.0	0.0	0.0	0.0	0.9	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	2.3	0.3	1.6	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.3	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.6	0.0	0.3	2.4	0.0	0.7	0.3	0.6	4.6	0.1	1.4	0.1	0.1	6.6	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0										
HIST1H3H	"H3/k, H3F1K, H3FK"	ENSG00000278828	"Histone cluster 1 H3 family member h"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 55.3;lymphoid tissue: 204.8"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5;SiHa: 15.2;U-266/70: 13.0;U-266/84: 31.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	6	"basophil: 15.9;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.9"									HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favourable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavourable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.2	2.6	0.0	25.2	0.0	7.5	1.7	0.2	0.3	1.7	4.7	0.0	2.5	2.3	1.6	2.5	9.0	0.6	3.0	1.3	0.0		0.4	3.1	4.4	8.1	0.0	0.0	2.2	1.5	1.4	0.0	3.4	0.1	2.7	5.3	0.5	0.9	2.8	0.8	0.3	3.9	1.0	0.2	11.0	3.1	3.4	0.0	204.8	1.3	10.6	22.6	1.7	0.9	1.1	1.8	15.9	1.1	0.3	2.0	55.3	1.0	3.8	1.6	1.3	2.3	0.3	0.2	0.5	0.3	1.9	0.7	1.1	1.1	0.7	3.6	0.4	2.1	0.6	0.9	1.2	4.8	2.4	0.9	3.5	4.9	0.6	0.8	1.5	3.2	0.3	0.4	0.4	0.7	17.5	8.4	0.3	7.6	1.5	1.8	0.8	1.5	0.8	0.0	8.7	1.9	0.4	5.1	1.0	15.2	3.1	0.6	7.3	0.2	0.8	0.8	2.5	0.4	0.2	13.0	31.5	2.6	0.0	4.1	0.1	15.9	1.1	2.1	0.3	0.3	0.4	0.3	0.6	0.5	0.8	1.1	0.4	0.3	10.3	0.3	0.3	1.8	2.0	55.3										
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Cell line enriched"	"Detected in single"	7	"HEL: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"									HPA065044	Uncertain				"Secreted - unknown location"					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071128	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 196.2;bone marrow: 105.4"	"Group enriched"	"Detected in some"	4	"HEL: 36.3;K-562: 30.9;NB-4: 25.1;THP-1: 73.3;U-937: 28.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	1061	"basophil: 196.2"	"Lineage enriched"	"Detected in single"	1963	"granulocytes: 196.2"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.2	0.0	0.1	0.1	0.3	105.4	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	14.7	0.1	0.1	0.1	0.5	6.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	8.6	0.0	1.0	0.0	7.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	196.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.0
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786554-48794311	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 78.3;bone marrow: 37.0"	"Group enriched"	"Detected in some"	9	"HEL: 49.6;HMC-1: 51.2;K-562: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 78.3"	"Lineage enriched"	"Detected in single"	784	"granulocytes: 78.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.7	0.2	0.1	2.4	0.7	37.0	0.3	0.0	0.3	0.7	0.3	0.0	0.0	0.6	4.9	2.4	0.4	0.3	0.6	2.3	0.1	0.3	0.4	0.8	5.6	0.2	0.6	0.0	0.1	0.1	0.1	0.5	2.8	0.3	1.4	0.4	1.6	0.3	0.2	0.1	0.6	0.8	2.4	0.3	4.9	0.5	3.1	0.0	1.5	0.6	1.1	0.6	0.9	0.6	0.0	0.0	78.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.1	0.3	0.6	0.0	0.3	0.0
HRH4	"AXOR35, GPCR105, GPRv53, H4R, HH4R"	ENSG00000134489	"Histamine receptor H4"	Q9H3N8	18	24460629-24479957	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"blood: 48.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.9;HL-60: 4.9;HMC-1: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	96	"basophil: 48.5;eosinophil: 16.7"	"Lineage enriched"	"Detected in single"	142	"granulocytes: 48.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035009	Uncertain									"HPA035009: AB_10671507"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.83e-6)"	"unprognostic (1.31e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.65e-7)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-4)"	"unprognostic (7.70e-2)"	1.7	0.6	0.4	1.5	0.4	2.8	0.6	0.3	0.3	0.4	0.6	0.3	0.3	2.1	1.4	1.9	1.3	0.3	0.8	0.5	0.4	0.4	0.4	1.7	1.9	0.7	0.4	0.3	0.8	0.4	0.0	2.5	0.3	0.8	1.0	0.4	1.0	1.1	0.3	0.8	2.3	1.9	2.8	2.6	1.4	0.9	1.4	0.3	0.3	0.5	0.3	5.1	1.9	0.6	0.0	0.0	48.5	0.0	0.0	0.3	0.1	0.4	0.3	0.2	0.9	0.1	0.0	0.5	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.5	0.2	0.8	0.2	0.3	0.2	0.2	0.2	2.9	0.9	0.6	0.2	4.9	2.9	0.2	1.0	0.1	0.0	0.3	0.2	0.5	0.1	0.4	0.4	0.8	0.3	0.3	0.3	0.3	0.3	0.5	0.6	0.4	0.2	0.2	0.1	0.2	0.3	1.1	0.3	1.2	0.2	0.8	0.1	0.5	0.2	0.2	0.9	0.8	0.5	48.5	0.0	16.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.3
AL031777.3		ENSG00000282988			6	26195595-26199293	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 184.8"	"Cell line enhanced"	"Detected in some"		"K-562: 7.8;SiHa: 7.4;U-2 OS: 5.6;U-266/70: 9.4;U-266/84: 6.1"									"Cell type enriched"	"Detected in many"	4	"neutrophil: 18.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.7"									HPA041189	Uncertain									"HPA041189: AB_2677357"																		1.3	1.3	0.1	10.9	0.2	13.1	4.8	0.3	0.7	3.9	3.4	0.0	2.2	0.7	1.0	2.2	7.1	1.2	1.9	4.2	0.0		1.0	1.1	3.5	12.7	0.0	0.1	2.4	1.2	0.7	0.0	3.4	0.4	2.9	0.9	0.9	1.1	3.2	0.7	0.7	3.2	1.5	2.6	8.5	1.7	4.3	0.1	184.8	0.9	3.9	11.4	4.0	0.0	2.7	1.1	18.7	1.0	0.6	1.1	0.7	0.8	0.5	0.2	0.7	0.2	0.1	0.0	0.7	0.1	1.4	0.4	0.6	0.9	0.8	2.4	0.0	1.2	0.3	0.0	0.0	2.6	0.3	0.7	2.4	1.5	0.0	0.2	0.8	1.1	0.0	0.8	0.5	0.2	7.8	1.6	0.0	1.1	2.8	1.7	0.2	2.3	0.7	0.2	4.3	0.0	0.0	0.9	0.2	7.4	0.0	0.5	4.7	0.0	0.8	0.8	5.6	0.0	0.2	9.4	6.1	0.9	0.5	2.2	0.3	4.3	0.0	1.2	0.3	0.3	0.4	0.9	0.6	0.6	0.4	2.7	0.5	0.8	18.7	0.6	1.0	1.1	1.1	0.7										
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"blood: 15.9"	"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	160	"basophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"																																					0.0	0.0		0.1		0.6	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.3	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.6			0.0		0.0	0.1		0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Group enriched"	"Detected in some"	4	"HEL: 59.8;HMC-1: 143.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.1	143.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 41.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		140000	140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: , HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	6.6	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	1.1	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.7	9.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"														"Secreted to blood"						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 71.0;bone marrow: 29.2"	"Group enriched"	"Detected in some"	5	"HEL: 54.3;HMC-1: 35.2;K-562: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"basophil: 31.2;eosinophil: 71.0"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 71.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004420, HPA006291"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.2	0.0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0.0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0.0	0.1	0.0	0.1	0.2	0.0	0.1	1.2	0.0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1.0	0.2	3.3	0.3	4.0	0.0	1.0	0.2	0.0	0.5	0.4	0.2	0.0	0.3	71.0	2.7	0.1	0.1	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	7.6	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	54.3	0.1	0.0	0.0	0.0	35.2	0.0	0.6	0.0	0.1	0.0	16.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	31.2	0.0	71.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.1	2.7	0.1	0.0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0
TEX54		ENSG00000283268	"Testis expressed 54"		11	62832319-62832803	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"blood: 47.4;testis: 21.2"	"Low cell line specificity"	"Detected in some"											"Cell type enriched"	"Detected in many"	8	"neutrophil: 47.4"	"Lineage enriched"	"Detected in all"	16	"granulocytes: 47.4"																																					1.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	4.2	0.0	0.6	1.5	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.1	1.7		0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.0	0.0	0.0	0.8	0.5	0.0	1.0	0.2	0.5	21.2	0.7	0.0	0.5	0.0	0.5	1.5	0.0	2.3	2.3	47.4	2.9	1.3	2.9	0.3	0.3	0.0	2.3	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	2.6	0.8	0.4	0.0	2.6	0.0	0.0	0.0	2.4	0.8	0.0	2.6	0.9	0.8	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	1.3	1.3	0.4	1.6	1.0	0.0	2.8	0.0	0.5	1.0	0.0	0.0	1.8	0.3	0.7	0.0	1.5	0.7	0.7	1.9	0.0	2.4	0.8	1.1	0.0	0.0	1.8	6.1	2.9	5.9	1.6	2.0	2.7	1.7	1.7	1.4	0.8	2.3	2.9	2.1	47.4	1.3	0.8	2.3	1.1	0.3										
TAS2R40	GPR60	ENSG00000221937	"Taste 2 receptor member 40"	P59535	7	143222037-143223079	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"blood: 6.3;lymphoid tissue: 4.1"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.1	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0										
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Group enriched"	"Detected in some"	4	"HL-60: 58.0;NB-4: 30.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1
AC107959.5		ENSG00000284956			8	23084403-23115536	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"blood: 69.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.3;HDLM-2: 16.3"									"Cell type enriched"	"Detected in some"	9	"neutrophil: 69.8"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 69.8"																																					0.3	2.0	0.0	1.5	0.0	3.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	2.7	0.0	0.0		3.5	0.0	0.4	0.0	0.7	0.0	0.4	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	9.7	0.5	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	69.8	0.4	0.0	0.0	0.1	2.6	3.7	0.7	13.3	0.0	1.7	2.8	0.0	0.5	0.2	2.1	0.4	1.1	2.7	4.0	0.9	0.1	0.4	0.5	1.9	16.3	1.6	0.0	2.0	7.5	1.6	0.5	5.7	1.7	2.1	0.7	0.7	2.5	0.7	0.0	0.6	0.0	0.0	0.7	3.5	0.5	0.1	0.9	0.3	0.8	0.1	0.1	0.1	0.2	1.9	4.8	1.8	0.3	1.3	4.7	6.7	6.7	0.8	6.3	4.7	0.2	5.2	1.2	4.0	0.6	0.4	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.8	0.0	0.3	0.0	0.0	0.1										
OR6N1		ENSG00000197403	"Olfactory receptor family 6 subfamily N member 1"	Q8NGY5	1	158747814-158772195	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 7.5;bone marrow: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206052723-206102459	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 117.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 185.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 42.8;ovarian cancer: 41.1"					"Cell type enriched"	"Detected in some"	51	"basophil: 117.7"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 117.7"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"				"Plasma membrane"		"HPA037859: "	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.3	0.0	0.0	3.9	0.0	0.0	1.8	0.0	0.0	13.1	3.1	0.0	12.1	0.9	6.2	8.2	3.4	1.6	16.2	0.4	0.0		6.8	1.8	5.2	4.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	9.4	3.3	2.9	0.0	16.9	1.5	0.2	4.0	7.0	0.0	0.4	2.4	1.1	0.0	0.6	0.0	1.7	2.5	4.3	10.0	0.3	2.2	117.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.1	0.0	8.4	185.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	37.2	0.0	0.0	0.0	0.0	0.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	117.7	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2										
AP002347.1		ENSG00000285231			11	59878809-59896481	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"blood: 7.4;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HAP1: 1.4;K-562: 2.4;U-698: 3.0"									"Cell type enriched"	"Detected in single"	24	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 7.4"														"Secreted - unknown location"																							0.0	0.0		0.5		0.7	0.0		0.3	0.0	0.3			0.6	0.1	0.0	0.2	0.0	0.0	0.0			0.5	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.6	0.0	0.6	0.0	0.0	0.0		0.0	0.4	2.5			0.0		0.0	0.0		0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.9	1.4	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	2.4	0.3	0.4	0.7	0.0	0.3	0.8	0.0	0.0	0.0	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	3.0	0.0	0.2	0.2	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0										
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"									HPA051334			Uncertain	Cytosol				Cytosol		"HPA051334: AB_2681446"	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2										
H3F3C	H3.5	ENSG00000188375	"H3 histone family member 3C"	Q6NXT2	12	31791185-31792241	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 34.7;testis: 23.5"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in all"		"neutrophil: 34.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 34.7"									HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (2.82e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.73e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.86e-2)"	1.8	0.5	0.5	2.1	0.9	4.2	1.6	0.6	0.6	2.0	0.8	0.6	1.3	0.9	1.8	1.7	1.9	0.8	0.8	0.5	1.1	0.5	0.5	1.1	1.0	0.7	0.6	0.9	3.1	1.0	0.5	0.6	0.7	0.6	1.5	0.3	1.5	1.7	1.4	0.6	1.3	1.2	1.7	0.6	1.9	1.0	23.5	0.9	0.9	1.0	3.3	1.1	1.7	0.8	6.7	6.1	34.7	7.0	6.7	6.1	14.9	3.6	0.7	1.6	0.7	0.4	0.0	1.4	0.5	0.2	0.9	0.4	1.1	1.5	0.5	1.4	0.0	1.2	0.1	0.1	0.2	1.1	0.0	0.1	0.9	0.5	0.0	1.0	1.3	0.2	0.1	0.0	1.2	0.1	0.4	1.6	0.0	0.1	2.7	3.6	0.7	0.2	1.7	0.8	2.4	0.2	0.6	2.9	5.5	0.1	2.1	4.0	1.2	3.5	0.3	2.0	3.5	1.4	4.5	2.7	1.0	1.4	1.7	1.7	1.7	13.8	6.7	18.9	5.1	7.0	4.5	6.7	5.3	5.0	6.1	5.2	5.6	5.3	34.7	6.7	6.1	5.9	6.1	14.9	0.5	0.9	0.6	0.5	1.1	0.5	0.6	0.9	0.6	0.9
CLC	"Gal-10, LGALS10, MGC149659"	ENSG00000105205	"Charcot-Leyden crystal galectin"	Q05315	19	39731250-39738028	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 489.7"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 408.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	256	"basophil: 489.7;eosinophil: 448.3"	"Lineage enriched"	"Detected in single"	1987	"granulocytes: 489.7"									HPA041751	Enhanced					240000	240000			"HPA041751: AB_10793973"		"unprognostic (4.53e-2)"	"unprognostic (3.04e-2)"		"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.34e-2)"	"unprognostic (6.60e-2)"		"unprognostic (2.21e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.24e-1)"	1.0	0.3	1.1	5.0	0.7	80.4	0.3	0.3	1.3	0.7	1.6	1.9	0.3	4.8	0.3	1.3	0.3	0.2	2.9	0.6	0.3	2.3	0.3	1.2	6.3	0.3	0.4	1.2	0.3	0.7	0.0	0.6	1.5	0.7	0.3	1.2	0.3	2.6	0.3	1.5	0.2	8.1	4.4	0.4	13.8	2.8	0.6	0.3	6.4	0.4	0.3	0.3	9.2	0.3	0.1	0.1	489.7	0.2	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	408.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	489.7	0.1	448.3	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	1.8	0.0	0.2	0.1	0.0	1.6	1.1	0.7	0.3	1.3	0.3	2.3	0.4	1.2	0.7	0.3
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	9	"HMC-1: 5.1;SK-MEL-30: 10.4;U-2 OS: 3.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2
TNFRSF10C	"CD263, DcR1, LIT, TRAILR3, TRID"	ENSG00000173535	"TNF receptor superfamily member 10c"	O14798	8	23102590-23117437	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 173.4"	"Group enriched"	"Detected in some"	5	"BEWO: 37.1;HUVEC TERT2: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 173.4"	"Lineage enriched"	"Detected in many"	113	"granulocytes: 173.4"									CAB025635	Enhanced									"CAB025635: "	"unprognostic (2.63e-1)"	"unprognostic (4.49e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.74e-3)"	"unprognostic (4.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.54e-2)"	5.5	1.5	1.9	14.0	3.6	12.6	2.0	1.4	3.9	2.9	1.5	0.7	0.1	1.2	1.5	1.2	1.4	3.7	13.5	5.6	1.9	1.1	2.8	3.2	13.7	28.4	9.2	0.0	2.4	2.1	2.5	4.5	12.8	3.1	2.7	1.8	1.7	1.7	0.8	2.3	0.8	2.2	1.9	4.4	26.4	1.8	1.4	2.3	0.8	4.4	0.5	0.9	5.2	1.9	0.0	0.3	173.4	1.5	0.0	0.0	0.4	0.4	1.4	0.5	2.4	0.0	0.3	37.1	1.5	0.0	0.1	0.1	0.0	1.4	0.1	0.7	1.4	0.2	0.1	0.1	0.1	2.5	0.5	0.1	0.3	1.1	3.6	0.2	1.0	4.1	0.3	0.7	0.3	30.9	0.0	0.0	0.2	1.0	0.0	0.9	1.6	0.0	0.1	0.1	0.0	5.9	0.1	0.0	0.0	0.1	0.2	0.7	5.1	0.2	6.5	0.6	1.2	1.4	0.1	1.5	0.8	0.0	2.2	0.3	0.9	2.7	1.5	25.4	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	173.4	0.0	1.1	0.0	0.0	0.4	1.9	3.6	1.4	3.9	1.9	1.1	9.2	0.0	3.1	2.3
NFE4	NF-E4	ENSG00000230257	"Nuclear factor, erythroid 4"		7	102973437-102988856	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"blood: 20.8;placenta: 15.7"	"Group enriched"	"Detected in some"	4	"BEWO: 23.0;HUVEC TERT2: 28.3"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	48	"eosinophil: 9.1;neutrophil: 20.8"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 20.8"																				"unprognostic (6.56e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.40e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.47e-2)"		"unprognostic (4.97e-2)"		"unprognostic (2.19e-2)"	"unprognostic (7.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.36e-9)"	"unprognostic (1.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.71e-3)"	0.2	1.9	0.2	0.4	0.2	2.6	0.2	0.2	2.2	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.5	0.0	0.4	0.6	0.2		0.2	0.2	1.2	0.6	0.2	0.2	1.1	0.6	0.0	0.2	15.7	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.7	0.2	0.2	0.2	2.5	0.1	1.5	0.2	0.2	1.5	2.9	0.2	0.2	0.2	0.1	0.1	20.8	0.1	0.0	0.3	0.0	0.2	0.2	0.7	0.2	0.0	0.0	23.0	0.2	0.0	0.0	0.0	1.1	0.6	0.6	0.3	0.0	0.3	0.0	0.0	0.1	0.1	1.4	5.6	4.1	0.1	0.3	2.0	0.3	0.2	0.0	0.8	0.0	28.3	2.5	0.3	0.6	0.3	1.0	1.7	0.2	0.3	0.9	0.5	0.2	0.0	0.5	0.9	0.3	0.2	0.4	0.0	0.5	0.6	0.3	1.0	2.8	1.4	0.2	0.7	5.8	0.3	1.8	6.0	0.6	0.0	0.1	9.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	20.8	0.0	0.1	0.1	0.0	0.0										
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137526-139067	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"blood: 4.5;pancreas: 3.6"	"Group enriched"	"Detected in some"	18	"PC-3: 1.4;U-266/70: 2.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Group enriched"	"Detected in some"	18	"basophil: 2.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"														"Secreted - unknown location"															"unprognostic (4.65e-2)"								0.0	0.0		0.7		0.6	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.6			0.0	0.0	0.1	0.0			0.0	3.6	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.5										
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 48.4;bone marrow: 40.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.4;HMC-1: 66.0;NB-4: 21.1;U-937: 18.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 48.4"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	6.8	1.6	1.9	4.1	2.3	40.9	5.6	1.1	1.5	2.6	4.9			1.8	4.2	2.2	1.1	2.1	2.7	3.7	2.1	1.5	2.7	1.7	5.2	2.9	1.8		1.8	1.0	0.8	1.3	6.3		3.6	1.1		1.2	1.7	2.8	1.9	3.2	3.6	2.3	4.1	3.2	0.9			3.0		2.7	4.5	1.4	0.0	2.5	48.4	2.1	0.5	3.0	1.0	8.6	2.3	1.1	5.5	3.9	2.8	6.1	14.1	6.2	4.7	2.3	0.1	0.3	0.0	0.3	27.4	0.8	3.2	0.3	4.3	0.0	1.9	0.3	0.4	0.6	5.7	3.2	66.0	1.5	0.1	1.4	0.5	4.7	1.3	0.1	5.2	0.1	0.1	21.1	2.5	0.0	0.9	2.5	0.0	0.8	0.0	0.1	12.9	5.7	0.0	5.0	0.1	9.9	0.9	3.7	3.3	2.2	0.0	2.1	2.1	0.0	0.0	18.3	5.7	48.4	2.1	21.6	1.8	1.4	1.8	0.0	1.8	1.5	0.6	0.0	3.0	2.7	10.2	0.5	1.8	2.5	1.1	1.0										
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 70.7;lung: 26.3"	"Cell line enriched"	"Detected in single"	38	"HMC-1: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 70.7"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"					"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.7	0.2	0.3	8.5	0.8	4.0	0.3	0.2	0.7	0.2	0.4	0.3	0.1	2.1	0.2	0.7	0.4	0.6	1.2	0.6	0.3	0.3	0.4	1.1	26.3	5.9	0.4	0.1	0.5	0.3	0.0	0.3	1.7	0.7	0.6	0.5	0.7	6.2	0.1	0.9	0.2	3.2	0.7	0.6	8.1	0.4	0.8	0.3	0.8	0.5	0.9	3.4	2.6	0.4	0.0	0.7	70.7	8.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	3.2	69.6	0.0	7.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	70.7	0.0	8.0	0.0	0.0	0.9	0.3	0.8	0.2	0.7	0.3	0.3	0.4	0.1	0.7	0.3
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 5.4;bone marrow: 4.8;testis: 3.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.0;MCF7: 4.3;NB-4: 2.7;THP-1: 2.5;U-937: 4.0"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"eosinophil: 5.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043553	Uncertain									"HPA043553: AB_10964566"	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.8	0.0	4.8	0.7	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	3.8			0.0		0.7	0.1	0.0	0.1	0.6	5.4	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	2.7	0.4	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.0	0.0	1.9	0.1	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.1	0.4	0.0	0.1										
HIST2H2AA4	H2A/r	ENSG00000272196	"Histone cluster 2 H2A family member a4"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 164.8;lymphoid tissue: 101.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8;U-266/70: 66.9;U-266/84: 59.4"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Cell type enriched"	"Detected in all"	5	"neutrophil: 164.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 164.8"									HPA041189	Supported									"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				4.5	6.5	0.0	9.8	1.2	9.0	2.5	0.3	2.6	5.2	5.7	1.5	2.5	5.7	5.5	3.4	9.1	2.4	4.2	4.0	0.7		3.0	2.5	8.8	7.1	0.1	0.0	4.3	5.0	0.0	0.5	6.5	1.6	9.5	0.0	2.1	4.2	2.6	3.5	5.8	5.4	0.9	0.8	8.4	4.2	21.6	0.1	101.1	1.9	4.8	11.5	5.8	2.3	9.3	17.2	164.8	17.9	3.5	4.2	18.8	3.8	9.6	1.2	2.2	0.0	1.2	3.1	8.1	0.0	0.0	0.0	6.4	3.9	0.0	9.1	0.0	5.2	0.0	0.0	0.0	5.2	12.6	1.2	7.9	4.3	0.0	1.1	7.4	0.0	0.0	0.0	0.0	0.0	8.2	19.3	0.0	24.3	4.1	1.2	3.6	10.0	3.7	1.5	6.6	0.0	2.0	9.7	4.1	26.8	7.4	2.1	12.7	2.6	0.0	2.7	20.5	3.7	1.0	66.9	59.4	4.5	0.0	6.1	3.1	24.2	17.9	32.8	3.2	10.5	3.3	5.9	2.8	3.0	12.0	9.3	2.2	2.0	164.8	3.5	12.4	17.2	4.2	18.8										
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 38.9;MOLT-4: 70.8;NB-4: 36.9;REH: 43.7;THP-1: 61.8;U-937: 33.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favourable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favourable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.2	1.8	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	24.8	0.1	0.0	0.0	38.9	19.6	0.0	0.0	0.1	0.0	0.0	20.1	3.7	0.2	2.0	70.8	36.9	0.2	0.3	43.7	1.0	6.0	0.0	0.2	1.9	1.2	0.0	1.9	0.0	1.4	61.8	0.0	0.0	0.3	1.4	0.4	4.7	1.2	12.0	0.0	33.7	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862855	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 75.8;lymphoid tissue: 22.1"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;HMC-1: 37.4;NB-4: 7.4;U-937: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 75.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 75.8"					"Not detected"	"Not detected"														"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.9	0.4	0.5	3.3	0.5	8.6	0.6	0.3	0.7	0.9	3.1	0.4	1.6	2.8	1.4	0.7	1.0	0.7	1.7	2.0	0.5	0.5	0.7	4.1	5.3	7.4	1.7	0.0	1.6	0.5	0.0	0.5	1.8	1.1	1.6	1.2	1.0	1.6	0.9	1.1	0.5	6.0	2.6	1.5	22.1	0.8	2.8	0.6	0.7	0.6	0.0	4.0	1.5	0.8	0.0	7.9	75.8	13.2	14.0	14.8	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	3.4	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	14.9	0.0	75.8	8.2	20.1	14.8	11.2	7.3	0.0	0.8	8.1	7.9	0.0	1.1	7.8	0.6	14.0	13.2	0.4	0.0	11.3	0.5	0.5	0.3	0.7	0.5	0.5	1.7	0.0	1.1	0.6
SMIM27	"C9orf133, TOPORS-AS1"	ENSG00000235453	"Small integral membrane protein 27"		9	32551144-32568621	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in many"	6	"blood: 102.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 102.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 102.4"																				"prognostic favourable (4.18e-5)"	"prognostic favourable (6.11e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.74e-3)"	"unprognostic (8.58e-2)"	"prognostic favourable (8.39e-4)"	"prognostic favourable (7.33e-5)"	"unprognostic (1.30e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (7.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-3)"	4.0	6.9	5.0	4.3	12.2	7.9	5.6	4.8	11.0	4.0	4.0	2.4	4.4	4.8	2.2	7.8	2.3	4.0	2.1	8.6	5.1		6.2	3.9	5.6	8.8	5.7	5.8	3.7	11.5	3.7	5.5	2.1	8.9	4.4	1.6	4.0	5.9	4.6	13.8	2.1	3.9	4.5	11.4	6.6	5.1	16.2	6.1	4.5	2.8	4.7	4.1	2.6	0.0	18.4	8.4	102.4	7.6	13.3	22.0	9.9	7.1	4.0	7.4	6.7	3.2	10.0	4.1	3.8	5.5	2.9	5.9	1.0	1.9	5.5	5.5	5.4	2.9	5.0	3.3	4.2	10.7	11.3	27.1	12.3	9.0	7.5	6.6	4.7	7.3	5.3	2.8	6.7	6.6	3.8	14.0	5.2	5.4	11.7	27.4	9.2	7.8	6.1	3.5	9.7	6.7	3.7	5.6	6.9	8.9	3.5	4.5	2.8	5.8	3.8	2.0	5.5	2.7	3.6	15.6	11.9	19.4	12.4	4.1	1.8	13.6	7.3	47.4	12.7	7.2	16.9	17.6	18.3	14.7	6.1	18.4	22.0	19.0	102.4	13.3	7.6	8.4	18.3	9.9										
AC106774.10		ENSG00000284552			5	17486231-17486829	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"blood: 12.2"	"Cell line enriched"	"Detected in single"	10	"U-937: 8.3"									"Cell type enriched"	"Detected in single"	122	"neutrophil: 12.2"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.2"																																					0.0	0.0		1.5		0.7	0.0		0.0	0.0	0.0			0.0	0.0	2.6	0.0	0.2	0.8	0.0			0.0	0.0	0.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		1.2	0.0	0.0			0.0		0.0	0.0		0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0										
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 35.2;WM-115: 9.0"	"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA044988: AB_2679171, HPA077883: AB_2732362"									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"				"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	14.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.2	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell line enriched"	"Detected in single"	166	"HEL: 37.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced					94000000	94000000			"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet alpha subunit"	P07359	17	4932297-4935030	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.8"	"Cell line enriched"	"Detected in some"	24	"HEL: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	7	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					2000000000	2000000000			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.7	0.1	0.4	15.8	1.2	5.3	0.7	1.9	0.7	0.7	1.0	0.2	0.2	1.5	0.6	0.7	5.7	0.8	0.3	4.2	0.5	0.4	1.0	1.6	3.5	37.8	0.4	0.2	0.7	0.4	0.0	0.4	1.1	0.4	0.7	0.6	0.3	7.7	0.2	3.0	4.6	3.7	0.2	0.4	13.0	0.9	0.6	0.2	2.0	0.8	0.8	17.6	0.9	1.1	0.0	0.3	7.5	0.2	0.0	0.2	3.6	0.0	1.3	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.1	1.2	0.4	0.0	1.3	0.0	0.0	0.0	0.4	1.0	39.3	0.5	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.3	0.2	0.1	0.2	0.6	0.3	0.2	0.0	0.7	0.0	0.2	0.5	0.0	0.2	1.6	0.7	0.1	0.2	0.2	0.8	0.1	0.7	0.2	0.9	0.6	0.6	0.4	7.5	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.3	0.0	3.6	0.4	1.2	1.9	0.4	0.5	0.4	0.4	0.2	0.4	0.2
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.6;HL-60: 19.9;NB-4: 39.2;U-937: 42.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	19.9	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	42.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 9.2;lymphoid tissue: 24.4"	"Cell line enriched"	"Detected in some"	4	"AF22: 20.5"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Low region specificity"	"Detected in many"							HPA014053	Uncertain									"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.8	1.0	2.2	3.4	2.3	0.0	0.1	0.8	9.2	0.1	0.9	0.4	0.1	0.6	3.1	0.1	1.2	0.7	0.6	0.5	2.7	7.3	0.6	2.5	1.5	24.4	6.9	0.5	0.6	0.4	0.0	0.1	2.9	1.7	0.1	1.0	0.1	3.4	0.1	0.6	0.1	0.9	2.2	7.3	2.6	0.1	0.2	0.1	2.2	0.2	2.1	1.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	2.3	0.8	3.7	2.7	7.3	6.9	0.5	1.7	0.1
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 53.5;bone marrow: 39.4"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 3.9;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	15	"eosinophil: 53.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 53.5"									HPA059365			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0.0	0.5	0.2	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4.0	7.2	0.6	0.0	0.2	1.1	0.1	8.7	2.0	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3.0	0.4	0.0	0.1	0.8	0.0	0.0	0.0	53.5	3.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	53.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	2.1	0.7	0.2	0.0	0.5	0.7	0.2	0.6	0.0	0.2	0.3
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959462-27968096	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in all"	10	"eosinophil: 47.1;neutrophil: 24.3"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favourable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	2.6	2.3	2.8	4.2	3.8	10.3	1.8	8.3	1.8	2.3	2.5			4.1	3.3	2.9	2.4	3.2	2.9	3.2	2.8	1.9	3.3	8.6	3.1	3.0	3.0		3.6	8.7	3.5	2.4	7.8		3.5	2.4		5.6	3.7	2.9	2.0	3.1	3.5	4.9	5.6	4.7	1.6			3.5		2.4	2.8	2.4	1.3	2.6	47.1	2.5	2.8	3.0	1.9	4.5	2.4	2.9	2.9	3.3	6.1	7.5	6.8	7.4	8.6	8.9	6.5	3.6	0.0	5.6	7.5	2.5	5.5	3.2	3.1	7.4	9.8	6.0	2.0	4.4	5.3	0.0	0.0	6.5	5.4	9.4	2.6	8.5	0.0	1.8	4.9	2.2	3.3	2.2	13.7	5.6	5.3	0.0	3.2	5.6	2.4	2.1	0.0	2.0	2.7	0.1	2.0	4.6	3.6	6.9	0.2	12.9	2.2	7.2	6.9	0.7	17.1	0.0	0.3	3.5	2.5	47.1	3.0	2.4	2.9	1.3	3.0	2.6	2.6	1.3	2.6	2.6	24.3	2.8	1.7	1.2	2.9	1.9										
OR11G2		ENSG00000196832	"Olfactory receptor family 11 subfamily G member 2"	Q8NGC1	14	20190894-20201075	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	5	"blood: 5.9"	"Cell line enriched"	"Detected in single"	14	"HEL: 7.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	6	"neutrophil: 5.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.9"																																					0.4	0.2	0.1	0.4	0.1	1.0	0.1	0.1	0.2	0.3	0.1			0.4	0.3	0.6	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1		0.2	0.4	0.0	0.1	0.2		0.2	0.0		0.5	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.2	1.2			0.4		0.0	0.2	0.1	0.3	0.2	5.9	0.3	0.4	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	7.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.8	0.3	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	5.9	0.4	0.2	0.2	0.0	0.0										
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.5;HaCaT: 21.8;RH-30: 14.4;RPTEC TERT1: 20.2;U-2 OS: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.5	2.1	0.2	0.1	0.0	8.2	0.9	0.3	0.6	0.2	21.8	1.1	0.6	0.1	0.2	1.9	2.8	1.6	0.7	0.4	0.8	1.3	2.9	0.2	0.5	0.2	4.5	3.2	1.0	1.5	5.1	3.2	4.9	10.6	0.9	0.6	14.4	0.8	20.2	1.2	0.2	0.2	3.3	0.7	0.2	1.2	3.5	3.5	0.7	31.5	1.8	0.9	0.2	0.1	0.4	2.4	1.2	12.0	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: , HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.5	0.6	4.5	3.0	0.3	7.7	4.0	5.9	5.2	0.3	2.2	0.4	0.6	4.4	1.3	0.1	0.5	4.6	1.2	0.9	0.4	1.5	0.0	6.6	0.2	1.7	5.4	0.0	7.6	1.9	3.3	1.2	2.3	0.8	0.9	3.1	3.7	0.4	1.0	0.3	1.1	0.7	2.8	0.4	2.6	7.2	4.1	3.5	0.3	1.3	9.6	1.4	1.5	0.0	11.2	2.0	31.4	1.0	1.3	5.2	0.3	3.3	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in some"	11	"neutrophil: 20.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.9"									"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	0.5	0.8		0.1		0.0	2.8		1.4	1.6	0.6			0.3	1.5	0.8	1.4	1.8	0.1	1.8			1.5	0.5	0.9	0.5			3.5	1.1	2.4		0.1		1.8	0.7		1.6	1.4	1.9	4.5	0.0	0.9		1.1	0.6	1.2			2.1		0.9	0.9		1.3	0.4	20.9	0.5	1.8	1.4	0.1	2.7	4.7	4.6	8.7	4.7	5.7	3.5	2.2	4.0	3.0	3.4	0.4	2.1	6.4	2.4	2.1	7.5	3.7	4.3	3.3	0.2	2.3	1.0	3.9	1.0	5.2	3.9	2.3	4.5	9.7	2.9	4.3	5.9	1.2	1.3	3.9	1.6	3.2	2.0	3.9	8.1	0.3	7.4	2.3	3.3	7.2	6.7	4.0	3.4	1.9	3.4	2.7	10.2	1.3	3.9	5.1	3.5	2.6	0.8	3.7	1.5	1.8	1.4	4.1	0.5	0.5	1.5	0.6	0.4	0.1	0.6	0.9	0.8	0.2	1.3	1.4	0.7	20.9	1.8	0.4	0.4	0.5	0.1										
FAM9C	TEX39C	ENSG00000187268	"Family with sequence similarity 9 member C"	Q8IZT9	X	13035618-13044682	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 29.8;testis: 12.0"	"Cell line enriched"	"Detected in some"	55	"AN3-CA: 63.6"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.0"																				"unprognostic (2.28e-1)"				"unprognostic (7.35e-2)"			"unprognostic (1.90e-1)"		"unprognostic (1.66e-1)"	"unprognostic (3.35e-2)"		"unprognostic (2.06e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"		0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.3	0.0	2.0	0.0	0.1	0.0	0.1	29.8	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	63.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.6	0.0	0.2	0.5	0.0	0.0	0.3	0.3	0.1	0.5	0.0	0.2	0.4	0.2	0.3	0.2	0.2	1.1	0.2	0.1	0.3	0.4	0.2	0.1	0.3	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770526	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 128.2;lymphoid tissue: 32.2"	"Cell line enriched"	"Detected in some"	18	"U-937: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 128.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 128.2"									HPA029154	Approved									"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	7.9	1.1	0.6	30.7	2.1	8.7	0.8	0.4	1.9	0.6	0.8	0.8	0.0	0.4	0.6	0.2	1.0	2.6	3.3	5.0	1.9	0.6	1.3	2.4	17.3	32.2	2.8	0.0	1.6	1.1	0.0	1.1	4.4	2.3	0.6	0.1	1.1	1.0	0.0	1.1	0.4	1.1	3.3	3.0	29.1	1.2	2.5	1.6	0.8	1.0	0.9	0.3	4.4	2.2	0.0	1.7	128.2	12.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.8	25.4	0.0	0.4	12.7	0.6	0.0	11.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	128.2	0.0	7.5	0.3	0.0	3.9	0.6	2.1	0.4	1.9	1.9	0.6	2.8	0.0	2.3	1.6
HIST1H4A	H4FA	ENSG00000278637	"Histone cluster 1 H4 family member a"	P62805	6	26021679-26021990	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 87.7"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.6;NB-4: 9.9;REH: 12.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	4	"neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.0"									"CAB021887, HPA042201"	Supported					30000000	30000000			"CAB021887: AB_2279758, HPA042201: "	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.5	0.5	0.0	5.2	0.0	7.1	2.1	16.7	3.2	0.6	1.5	0.0	0.0	5.2	1.5	1.8	3.7	0.3	1.2	3.2	0.0		0.5	0.1	2.0	3.5	0.0	1.8	1.4	0.8	0.1	0.0	0.8	0.2	0.4	1.0	1.6	0.8	1.0	0.8	0.9	1.1	3.6	0.1	2.5	0.7	2.6	0.0	87.7	2.5	3.6	9.6	2.0	0.0	0.8	0.9	14.0	1.0	1.2	1.4	0.2	3.7	1.7	3.5	0.0	0.8	0.0	0.0	0.3	1.3	1.6	2.3	0.0	5.6	2.6	0.9	0.0	4.9	2.6	0.0	0.5	0.4	1.8	2.5	1.5	0.0	0.0	0.6	6.0	0.0	0.0	0.5	0.0	1.6	1.3	4.1	0.0	1.5	13.6	9.9	2.3	0.0	12.4	2.2	2.2	0.0	0.4	4.2	1.8	1.6	6.1	0.1	3.2	2.7	0.0	3.0	7.7	3.0	3.0	1.5	2.4	0.0	1.4	4.1	5.8	0.0	1.0	3.4	1.3	0.8	0.2	0.4	1.1	0.3	0.9	0.8	0.4	0.3	14.0	1.2	0.2	0.4	1.4	0.2										
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"					"CAB026008: , HPA052485: "		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.7	0.0	0.0	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell line enriched"	"Detected in some"	8	"Daudi: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"					"Low region specificity"	"Detected in single"									270000	270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938210-1943326	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 195.6;liver: 94.8;pancreas: 107.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 85.8;neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 195.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB008650: AB_1619225, HPA043463: , HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	7.9	4.0	5.2	9.0	6.3	27.3	5.1	3.2	6.1	5.2	13.1	5.6	7.5	8.7	7.9	13.5	16.9	9.6	13.5	13.7	4.7	4.1	24.9	94.8	9.6	15.6	5.5	4.1	7.3	107.2	2.9	3.9	11.6	4.1	11.0	5.1	6.2	4.7	9.4	20.5	8.0	17.0	14.3	4.3	18.2	9.6	8.1	3.6	3.7	5.5	19.8	4.5	14.8	4.8	1.7	10.9	195.6	26.2	2.4	2.8	12.2	6.6	17.0	6.3	14.9	11.8	5.2	10.8	8.3	10.4	12.1	10.5	27.2	7.4	6.5	27.1	9.5	11.0	10.5	7.2	3.8	36.3	11.9	5.0	6.3	43.4	10.8	14.1	11.9	9.6	6.4	8.7	1.7	12.1	7.8	3.6	6.4	36.8	7.9	23.2	8.6	9.7	11.6	8.7	30.5	18.9	11.2	6.1	8.1	9.3	10.4	5.0	11.3	25.1	7.2	3.7	10.2	7.2	4.8	9.6	15.2	12.4	3.8	13.4	6.4	26.0	26.2	85.8	2.2	12.0	2.1	1.7	1.8	1.8	10.9	1.7	1.4	1.6	195.6	2.4	10.7	4.6	2.8	12.2	5.2	6.3	3.2	6.1	4.7	4.1	5.5	4.1	4.1	3.6
MTRNR2L12		ENSG00000269028	"MT-RNR2-like 12"	P0DMP1	3	96617188-96618236	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"blood: 603.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 487.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 603.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 603.3"														"Secreted to blood"						"unprognostic (3.79e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.81e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.85e-2)"	18.0	29.1	32.5	5.2	31.0	4.5	7.5	8.8	19.2	5.1	20.2	6.4	5.7	8.1	5.1	75.3	10.9	3.8	40.2	114.2	26.3	19.8	32.9	29.8	5.4	7.8	26.2	7.5	4.9	9.7	4.3	6.6	5.0	10.4	6.9	16.5	6.8	10.8	9.3	101.3	10.6	9.3	6.9	15.3	5.3	13.3	9.7	8.7	72.1	5.1	11.0	5.3	6.0	8.5	69.1	53.1	603.3	81.8	37.9	45.5	57.6	97.6	120.2	90.1	323.3	140.0	75.5	82.8	127.4	26.1	24.5	31.8	66.0	157.9	215.4	103.8	48.0	270.1	6.3	53.8	33.6	63.0	116.3	228.1	487.9	278.0	53.3	45.2	126.3	136.6	64.5	25.8	70.9	27.3	161.6	74.3	83.3	51.1	39.0	142.9	26.2	36.3	62.5	86.6	66.4	147.3	72.7	41.1	80.1	82.9	84.4	109.3	86.7	132.1	120.8	101.7	84.5	113.6	36.0	39.5	24.7	107.0	63.0	285.2	27.4	183.7	81.8	153.2	28.1	44.0	37.0	65.7	35.7	29.9	31.2	69.1	45.5	40.8	603.3	37.9	42.3	53.1	31.4	57.6	32.5	31.0	8.8	19.0	26.3	19.8	26.2	7.5	10.4	8.7
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 86.9;NB-4: 30.8;REH: 15.8;RPMI-8226: 30.6;THP-1: 29.0;U-937: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB010146: AB_627989, HPA036156: , HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.2	0.0	0.0	0.0	2.6	86.9	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	30.8	0.0	0.0	15.8	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	16.1	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 117.8"	"Cell line enhanced"	"Detected in some"		"HEL: 26.8;HL-60: 15.5;NB-4: 16.1;THP-1: 12.7;U-937: 44.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 117.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 117.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011070	Uncertain									"HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.4	0.8	1.4	15.5	2.7	8.5	1.0	0.6	1.2	1.8	1.4	1.6	0.4	1.8	1.3	2.2	3.3	1.2	3.1	1.1	1.5	1.7	1.6	1.0	7.2	19.4	4.5	0.9	0.7	1.2	0.0	1.5	0.8	4.4	2.6	2.0	1.4	2.3	0.4	0.5	0.9	8.2	2.4	5.9	25.8	1.7	0.8	3.2	5.2	1.1	0.5	23.5	5.1	1.2	12.0	25.4	117.8	8.2	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	15.5	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.6	0.0	12.3	8.2	117.8	0.0	5.7	0.0	12.0	0.0	0.0	9.4	11.9	0.0	0.0	10.1	0.1	6.6	25.4	0.0	3.4	1.4	2.7	0.6	1.2	1.5	1.7	4.5	0.9	4.4	3.2
CEACAM4	CGM7	ENSG00000105352	"Carcinoembryonic antigen related cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2"	"Cell line enriched"	"Detected in some"	6	"U-937: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 41.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 41.5"																				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	1.8	0.5	0.2	5.5	0.5	22.5	0.5	0.1	1.0	0.4	0.5	0.1	0.2	0.4	0.4	3.3	1.0	1.0	1.6	3.4	0.9	0.3	2.2	1.2	6.4	30.2	1.7	0.1	0.5	1.5	0.0	0.7	1.1	0.9	0.9	0.3	1.6	0.9	0.2	0.3	0.3	1.4	1.2	1.2	27.5	0.8	0.6	0.3	1.0	0.4	0.0	1.4	0.9	0.5	0.1	7.9	41.5	10.3	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	10.3	1.8	0.0	7.5	0.0	0.1	0.4	0.0	7.9	0.0	0.2	0.0	41.5	0.0	3.2	0.0	3.5	3.5	0.2	0.5	0.1	1.0	0.9	0.3	1.7	0.1	0.9	0.3
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.2;Hep G2: 21.9;NB-4: 14.6;THP-1: 8.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"						"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	21.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098466	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 72.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.9;NB-4: 2.6;THP-1: 4.1;U-937: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	720	"basophil: 72.0"	"Lineage enriched"	"Detected in single"	720	"granulocytes: 72.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059967	Enhanced									"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	4.9	0.5	0.4	5.1	0.4	0.2	2.1	0.4	0.4	11.9	4.6	0.1	4.5	4.7	14.3	11.2	5.9	1.1	14.6	2.1	0.4	0.4	1.5	0.9	12.9	0.5	0.4	0.1	1.1	1.2	0.2	0.6	0.6	0.1	17.5	5.6	4.5	3.2	5.4	1.5	4.3	7.4	15.9	0.4	0.6	4.5	2.7	0.2	1.2	0.6	6.7	3.4	5.1	4.1	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	6.9	0.4	0.2	0.3	0.8	0.4	0.1	0.1	0.0	0.1	0.1	0.9	0.3	0.0	0.1	0.0	2.6	0.1	0.1	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.1	0.2	0.0	0.3	4.1	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.2	1.8	0.2	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.2
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 63.0"	"Cell line enriched"	"Detected in some"	45	"HMC-1: 57.4"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	42	"eosinophil: 63.0"	"Lineage enriched"	"Detected in single"	623	"granulocytes: 63.0"									HPA012556	Uncertain		Uncertain	Cytosol				Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.6	6.7	5.8	2.4	8.4	0.7	2.3	0.7	7.0	1.4	2.9	7.4	0.0	2.9	1.0	1.1	1.1	1.1	2.7	0.3	8.6	4.8	0.4	1.6	4.1	9.6	8.3	3.6	0.3	0.7	0.7	1.2	0.1	7.5	1.0	2.8	0.1	1.1	0.9	0.3	0.8	4.5	1.5	14.8	9.2	2.1	0.5	6.2	0.6	0.7	0.0	4.1	2.0	0.7	0.0	0.0	63.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.5	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.8	8.4	0.7	5.6	8.6	4.8	8.3	3.6	7.5	6.2
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase"	Q8TCT1	17	49223362-49230766	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 80.0;testis: 52.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;EFO-21: 6.2;HDLM-2: 6.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 10.2;pons and medulla: 8.2"	"Group enriched"	"Detected in some"	171	"eosinophil: 30.6;neutrophil: 80.0"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 80.0"	"Low region specificity"	"Detected in all"							HPA065025			Approved	"Plasma membrane,Actin filaments"				"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1.0	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1.0	1.7	1.3	1.0	0.9	2.5	2.0	2.1	1.5	1.1	1.0	0.1	0.8	7.6	8.2	0.9	0.0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0.0	0.8	0.1	0.1	1.4	1.3	0.0	0.0	80.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	2.1	0.1	0.2	0.0	0.3	0.4	0.0	0.2	2.9	0.0	9.2	6.2	0.0	0.0	1.7	0.5	0.1	6.5	0.2	1.2	1.2	0.4	0.0	0.0	1.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.4	0.0	1.7	1.8	3.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.2	3.7	0.5	3.0	2.0	0.0	0.3	0.3	0.6	2.7	3.5	0.3	0.0	0.1	30.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.0	0.0	0.3	0.0	0.0	0.1	1.1	1.9	1.0	10.2	1.7	1.3	2.1	1.5	8.2	0.1
PRSS41	TESSP1	ENSG00000215148	"Serine protease 41"	Q7RTY9	16	2798485-2805302	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 11.6;testis: 4.0"	"Cell line enriched"	"Detected in single"	11	"BEWO: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"					"Cell type enriched"	"Detected in single"	116	"eosinophil: 11.6"	"Lineage enriched"	"Detected in single"	116	"granulocytes: 11.6"																						"unprognostic (1.58e-1)"	"unprognostic (3.65e-1)"		"unprognostic (3.04e-3)"				"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"			"unprognostic (1.69e-1)"	"unprognostic (1.98e-1)"		"unprognostic (1.24e-2)"	0.0	0.0		0.1		0.0	0.1		0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0		0.0	1.2	4.0			0.0		0.0	0.0		0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162845-218166995	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 144.6"	"Cell line enriched"	"Detected in single"	26	"HMC-1: 11.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	16	"neutrophil: 144.6"	"Lineage enriched"	"Detected in many"	59	"granulocytes: 144.6"	"Not detected"	"Not detected"							HPA031991	Uncertain									"HPA031991: AB_2674103"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.85e-2)"	11.5	0.4	0.8	21.1	0.7	7.3	0.6	0.9	2.6	0.6	0.6	0.2	0.0	0.0	0.5	0.1	1.3	2.8	3.6	3.8	0.9	0.6	0.7	2.9	20.3	33.4	5.9	0.0	1.7	1.2	0.0	0.8	2.1	2.3	0.9	0.1	1.4	0.6	0.0	1.0	0.5	0.6	1.4	3.4	33.7	1.0	1.4	0.7	0.1	0.9	0.6	0.4	4.5	4.1	0.0	0.0	144.6	0.2	0.1	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.2	2.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.9	144.6	0.1	0.2	0.0	0.0	0.7	0.8	0.7	0.9	2.6	0.9	0.6	5.9	0.0	2.3	0.7
OR6K6		ENSG00000180433	"Olfactory receptor family 6 subfamily K member 6"	Q8NGW6	1	158754720-158755891	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"blood: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	57	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	57	"granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADORA3	AD026	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503760	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 88.6;brain: 25.5"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 47.5"									"Cell type enriched"	"Detected in some"	40	"eosinophil: 88.6"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 88.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																															5.2	13.4	8.7	3.1	12.0	0.0	4.5	1.0	6.7	3.7	5.2	10.3	0.0	3.5	0.5	1.0	1.8	2.8	4.8	1.6	7.5		1.9	2.1	2.8	3.8	17.7	2.2	1.2	1.0	0.9	1.2	2.0	12.1	1.0	4.2	2.7	1.1	1.9	0.5	0.0	7.9	3.8	25.5	1.5	2.2	1.1	13.3	0.4	0.5	0.0	1.9	3.4	0.0	0.0	2.2	88.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	88.6	0.0	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.3										
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;hTCEpi: 2.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"														"Secreted to blood"						"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2
OR52N2		ENSG00000180988	"Olfactory receptor family 52 subfamily N member 2"	Q8NGI0	11	5820314-5821348	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 7.0;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;SK-BR-3: 1.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	29	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 7.0"																											"unprognostic (3.45e-1)"		"unprognostic (2.81e-1)"	"unprognostic (3.44e-1)"				"unprognostic (7.82e-2)"			0.7	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.1			0.0	0.2	0.3	0.1	0.7	0.9	0.3	0.1	0.0	0.3	0.0	0.3	0.3	0.0		0.3	0.1	0.0	0.3	0.0		0.2	0.0		0.2	0.5	0.2	0.7	0.8	0.0	0.1	1.1	0.0	2.9			0.0		0.5	0.1	0.1	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0										
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: "	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	2.9	1.7	0.9	0.9	0.9	0.5	1.1	2.9	1.1	2.0	1.6	2.4	1.8	1.1	5.6	1.0	2.2	1.2	1.2	1.0	2.6	1.0	0.9	2.7	4.1	1.1	1.4	3.7	12.3	0.7	0.8	0.5	0.7	16.6	9.3	3.8	3.3	3.1	3.0	0.9	5.4	1.4	1.3	6.9	3.4	0.7	4.2	1.3	32.9	2.5	1.1	14.0	1.3	2.4	2.4	23.0	1.5	1.2	19.0	23.3	5.5	1.0	3.6	1.6	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5
HIST1H2AC	H2AFL	ENSG00000180573	"Histone cluster 1 H2A family member c"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 116.1;lymphoid tissue: 202.5"	"Cell line enhanced"	"Detected in many"		"HSkMC: 31.7;SiHa: 27.2;U-2 OS: 27.4;U-266/84: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 116.1"	"Lineage enriched"	"Detected in all"	17	"granulocytes: 116.1"					"Low region specificity"	"Detected in all"			HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	13.6	14.5	13.6	22.5	16.4	19.0	29.9	7.3	9.8	35.6	21.0	12.2	17.9	18.1	13.2	32.8	27.5	23.6	13.9	12.6	18.5	12.4	21.4	34.1	29.2	28.5	18.6	8.5	23.8	15.7	3.7	13.4	26.2	8.5	37.2	15.0	21.1	10.4	17.0	17.5	15.4	21.6	14.4	27.0	26.4	26.9	16.3	10.4	202.5	24.5	9.2	34.9	29.6	25.8	6.6	4.5	116.1	3.6	1.9	2.1	48.3	5.6	1.6	1.9	0.6	16.2	8.9	0.8	2.8	1.8	8.6	7.4	2.1	1.4	0.2	14.0	5.6	6.7	1.6	2.9	6.2	5.3	0.9	0.9	0.7	0.3	12.8	0.9	6.5	31.7	5.0	1.8	5.6	0.5	14.0	10.3	3.8	4.6	0.9	1.0	2.3	0.5	0.6	1.0	16.5	8.2	0.6	3.0	1.2	27.2	5.8	8.8	13.2	1.4	1.9	5.3	27.4	2.3	1.2	13.4	27.2	1.5	1.9	14.2	2.2	36.0	2.0	24.4	1.4	1.5	1.2	3.3	1.5	1.0	1.4	6.6	2.1	1.1	116.1	1.9	3.6	4.5	2.0	48.3	13.6	16.4	7.3	9.8	18.5	12.4	18.6	8.5	8.5	10.4
AP000790.4		ENSG00000285010			11	59964033-59970146	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"blood: 5.9;kidney: 1.5"	"Group enriched"	"Detected in some"	5	"HEL: 2.8;K-562: 7.1"									"Cell type enriched"	"Detected in single"	10	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.9"														"Secreted - unknown location"																							0.0	0.1		0.4		0.2	0.0		0.7	0.2	0.2			0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.5	0.0	0.0	0.0			0.5	0.0	0.0		0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.8			0.0		0.0	0.0		0.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	2.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MTRNR2L11		ENSG00000270188	"MT-RNR2-like 11"	S4R3Y5	1	237943724-237945275	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 64.8;skeletal muscle: 46.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 65.5;Hep G2: 41.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 64.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 64.8"														"Secreted to blood"										"unprognostic (1.07e-1)"					"unprognostic (9.70e-2)"			"unprognostic (4.49e-2)"	"unprognostic (5.26e-2)"				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2.0	7.0	1.4	3.7	2.9	2.0	3.1	2.0	2.0	0.2	12.4	4.2	2.3	11.1	7.2	3.0	2.8	2.2	2.6	2.0	3.3	0.0	2.0	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2.0	3.5	0.7	3.3	2.0	4.3	4.0	3.0	0.8	2.0	7.4	0.3	2.0	2.0	5.9	3.4	64.8	7.0	2.9	3.1	8.2	7.0	16.5	7.7	21.7	6.6	1.7	6.2	11.7	0.9	0.6	0.9	6.9	10.2	12.0	7.5	2.3	21.4	0.2	1.5	0.6	5.2	11.6	12.1	65.5	41.9	2.2	3.3	9.7	6.7	2.3	0.8	2.9	0.9	8.4	7.2	2.0	6.0	3.3	11.5	2.0	3.0	6.4	6.2	4.9	4.5	9.7	2.9	5.2	4.6	5.4	8.6	6.6	10.6	19.0	8.8	6.2	7.0	3.3	5.5	1.8	4.9	4.8	11.8	2.1	14.8	7.0	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2.0	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3.0
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921209-112975122	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 46.7;lymphoid tissue: 21.2"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 46.7;eosinophil: 12.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 46.7"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	1500000	1500000	"Plasma membrane"		"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	3.6	1.6	1.0	9.5	1.4	1.8	3.8	0.8	1.4	5.0	3.5	0.3	1.5	2.0	3.9	5.4	7.5	1.3	2.7	5.8	1.0	1.2	1.4	3.4	4.3	9.0	1.0	0.0	1.0	1.1	0.5	1.0	7.8	0.4	4.2	3.5	2.4	2.5	1.6	0.9	3.4	3.3	1.7	0.9	21.2	1.7	2.5	0.5	15.8	2.0	3.9	17.0	3.8	2.0	2.3	5.8	46.7	0.8	0.6	3.7	1.3	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.2	25.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.0	46.7	0.8	12.7	1.0	0.4	1.8	2.3	3.7	2.1	5.8	1.2	3.6	1.7	0.2	0.6	0.1	0.1	1.0	1.3	1.0	1.4	0.8	1.4	1.0	1.2	1.0	0.0	0.4	0.5
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7"	"Group enriched"	"Detected in some"	18	"BEWO: 34.1;NB-4: 9.2;THP-1: 22.4;U-937: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 167.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 167.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"					"CAB017116: , HPA048086: "	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	8.5	1.5	2.9	39.5	3.2	88.9	2.4	0.7	2.9	1.1	1.1	4.2	0.4	0.6	0.7	1.1	1.2	6.9	4.3	5.6	2.6	2.0	1.7	4.5	26.9	27.5	7.2	1.1	1.1	1.3	0.3	1.1	152.7	3.8	1.3	0.5	2.1	1.6	0.5	0.6	0.3	1.6	3.1	7.1	71.4	2.2	1.4	3.3	1.1	1.0	0.4	0.9	4.6	3.9	0.0	8.2	167.3	22.1	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.6	0.0	0.0	22.1	0.6	0.0	4.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	167.3	0.2	1.8	0.2	0.0	10.3	2.9	3.2	0.7	2.9	2.6	2.0	7.2	1.1	3.8	3.3
MTRNR2L1		ENSG00000256618	"MT-RNR2-like 1"	P0CJ68	17	22523111-22524663	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	4	"blood: 249.5"	"Cell line enhanced"	"Detected in all"		"HeLa: 184.9;Hep G2: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 249.5"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 249.5"														"Secreted to blood"						"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.82e-3)"	"prognostic favourable (8.99e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.21e-3)"	9.4	16.2	7.9	3.7	10.0	2.3	3.0	4.0	8.4	2.5	8.9	3.3	4.8	4.5	2.6	6.8	4.8	2.6	3.3	34.3	8.1	6.1	17.8	12.8	4.2	5.6	8.9	3.0	4.1	15.0	1.5	3.4	2.5	4.6	3.5	7.7	3.3	5.9	5.0	55.5	5.3	5.2	7.5	5.9	3.3	5.6	4.4	4.0	1.8	2.7	6.8	1.8	3.3	2.6	29.4	21.6	249.5	34.3	15.0	18.3	28.7	20.2	47.2	18.2	61.2	28.9	11.9	23.1	19.1	4.5	4.4	5.1	28.9	32.8	27.5	20.9	9.8	53.9	1.3	6.9	5.5	16.1	33.8	25.2	184.9	127.1	9.4	5.9	30.3	26.7	14.8	4.9	12.0	4.7	20.4	16.9	13.2	16.4	9.1	40.4	5.2	10.6	15.0	11.5	14.3	25.1	28.9	9.7	17.2	9.2	17.5	28.1	16.4	42.1	9.1	24.3	20.6	29.0	11.8	15.7	5.0	13.0	13.9	37.2	5.3	74.4	34.3	62.1	10.9	16.7	13.5	28.7	13.9	11.8	12.1	29.4	18.3	15.9	249.5	15.0	16.1	21.6	12.1	28.7	7.9	10.0	4.0	6.8	8.1	6.1	8.9	3.0	4.6	4.0
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060767-129062406	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 8.8;neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced					68000000	68000000			"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.2	0.1	0.1	0.1	0.1	10.0	0.1	0.0	0.6	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.1	5.0	0.8	0.1	0.1	0.4	4.8	0.0	0.8	0.2	0.5	0.1	0.0	0.3	1.5	0.4	0.1	0.4	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	24.5	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.6	3.0	0.1	1.5	8.8	0.6	0.0	0.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	7.5	0.0	0.0	1.5	0.0	27.1	0.1	0.1	0.0	0.6	0.8	0.1	0.8	0.2	0.4	0.0
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell line enhanced"	"Detected in many"		"K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: "	"unprognostic (4.02e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.7	4.7	1.4	1.3	7.1	0.5	1.8	2.1	1.2	8.3	3.6	4.0	2.2	0.6	6.7	2.2	2.7	2.0	1.8	4.6	4.4	3.5	1.1	5.3	0.2	0.6	0.4	3.0	3.4	0.2	1.7	0.8	0.4	41.2	24.3	2.2	2.0	1.7	2.4	1.7	4.4	0.9	1.2	3.7	1.0	1.4	9.2	1.0	37.1	2.5	1.0	0.1	1.5	1.0	2.1	41.1	1.6	0.9	35.0	43.1	9.9	0.5	11.6	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301121	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	4	"HEL: 83.6;K-562: 36.2;NB-4: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 119.7;neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 119.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	2.3	0.3	0.9	3.5	1.5	54.3	0.5	0.4	1.7	0.9	0.4	0.2	0.0	0.5	0.4	0.4	0.7	2.0	0.9	7.8	1.5	0.4	0.9	2.6	9.6	20.9	5.2	0.2	1.2	0.6	1.2	0.8	15.9	1.2	1.0	0.3	1.2	0.5	0.2	1.0	2.9	0.5	1.1	1.0	32.2	0.7	0.9	0.7	1.8	1.7	0.2	0.5	1.2	8.1	0.0	15.2	119.7	23.1	0.0	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.1	0.2	1.1	2.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	83.6	0.2	1.9	0.0	1.2	11.0	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	3.3	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	4.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	119.7	23.1	21.7	0.0	6.4	0.1	0.0	0.0	0.0	15.2	0.0	0.1	0.0	80.0	0.0	3.8	0.2	0.0	12.9	0.9	1.5	0.4	1.7	1.5	0.4	5.2	0.2	1.2	0.7
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: "	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.4	41.2	13.4	20.7	28.7	17.7	21.6	32.6	23.3	20.4	27.4	27.0	29.5	11.8	48.8	22.0	25.5	15.5	18.7	25.4	30.2	19.5	15.1	23.6	28.4	28.0	17.1	18.6	27.0	16.0	26.2	22.3	21.6	19.8	20.9	21.0	56.4	15.9	9.0	15.1	21.3	8.8	23.5	24.3	25.2	23.9	9.6	21.9	18.6	15.8	21.6	32.8	14.7	30.4	27.4	26.2	21.7	26.9	32.4	37.2	16.4	30.2	10.5	27.6	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 79.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	79.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Group enriched"	"Detected in some"	73	"HEL: 27.8;HMC-1: 110.6"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"					"Not detected"	"Not detected"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol				Cytosol		"HPA027507: AB_10600756, HPA027510: "	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066326-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 70.1;fallopian tube: 18.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 41.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	196	"basophil: 31.4;eosinophil: 70.1"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 70.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	92000	92000				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.5	0.2	6.7	0.6	6.2	0.7	1.3	0.2	0.3	1.8	0.9	1.8	0.0	2.2	0.6	8.2	0.6	18.6	2.0	2.4	2.3	2.1	0.6	1.3	7.9	1.2	0.1	0.0	3.8	0.5	0.1	7.5	0.1	11.8	2.6	1.4	0.5	2.2	0.1	0.3	0.4	2.1	0.6	0.6	4.6	1.3	1.6	0.7	1.1	0.4	1.1	1.9	4.2	0.4	0.1	0.0	70.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.4	0.0	70.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	6.7	6.2	0.2	0.3	2.3	2.1	0.1	0.0	11.8	0.7
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 78.9;EFO-21: 201.6;RPTEC TERT1: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"														"Secreted to blood"						"prognostic favourable (7.83e-4)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.1	78.9	1.9	2.0	0.0	1.4	0.0	201.6	0.1	4.0	0.0	0.3	10.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	14.2	1.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	72.8	1.7	0.0	0.0	0.1	0.0	3.9	0.0	0.1	18.2	0.0	0.6	3.9	0.1	0.0	0.1	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 45.9;TIME: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 20.4"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047992			Supported	Nucleoplasm,Vesicles		69000	69000	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	37.3	3.1	4.1	4.4	6.3	1.1	27.5	3.0	7.7	16.2	8.4	1.5	5.2	3.1	14.5	9.4	14.4	6.8	9.1	17.2	5.1	4.2	6.9	11.1	24.1	4.9	5.8	1.9	8.2	2.5	3.4	2.7	17.4	6.6	8.8	5.3	8.3	4.0	3.7	14.2	4.8	5.5	10.8	5.4	39.4	4.6	7.7	5.2	0.6	12.5	11.0	2.8	17.0	12.3	0.1	0.0	20.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	45.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.2	0.2	0.5	0.0	0.4	0.0	5.7	0.0	0.0	0.0	0.4	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	4.1	6.3	3.0	7.7	5.1	4.2	5.8	1.9	6.6	5.2
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630902-4642294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9;blood: 89.8;lung: 24.4"	"Group enriched"	"Detected in some"	7	"HMC-1: 16.1;MCF7: 14.0;T-47d: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	183	"eosinophil: 89.8"	"Lineage enriched"	"Detected in single"	183	"granulocytes: 89.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved									"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3.0	0.2	0.0	6.3	1.5	0.4	0.3	0.9	0.2	1.0	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1.0	1.4	0.4	2.0	0.2	0.2	0.4	1.9	0.2	0.0	0.4	89.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	0.0	0.3	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017968	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3"	"Group enriched"	"Detected in some"	4	"HEL: 12.6;THP-1: 26.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	173	"eosinophil: 50.3"	"Lineage enriched"	"Detected in single"	173	"granulocytes: 50.3"									HPA042015	Uncertain				"Secreted to blood"	57000	57000			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	5.8	0.5	0.0	13.1	0.0	2.1	3.7	0.0	0.5	2.1	2.0	0.0	1.0	0.0	1.8	3.0	1.3	1.5	2.2	4.6	0.0		3.0	5.9	7.9	8.0	0.3	0.0	1.2	0.0	0.0	0.5	1.5	0.2	1.7	7.2	0.7	0.0	1.1	0.5	0.4	1.0	8.4	0.0	2.0	0.0	0.1	0.0	0.4	1.1	0.6	0.5	3.0	0.0	0.2	0.1	50.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.2	50.3	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0										
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 65.1;skin 1: 31.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.7;Hep G2: 4.4;HSkMC: 4.2;NTERA-2: 9.3;U-138 MG: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.76e-3)"	"prognostic favourable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	3.3	10.8	13.4	3.3	13.1	0.6	5.3	5.4	17.7	3.8	2.7	2.7	2.7	4.6	2.2	1.8	10.1	2.8	4.9	3.4	8.6	6.6	2.6	1.6	7.6	5.6	3.9	9.5	1.6	1.5	1.5	5.5	0.9	4.8	2.6	2.2	9.8	6.7	3.4	3.4	31.9	5.1	2.3	1.7	65.1	1.9	2.7	3.0	0.3	2.3	5.0	4.3	3.7	6.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.4	3.7	0.4	0.2	3.3	0.3	0.3	0.7	0.1	0.0	0.5	0.5	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.0	4.4	1.6	0.0	2.8	4.2	0.2	0.4	0.0	0.8	0.0	0.0	1.1	0.0	0.1	0.1	9.3	0.0	0.2	3.1	0.0	0.0	0.0	0.3	0.8	0.2	0.3	0.1	0.0	0.0	0.0	6.1	0.3	0.3	0.4	0.4	0.0	0.0	0.7	1.8	0.1	1.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.1	5.4	17.7	8.6	6.6	3.9	9.5	4.8	3.0
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	7300000	7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein like 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;esophagus: 9.5"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;AF22: 15.1;TIME: 9.5;WM-115: 25.2"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	22	"neutrophil: 10.6"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.6"									HPA047731	Uncertain				"Intracellular and membrane"					"HPA047731: AB_2680137"	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.9	0.1	1.2	0.3	4.8	1.0	2.6	0.4	2.5	0.8	2.4			0.6	0.2	0.2	9.5	1.6	1.1	4.1	1.2	1.3	1.1	0.0	0.8	0.0	0.8		0.0	0.0	0.0	0.3	1.7		1.6	1.4		2.8	1.7	0.0	8.3	1.0	2.5	1.1	2.4	0.1	1.9			1.3		0.3	0.5	1.9	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.7	12.4	15.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	3.1	1.2	2.9	0.0	0.0	1.1	0.0	3.3	0.3	0.1	0.1	0.0	0.4	2.8	0.0	1.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	2.6	3.8	0.0	0.4	3.4	0.3	0.5	1.4	0.5	4.4	0.0	2.4	0.0	2.1	9.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0										
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836497-73849064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 16.8;EFO-21: 40.5;HUVEC TERT2: 26.4;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	107	"neutrophil: 10.7"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.7"														"Secreted to blood"						"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	3.5	0.1	0.1	5.7	0.2	0.5	0.3	0.1	0.2	7.4	3.7	0.0	1.7	3.1	0.1	0.9	1.6	1.7	16.3	2.7	0.5	0.1	4.4	4.6	8.9	0.9	0.3	0.3	0.7	9.4	0.0	0.2	0.0	1.3	3.5	0.1	0.3	2.4	4.7	0.1	0.1	5.2	0.0	0.5	59.6	0.3	1.4	0.0	1.4	0.1	0.6	2.2	13.7	3.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.4	0.0	0.9	16.8	0.1	0.2	0.0	0.0	0.0	40.5	0.0	3.4	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	8.5	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	31.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.3	0.3	1.3	0.0
CNTNAP3B		ENSG00000154529	"Contactin associated protein like 3B"	Q96NU0	9	41890314-42129510	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 18.1;AF22: 25.9;WM-115: 17.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	9	"neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"									HPA047731	Uncertain									"HPA047731: AB_2680137"	"unprognostic (2.68e-2)"	"unprognostic (9.63e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.78e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-4)"	4.1	0.6	1.1	0.3	2.2	0.0	4.7	0.5	2.2	1.5	1.1			0.4	1.3	0.0	7.3	1.9	1.3	2.5	1.3	1.4	4.9	1.0	2.1	0.0	0.9		0.4	0.3	0.0	1.2	2.4		1.0	1.7		1.9	1.1	0.7	6.5	0.6	1.9	0.9	1.6	0.5	1.1			0.8		0.1	2.0	1.4	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	18.1	25.9	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	2.2	1.5	1.4	0.0	0.0	0.9	0.0	3.2	1.6	0.5	0.9	0.0	2.0	2.1	0.2	0.3	4.2	0.4	0.1	0.0	0.1	0.0	0.0	2.5	5.5	0.0	0.4	7.0	0.8	0.5	1.9	0.2	0.7	0.0	3.5	0.0	2.5	4.5	0.1	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.8	17.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0										
OXER1	"GPCR, GPR170, TG1019"	ENSG00000162881	"Oxoeicosanoid receptor 1"	Q8TDS5	2	42762481-42764261	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.9;liver: 26.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.8;Hep G2: 9.8;HMC-1: 8.4;REH: 4.2;THP-1: 3.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 17.4;eosinophil: 42.9"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 42.9"									HPA051433	Uncertain									"HPA051433: AB_2681485"	"unprognostic (6.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.46e-2)"	8.2	0.7	0.7	1.2	0.7	2.0	0.9	0.7	1.5	1.9	2.1	0.7	0.7	4.9	1.7	2.9	1.1	1.4	1.1	2.0	1.5	0.3	4.1	26.9	9.1	4.1	0.7	0.7	5.4	3.8	0.4	2.0	2.7	1.3	3.4	1.6	3.3	3.4	1.7	2.1	2.9	8.3	0.7	0.7	6.4	1.6	1.1	2.7	3.8	1.6	2.2	1.6	2.5	4.8	0.0	0.4	42.9	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	8.8	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.2	0.0	0.5	2.9	0.0	9.8	0.1	0.2	8.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.9	0.0	4.2	1.4	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	17.4	0.5	42.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.7	1.5	1.5	0.3	0.7	0.7	1.3	2.7
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.2;Hep G2: 39.1;hTCEpi: 43.6;RT4: 80.0;SK-BR-3: 44.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"									HPA019502	Enhanced		Supported	"Nuclear bodies"		1200000	1200000	"Nuclear bodies"		"HPA019502: AB_1856530"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	5.0	3.2	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	6.2	0.0	0.0	0.0	2.4	0.0	0.1	3.6	39.1	0.0	2.3	0.1	0.0	43.6	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.5	0.0	5.7	0.0	0.0	0.0	0.0	80.0	0.0	0.0	7.3	44.8	0.0	1.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4										
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451264-6556494	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.1	2.4	17.9	1.2	18.8	0.5	1.7	18.7	23.0	2.4	4.5	0.7	3.4	1.5	1.9	3.4	9.4	4.3	3.8	0.8	7.2	5.2	1.5	1.6	3.1	0.6	2.9	11.9	24.2	0.9	1.9	0.7	0.6	2.5	2.7	3.6	2.3	1.9	8.3	1.1	14.3	1.4	3.8	0.9	43.3	3.2	2.4	1.5	0.0	2.4	0.7	2.1	1.3	2.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.4	0.5	0.4	0.2	0.0	0.1	0.4	0.4	0.1	0.5	0.3	0.3	3.9	0.1	2.1	0.1	11.1	0.2	2.3	0.2	0.2	0.4	0.1	8.6	0.1	0.6	0.2	0.3	0.1	32.3	0.6	1.8	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.6	1.6	0.1	1.2	0.0	0.8	0.1	0.3	0.3	5.0	2.4	0.1	0.8	0.0	0.2	0.3	2.1	0.4	1.3	0.3	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	17.9	18.8	18.7	23.0	7.2	5.2	2.9	11.9	2.5	1.5
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Group enriched"	"Detected in some"	13	"HEL: 69.4;HMC-1: 118.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		1100000000	1100000000	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10670151, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	69.4	0.0	0.6	0.0	0.0	118.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.4	1.5	2.2	1.6	4.9	2.4	8.2	3.8	2.2	1.9	1.3	4.9	2.7	2.0	2.0	1.5	12.3	4.2	7.7	2.0	1.1	5.0	4.1	4.4	4.8	16.4	4.9	4.1	2.8	13.0	4.3	20.0	2.4	7.1	7.9	1.2	2.8	2.4	9.9	0.6	2.5	1.1	2.2	4.9	2.5	4.1	7.1	3.0	5.1	6.8	2.7	1.0	2.9	9.4	2.7	0.7	2.9	3.6	5.4	9.1	0.7	2.8	8.7	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771656-71785206	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 82.6;bone marrow: 42.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.8;NB-4: 7.6;NTERA-2: 5.4;U-266/70: 12.1;U-266/84: 19.7;U-937: 8.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	49	"neutrophil: 82.6"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 82.6"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3"	"Region enhanced"	"Detected in many"		"olfactory region: 11.4"	HPA041408	Approved				"Secreted to blood"					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	5.7	0.2	0.8	12.6	0.9	42.8	0.3	0.5	2.1	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.5	2.7	0.9	9.0	0.8	0.8	0.5	2.0	10.7	21.9	3.7	0.0	0.7	0.7	0.0	0.5	2.2	0.8	0.8	0.1	0.9	0.2	0.0	0.6	0.2	0.7	1.0	1.3	20.8	0.6	22.1	1.1	0.4	1.4	0.1	0.3	2.0	4.3	0.0	0.1	82.6	1.6	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	7.6	5.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	19.7	0.0	0.0	8.1	0.0	0.0	1.6	0.6	0.7	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.2	1.1	82.6	0.0	0.0	0.0	0.3	0.5	0.8	0.9	0.5	2.1	0.8	0.8	3.7	0.0	0.8	1.1
FFAR2	"FFA2R, GPR43"	ENSG00000126262	"Free fatty acid receptor 2"	O15552	19	35443907-35451767	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;lymphoid tissue: 22.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.8;SK-BR-3: 2.5;THP-1: 2.8;U-937: 3.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Region enhanced"	"Detected in many"		"midbrain: 7.0"	"Group enriched"	"Detected in some"	27	"eosinophil: 18.9;neutrophil: 60.2"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 60.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023985	Approved									"HPA023985: "	"unprognostic (7.75e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.17e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-2)"	4.3	0.3	1.1	16.5	0.8	16.7	9.2	0.3	1.8	0.4	1.6	0.2	0.0	3.0	0.5	0.9	1.5	1.3	1.2	1.4	0.9	0.3	0.5	1.6	8.9	15.2	7.0	0.5	0.8	0.4	0.3	0.3	1.9	1.3	1.1	0.5	0.8	0.7	0.0	0.3	0.8	4.1	1.0	1.2	22.9	1.0	0.9	0.3	0.8	0.6	1.2	0.7	2.3	4.6	0.0	0.2	60.2	1.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.3	0.1	8.8	0.2	0.3	0.1	0.0	0.0	0.2	0.4	0.0	1.8	0.0	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.1	0.0	2.5	0.1	0.3	2.8	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	3.5	0.0	0.6	0.4	18.9	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	60.2	0.0	1.4	0.0	0.0	0.1	1.1	0.8	0.3	1.8	0.9	0.3	7.0	0.5	1.3	0.3
NCBP2L		ENSG00000170935	"Nuclear cap binding protein subunit 2 like"	A6PVI3	X	107774899-107795829	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 8.7;testis: 6.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;MCF7: 1.4;SK-BR-3: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	39	"basophil: 8.7"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 8.7"					"Low region specificity"	"Detected in single"			HPA010664	Uncertain									"HPA010664: AB_1079451"	"unprognostic (3.22e-1)"				"unprognostic (8.00e-2)"						"unprognostic (5.64e-2)"	"unprognostic (7.29e-2)"				"unprognostic (2.64e-1)"		0.0	3.1	0.3	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.0			0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.0	0.2		1.9	1.6	0.0	0.1	0.0		0.3	0.0		0.9	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	6.4			0.0		0.0	0.0	0.0	0.2	0.0	8.7	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4										
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660306	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.9"	"Cell line enriched"	"Detected in some"	17	"Daudi: 33.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	35	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 9.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA044952	Uncertain									"HPA044952: AB_10964914"	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	2.2	0.1	0.1	46.9	0.6	0.2	1.3	0.1	0.1	2.4	4.2	0.0	1.1	2.2	1.5	1.3	1.3	0.4	3.5	0.4	0.1	0.4	0.5	0.2	3.6	31.7	0.2	0.0	0.2	0.7	0.0	0.8	0.0	0.1	3.9	1.0	0.5	1.4	1.6	0.3	1.9	11.9	2.9	0.2	1.2	1.9	0.7	0.0	0.6	0.6	1.7	22.9	1.4	1.8	0.2	0.1	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853189-73854155	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;lymphoid tissue: 27.8"	"Cell line enhanced"	"Detected in some"		"BJ: 2.7;CAPAN-2: 3.5;EFO-21: 5.5;HHSteC: 2.2;HSkMC: 3.4;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	28	"basophil: 9.1;neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.2"									HPA052485	Supported				"Secreted to blood"	1400000000	1400000000			"HPA052485: AB_2681847"		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.3	0.2	0.1	0.9	0.4	2.8	0.6	0.2	0.5	0.8	0.7	0.0	0.7	4.8	0.1	1.1	0.6	0.5	0.5	8.7	0.4	0.6	2.0	1.9	2.6	0.9	0.4	0.3	7.4	0.4	0.1	0.4	2.0	1.2	1.0	0.7	0.2	1.5	4.0	0.1	0.2	3.2	0.0	0.6	27.8	0.2	0.3	0.0	0.1	0.2	1.1	0.2	5.0	1.0	0.1	0.3	11.2	0.2	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.7	0.6	0.3	2.7	0.4	0.0	0.0	0.0	3.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.2	0.0	0.1	0.3	0.0	12.6	0.1	0.4	0.2	0.5	0.4	0.6	0.4	0.3	1.2	0.0
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Cell line enriched"	"Detected in some"	19	"HDLM-2: 100.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	21000000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.6	0.0	0.1	0.0	100.0	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219505-44234151	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	25	"eosinophil: 117.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved									"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	42.9	40.9	5.8	9.4	9.6	17.9	57.2	10.4	15.2	21.2	35.8	5.9	6.9	5.2	19.8	11.7	22.8	14.9	24.4	46.8	5.4	6.4	14.7	23.2	15.3	14.4	5.5	8.4	12.5	35.8	8.7	15.2	23.2	9.8	21.4	7.4	18.0	15.7	8.4	53.0	23.8	12.4	39.0	5.3	11.4	33.0	8.8	4.8	53.9	18.8	17.2	11.1	28.7	20.7	0.5	4.7	117.2	4.5	0.3	0.9	0.7	16.5	16.5	11.8	18.9	18.1	1.7	70.4	12.2	4.8	17.1	11.7	17.9	6.8	33.6	12.3	3.6	20.6	21.0	14.7	10.3	19.1	19.3	29.0	11.4	23.3	2.9	32.6	28.1	2.2	3.7	25.1	8.8	42.8	39.2	19.9	9.3	18.2	26.9	21.9	17.9	11.0	18.0	23.8	40.7	9.9	9.7	15.2	19.6	3.5	11.9	8.6	16.1	20.7	64.8	9.4	15.4	12.7	23.1	13.6	17.6	42.9	5.7	26.7	11.3	1.8	1.4	117.2	0.6	4.5	0.4	0.5	0.3	0.4	0.8	0.3	0.1	0.3	0.2	0.3	3.6	4.7	0.9	0.7	5.8	9.6	10.4	15.2	5.4	6.4	5.5	8.4	9.8	4.8
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.0;HaCaT: 8.3;HMC-1: 17.0;MCF7: 8.6"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.6	1.4	10.0	0.4	0.1	1.9	6.0	1.0	1.1	0.8	1.4	0.2	0.6	6.0	8.3	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.0	1.0	7.2	0.3	0.2	0.6	0.4	0.1	0.7	8.6	0.0	0.3	0.6	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.3;HEL: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: "	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.3	1.2	1.8	1.0	1.5	8.3	1.8	1.2	1.6	1.3	2.6	2.2	0.0	4.0	2.6	3.0	1.4	0.0	2.9	1.0	1.4	11.5	1.4	0.6	1.3	0.9	1.4	2.7	1.2	1.3	0.2	1.2	2.7	0.2	4.1	0.5	1.1	1.0	2.2	0.3	0.0	1.8	0.1	2.7	0.8	2.0	1.3	1.3	2.4	2.5	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724047-246768137	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 95.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	17	"basophil: 95.3"	"Lineage enriched"	"Detected in all"	22	"granulocytes: 95.3"	"Low region specificity"	"Detected in all"							"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		2100000	2100000	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	14.1	25.8	15.7	6.4	17.5	13.4	11.3	11.3	20.5	10.9	11.7	24.7	8.5	15.1	12.0	8.5	4.8	14.4	9.7	15.8	15.6	19.8	23.0	67.3	9.3	7.3	26.1	15.0	10.6	12.7	15.0	12.7	14.1	21.7	18.1	12.2	7.3	7.4	16.7	23.9	10.7	15.3	10.8	62.1	5.1	12.4	65.1	17.5	8.5	18.2	7.3	4.8	25.0	13.2	1.4	2.3	95.3	3.2	4.2	3.0	2.1	12.8	12.6	9.2	5.5	11.0	14.0	0.1	10.1	14.1	17.1	14.3	7.7	36.3	6.8	13.3	11.6	4.2	7.8	3.0	17.6	9.5	2.8	11.6	11.5	15.3	10.4	22.5	10.0	9.3	1.4	11.5	1.2	18.3	14.4	0.0	17.0	3.1	23.4	28.6	13.8	10.0	19.7	11.8	0.0	52.5	30.4	10.5	11.8	13.7	0.6	8.9	10.2	23.5	11.9	7.9	7.1	19.2	26.0	34.1	11.7	4.1	13.5	30.7	10.4	95.3	3.2	5.5	2.5	2.8	3.0	1.4	0.7	2.1	1.3	1.1	1.0	3.0	0.8	4.2	1.8	2.3	0.5	2.1	15.7	17.5	11.3	20.5	15.6	19.8	26.1	15.0	21.7	17.5
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380048	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.4;HHSteC: 18.9;hTEC/SVTERT24-B: 25.1;SH-SY5Y: 9.9;U-2197: 20.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Approved				"Secreted to blood"	15000	15000			"CAB032719: AB_2204650, HPA050884: "	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (9.16e-5)"	14.0	0.6	4.8	23.7	5.6	5.8	10.3	0.3	3.8	9.4	6.8	0.4	0.2	0.7	2.0	4.0	8.2	2.4	17.9	17.3	6.3	1.9	0.8	1.1	17.3	2.2	9.9	1.2	1.4	1.1	0.7	0.6	1.8	5.6	4.3	2.6	2.2	2.8	1.0	4.7	3.2	2.5	7.8	4.3	3.9	3.8	9.7	5.8	0.7	1.9	6.6	0.5	13.5	2.8	0.0	0.0	50.9	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	7.3	0.0	1.1	30.4	1.1	5.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	18.9	0.0	0.0	9.1	0.0	25.1	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	7.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	1.0	2.1	20.2	0.3	0.0	0.0	0.0	2.2	0.3	1.5	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.9	0.0	0.5	0.0	0.0	0.6	4.8	5.6	0.3	3.8	6.3	1.9	9.9	1.2	5.6	5.8
AC233724.6		ENSG00000249156			5	17610496-17611583	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.1;testis: 1.3"	"Group enriched"	"Detected in some"	7	"HEK 293: 1.7;U-2 OS: 5.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	21	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.1"																																		"unprognostic (2.61e-1)"			0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.7		0.0	0.0	1.3			0.0		0.0	0.3		0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0										
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: , HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.1;U-937: 1.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.3	0.5	0.1	1.1	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.4	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	410000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: , HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	18.9	12.6	4.6	7.6	19.4	22.6	7.5	6.0	34.0	12.2	21.6	7.4	11.5	15.9	14.4	6.7	15.0	8.4	18.1	26.8	9.4	9.1	6.4	5.4	5.8	72.5	12.4	11.9	21.6	20.7	21.8	25.5	38.8	13.4	60.9	14.5	9.9	12.3	5.2	8.8	10.2	5.9	6.5	34.9	11.6	17.8	9.3	5.1	8.4	18.5	21.4	5.9	3.6	33.0	18.2	14.1	26.1	11.0	42.0	23.8	22.8	108.1	14.1	26.9	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Group enriched"	"Detected in many"	6	"MCF7: 13.7;SK-BR-3: 48.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Not detected"	"Not detected"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.8	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	2.1	0.4	0.9	0.7	13.7	0.4	0.9	1.1	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597379-23644708	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 75.4"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026883	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	31000000	31000000	Nucleoplasm		"HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.7	8.1	8.7	4.4	9.2	6.9	19.5	11.6	13.2	7.4	6.5	5.6	5.8	8.7	8.0	5.3	6.6	6.7	6.2	5.7	13.8	8.9	7.6	11.7	6.5	9.3	10.5	3.9	7.4	9.8	12.2	12.6	4.6	11.1	6.0	6.5	5.8	7.5	6.5	10.0	6.6	9.4	6.7	12.9	6.1	6.8	41.3	8.1	5.4	9.9	5.0	8.6	7.0	7.7	3.8	3.0	75.4	3.6	2.9	4.1	2.9	4.8	3.4	7.5	9.5	12.6	7.0	17.2	6.1	6.0	5.2	7.7	3.5	1.6	10.4	9.6	5.1	2.8	3.2	2.9	6.9	2.1	4.3	1.8	1.4	4.5	5.1	4.7	9.2	7.5	8.5	1.7	1.6	7.0	4.1	2.9	6.3	2.2	3.2	5.7	3.5	4.2	2.2	11.8	3.1	5.5	2.2	4.6	8.6	6.3	6.1	4.5	5.1	4.4	8.4	3.1	5.6	7.1	4.8	8.4	8.3	7.4	3.4	6.9	16.8	75.4	3.6	16.4	3.0	3.3	3.7	3.8	3.3	3.5	3.0	3.2	4.1	3.2	6.9	2.9	3.1	0.6	3.6	2.9	8.7	9.2	11.6	13.2	13.8	8.9	10.5	3.9	11.1	8.1
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384254-21385388	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.6;brain: 1.3;lymphoid tissue: 1.1"	"Cell line enriched"	"Detected in single"	11	"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"									HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.1	0.0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	1.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.3	0.4	1.0	0.4	0.6	0.1	0.1	0.1
TRIM64C		ENSG00000214891	"Tripartite motif containing 64C"		11	49053714-49059112	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"blood: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	16	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"									HPA045370	Uncertain									"HPA045370: AB_2679298"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.3		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
A3GALT2	"A3GALT2P, IGB3S, IGBS3S"	ENSG00000184389	"Alpha 1,3-galactosyltransferase 2"	U3KPV4	1	33306766-33321098	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"HeLa: 5.1;SiHa: 3.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (1.86e-2)"	"unprognostic (2.36e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-3)"		"unprognostic (4.96e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-8)"	"unprognostic (1.17e-1)"		"unprognostic (1.12e-2)"	"unprognostic (7.87e-2)"	0.7	0.1	0.1	1.2	0.2	1.3	0.4	1.3	0.9	0.4	0.2			0.0	0.5	0.0	0.2	0.2	1.4	0.1	0.2	0.1	0.4	0.1	0.5	0.1	0.0		0.4	0.1	0.0	0.4	0.1		0.6	0.0		0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.8	0.3	2.1			0.4		0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	5.1	0.0	0.2	0.0	0.0	0.7	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0										
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.5;HaCaT: 16.9;MCF7: 26.0;RT4: 29.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.1	0.0	0.0	26.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	2.1	29.7	0.1	0.0	0.0	2.9	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36312229	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 28.5;skin 1: 25.1"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 28.5;eosinophil: 9.5"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	10	"cerebellum: 0.4"	HPA037853			Uncertain	"Intermediate filaments"				"Intermediate filaments"		"HPA037853: "	"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.8	0.2	0.1	0.5	0.1	3.6	0.5	0.1	0.5	0.3	1.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.5	1.0	1.0	5.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.2	25.1	7.4	0.1	0.8	3.7	1.4	0.8	0.1	0.9	0.1	0.1	0.1	0.1	0.5	0.0	0.9	28.5	1.9	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	20.5	0.0	28.5	1.9	9.5	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.1	0.0	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019254-59026654	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 58.6;lymphoid tissue: 28.2"	"Cell line enriched"	"Detected in some"	19	"HEL: 24.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"basophil: 8.7;neutrophil: 6.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB004286, HPA043640, HPA046280"	Approved					480000000	480000000			"CAB004286: AB_2288090, HPA043640: , HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.6	0.3	0.2	0.4	0.6	12.2	0.2	0.7	0.7	0.2	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.5	0.6	10.8	0.2	0.2	0.2	1.0	8.3	0.4	0.2	0.4	0.8	0.4	0.0	0.7	3.2	0.6	0.3	0.0	0.5	0.2	0.6	0.6	0.2	0.5	0.0	0.6	28.2	0.3	1.8	0.0	0.0	0.5	0.3	0.2	0.4	1.8	0.1	0.6	8.7	0.5	0.0	0.1	58.6	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	24.4	0.6	1.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.1	0.2	0.0	0.2	0.3	0.2	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	8.7	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	6.5	0.0	0.0	0.6	0.1	58.6	0.2	0.6	0.7	0.7	0.2	0.2	0.2	0.4	0.6	0.0
C20orf203	FLJ33706	ENSG00000198547	"Chromosome 20 open reading frame 203"	Q8NBC4	20	32631652-32673941	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;ovary: 2.1"	"Cell line enhanced"	"Detected in some"		"HEL: 7.5;HMC-1: 5.2;NB-4: 2.2;U-266/70: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	13	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 4.2"																				"unprognostic (6.24e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.25e-10)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-5)"	0.1	0.0		0.0		0.3	0.3		1.1	0.2	0.0			0.0	1.0	1.1	0.4	1.1	0.0	0.5			0.0	0.0	0.0	0.4			2.1	0.0	0.0		0.0		0.0	0.0		1.0	0.5	0.0	0.8	0.0	0.0		0.3	0.0	0.3			0.0		0.0	0.0		0.0	0.0	4.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.0	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	2.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0										
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.2;THP-1: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		960000000	960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favourable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.1	6.8	5.0	7.8	48.4	21.1	10.6	7.8	9.9	8.8	9.7	3.8	6.2	15.2	7.6	15.5	14.7	8.4	8.5	9.8	13.2	7.7	12.8	7.3	21.9	5.7	75.2	6.4	11.3	5.9	2.6	1.0	10.6	26.5	6.3	11.1	5.8	15.4	13.4	0.0	16.6	10.9	23.8	12.4	24.1	23.3	2.6	4.0	8.8	14.2	11.6	20.3	62.8	7.5	5.3	5.2	13.2	4.6	5.1	2.9	3.2	10.4	51.8	3.8	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6
CEP19	"C3orf34, MGC14126"	ENSG00000174007	"Centrosomal protein 19"	Q96LK0	3	196706277-196712293	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047614, HPA071138"	Enhanced		Supported	Centrosome				Centrosome		"HPA047614: AB_2680103, HPA071138: AB_2686348"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.51e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.33e-2)"	3.2	5.2	10.2	5.7	11.7	2.4	2.4	7.3	10.8	3.6	2.3	3.0	2.6	2.0	3.3	6.2	3.2	8.0	3.8	2.4	8.4	9.0	5.2	2.3	3.2	5.0	6.5	6.0	3.8	1.4	6.1	9.2	3.9	8.3	3.5	2.2	2.5	2.3	4.4	1.3	3.3	2.0	3.0	4.4	6.1	1.7	17.5	4.4	8.3	5.1	0.4	6.3	4.0	2.6	1.4	3.4	45.3	1.3	2.3	3.5	1.2	5.1	3.6	5.0	3.1	11.6	9.0	1.5	4.2	8.0	4.6	6.0	1.8	3.5	3.9	12.2	2.1	2.3	3.3	1.1	5.5	5.3	3.4	5.9	1.8	0.5	4.7	2.7	7.6	4.1	5.0	6.0	1.6	1.9	3.2	4.8	4.7	2.7	6.6	4.8	2.6	6.1	7.9	3.1	2.7	4.9	0.5	5.0	3.6	5.8	0.8	6.5	4.5	5.2	1.5	5.4	1.2	8.2	2.8	14.8	14.1	8.0	7.6	6.9	5.2	12.9	1.3	17.5	1.8	0.9	2.0	1.1	2.6	2.3	0.8	1.4	3.5	2.2	45.3	2.3	1.0	3.4	1.4	1.2	10.2	11.7	7.3	10.8	8.4	9.0	6.5	6.0	8.3	4.4
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		31000	31000	Cytosol	"Vesicles, Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.7	0.0	0.0	1.8	0.0	0.0	0.0	9.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favourable (4.53e-4)"	"prognostic unfavourable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.6	10.6	2.8	14.5	10.0	10.9	18.8	18.4	11.2	12.4	12.6	9.4	12.0	18.8	35.0	17.6	21.3	9.3	9.4	3.3	12.2	4.4	5.8	14.0	7.4	18.4	6.9	9.5	13.6	10.7	11.6	6.3	8.5	6.5	18.5	8.1	32.8	3.7	6.2	2.2	20.5	6.1	7.6	14.2	9.4	9.2	2.6	4.7	11.6	21.0	4.8	6.8	5.5	11.1	14.9	9.3	34.4	23.2	13.2	12.7	19.4	15.8	14.5	7.6	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7
ST20	HCCS-1	ENSG00000180953	"Suppressor of tumorigenicity 20"	Q9HBF5	15	79898840-79923702	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 69.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 18.6;neutrophil: 69.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 69.3"																				"unprognostic (2.48e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.35e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (7.69e-8)"	"unprognostic (6.49e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.19e-2)"	7.5	5.4	9.9	15.0	10.7	7.9	8.6	15.4	8.0	5.5	8.2	6.4	4.5	4.0	6.5	16.3	6.0	8.3	10.3	9.3	8.8	8.2	12.3	23.1	12.7	13.1	10.8	5.3	7.1	6.2	9.2	12.7	7.7	10.1	13.3	5.4	8.6	11.5	8.4	5.6	12.6	9.8	5.4	10.7	22.9	5.5	10.8	6.1	9.0	12.2	5.7	10.5	5.5	10.1	4.0	3.0	69.3	5.3	3.9	2.1	2.6	4.8	10.3	4.4	5.5	7.6	6.4	9.9	5.0	3.3	2.6	3.3	2.2	7.8	6.1	3.3	3.6	8.2	9.2	2.8	1.9	8.5	8.6	6.8	7.1	3.4	7.2	2.5	3.9	7.1	3.9	1.8	5.4	2.8	5.8	3.6	4.0	15.7	3.5	17.8	10.3	6.9	5.1	1.4	3.7	6.5	4.0	6.5	7.2	9.7	6.1	28.5	5.1	16.4	3.6	6.7	1.8	0.0	4.1	4.1	19.9	9.1	5.2	14.3	3.3	0.5	3.9	18.6	1.9	2.2	1.5	4.0	2.1	2.1	3.0	3.8	2.1	1.9	69.3	3.9	5.3	1.8	1.8	2.6	9.9	10.7	15.4	8.0	8.8	8.2	10.8	5.3	10.1	6.1
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.5	0.7	1.5	7.2	6.8	5.7	5.0	8.6	3.4	4.8	0.2	6.6	1.4	8.9	3.8	1.4	0.0	3.7	0.8	14.5	2.1	2.3	13.4	1.8	5.7	0.3	7.0	8.5	4.0	3.5	0.9	3.6	0.1	10.2	3.7	5.0	3.4	9.8	0.6	8.3	2.1	4.2	9.7	5.1	1.9	7.0	4.6	3.6	4.3	18.1	1.1	2.5	6.5	3.6	3.0	6.4	1.6	8.3	2.7	0.4	8.4	2.9	5.6	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5
AC099489.1		ENSG00000188897			16	11359845-11523588	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 7.2;lymphoid tissue: 9.9;skin 1: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;HDLM-2: 7.0;U-266/70: 3.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"					"Low region specificity"	"Detected in single"			HPA042154	Uncertain									"HPA042154: AB_2677877"	"unprognostic (4.69e-2)"	"unprognostic (3.80e-2)"	"unprognostic (7.24e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.91e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.04e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.72e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.33e-5)"	1.5	0.0	0.3	6.4	0.2	2.0	0.8	0.1	0.1	0.5	0.1			0.0	0.5	0.2	0.1	1.6	0.6	0.7	0.4	0.1	1.1	1.1	2.4	0.9	0.5		0.3	0.5	0.0	0.3	0.3		1.0	0.0		5.0	0.6	1.3	6.2	0.3	0.0	0.5	9.9	0.7	2.8			0.3		0.2	0.7	0.3	0.2	0.0	7.2	0.0	0.0	0.5	0.0	0.1	0.8	0.8	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	6.5	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.5	0.0	0.4	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.5	0.8	0.0	0.2	0.2	2.1	0.7	0.0	0.6	0.3	2.3	0.0	0.4	0.7	0.4	0.0	0.9	0.9	0.0	0.2	0.3	0.1	0.1	0.3	0.0	3.6	0.2	0.2	0.0	0.7	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	7.2	0.0	0.0	0.0	0.1	0.0										
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4"	"Cell line enriched"	"Detected in single"	77	"HDLM-2: 43.7"	"Group enriched"	"Detected in many"	6	"melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 37.2"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 37.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046528	Uncertain									"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.0	11.4	3.4	3.9	4.2	0.7	1.0	1.6	8.0	0.9	1.0	1.1	25.1	2.1	1.3	1.7	0.7	3.4	1.6	11.5	4.1	3.4	1.8	1.0	1.5	4.4	3.3	1.5	5.4	0.5	0.7	2.3	22.6	3.7	3.4	1.1	2.9	0.7	22.4	0.5	1.3	2.5	0.7	2.3	6.9	1.1	1.0	2.9	1.0	1.1	0.5	1.5	1.0	1.2	0.0	0.9	37.2	3.2	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.0	37.2	0.2	3.2	0.0	0.0	0.4	0.0	0.9	0.0	0.5	0.1	0.1	0.4	2.0	0.0	0.3	0.4	3.4	4.2	1.6	8.0	4.1	3.4	3.3	1.5	3.7	2.9
IFITM2	1-8D	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	307631-315272	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 875.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 98.0;HMC-1: 111.9;HSkMC: 121.1;U-937: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 875.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 875.3"									HPA004337	Uncertain									"HPA004337: AB_1851427"	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	101.0	25.2	14.3	95.5	20.9	56.3	143.6	8.2	16.6	70.8	40.2	10.9	14.3	9.5	63.6	46.1	56.0	70.8	28.5	91.1	13.3	10.8	83.0	326.2	141.9	255.5	29.3	3.3	106.5	31.1	68.6	18.9	48.0	21.1	54.3	17.7	39.1	20.1	37.7	72.7	20.1	24.0	63.2	21.7	233.4	28.4	38.5	15.6	12.5	83.4	26.2	35.4	98.0	119.7	27.5	21.6	875.3	74.9	52.8	33.3	47.1	4.1	12.8	35.3	0.2	23.0	66.8	0.1	13.0	25.1	7.4	17.2	0.4	38.1	0.0	31.6	66.2	8.5	0.1	2.2	3.1	0.0	5.3	12.7	14.5	14.1	98.0	20.4	111.9	121.1	0.4	2.1	1.1	24.3	0.5	42.0	5.3	28.4	0.1	74.8	4.3	29.9	14.0	3.7	0.2	68.6	0.0	0.1	0.8	9.6	11.1	3.9	16.1	7.3	63.7	1.1	4.0	5.8	0.2	0.1	0.6	0.6	2.1	86.9	3.9	77.9	19.8	138.8	33.3	53.2	24.6	27.5	30.0	29.4	21.6	24.5	26.0	28.1	875.3	52.8	74.9	9.1	15.8	47.1	14.3	20.9	8.2	16.6	13.3	10.8	29.3	3.3	21.1	15.6
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 93.1"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 93.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favourable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	15.4	11.7	23.3	33.2	19.5	57.7	15.4	12.7	26.6	15.9	16.5	16.3	10.0	17.1	15.3	13.2	33.0	15.7	20.1	12.5	20.2	11.9	18.8	24.1	22.7	43.3	14.8	11.9	19.2	34.9	10.0	16.2	18.5	12.8	17.7	12.6	15.5	24.2	14.5	21.6	22.4	18.0	13.4	10.3	41.1	24.1	8.1	12.5	31.9	14.6	19.6	43.0	20.6	19.0	6.4	2.2	93.1	2.0	1.2	7.7	3.8	17.9	10.5	11.3	15.2	7.2	12.7	18.5	12.2	9.7	12.3	10.9	11.1	15.4	13.0	10.2	13.8	16.4	6.5	14.5	5.6	19.9	13.8	17.9	9.2	19.5	21.6	9.7	31.7	16.9	28.0	8.0	16.8	14.1	33.0	26.6	11.4	32.1	13.9	18.8	14.5	17.3	13.8	5.4	24.7	20.3	18.9	19.9	19.3	10.7	23.8	19.9	20.9	23.6	14.2	22.5	12.5	26.2	12.1	29.6	15.4	19.0	14.4	14.1	19.6	14.6	2.0	16.2	2.5	1.5	3.9	6.4	5.0	3.4	2.2	3.8	4.8	3.3	93.1	1.2	2.0	0.9	7.7	3.8	23.3	19.5	12.7	26.6	20.2	11.9	14.8	11.9	12.8	12.5
TIGD3		ENSG00000173825	"Tigger transposable element derived 3"	Q6B0B8	11	65354767-65357613	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 14.9;brain: 8.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040016			Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA040016: AB_10805600"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.48e-4)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-3)"	0.1	0.7	1.8	0.8	2.7	1.3	3.0	8.6	4.6	0.3	4.1	0.9	0.0	2.6	0.4	0.8	0.4	0.5	0.6	0.4	2.0	1.9	0.8	0.7	1.1	1.1	1.2	0.0	1.0	1.5	1.5	1.9	0.4	3.1	0.5	0.4	1.1	0.5	0.5	0.3	0.2	6.4	0.3	2.0	2.6	1.0	6.9	0.4	3.0	0.4	1.0	0.8	0.6	0.0	0.3	1.2	14.9	1.2	0.1	0.1	0.1	1.3	2.6	2.2	5.9	0.0	0.0	0.8	0.1	0.3	0.6	0.8	2.0	0.3	1.0	1.0	0.2	1.4	2.2	0.1	0.2	1.7	2.3	0.4	1.3	4.6	0.1	0.9	4.4	0.0	0.2	0.3	0.0	0.3	1.4	3.0	0.0	3.4	2.8	1.9	1.3	1.1	4.1	1.0	4.0	0.1	1.3	6.6	4.2	1.7	2.6	1.0	4.2	1.4	0.0	0.2	1.1	1.5	1.0	6.3	4.0	1.3	0.1	1.8	0.6	6.5	0.5	8.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.1	0.0	14.9	0.1	1.2	1.2	0.0	0.1	1.8	2.7	8.6	4.6	2.0	1.9	1.2	0.0	3.1	0.4
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.3;testis: 8.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 5.1"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.2"									HPA024743	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.3	0.3	0.6	3.2	2.1	3.3	1.5	1.6	1.0	0.6	1.0	0.0	0.0	0.4	0.6	0.0	1.3	0.3	0.2	0.3	5.1	0.4	0.7	0.2	0.9	1.1	0.5	0.9	0.6	1.7	0.0	0.6	2.5	0.3	0.4	1.5	0.1	1.1	0.1	0.2	0.5	2.3	1.4	0.7	0.4	0.6	8.3	0.0	8.3	0.3	0.0	2.2	0.4	0.7	0.1	0.1	3.2	0.2	0.2	0.2	0.0	6.5	0.8	4.1	10.3	0.1	0.1	10.7	2.2	0.1	3.1	4.2	6.9	0.4	5.4	4.3	1.2	2.0	11.5	0.6	3.6	0.0	4.0	3.5	1.5	4.2	0.0	0.0	1.3	0.2	0.0	3.5	2.9	1.2	4.7	0.0	3.2	2.6	7.4	3.8	7.6	4.2	4.1	9.4	0.0	0.7	3.6	3.6	6.3	3.3	2.6	1.2	2.9	4.9	0.5	0.5	5.9	3.1	0.0	0.7	1.8	0.1	0.0	0.0	2.2	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	3.2	0.2	0.1	0.1	0.0	0.0	0.6	2.1	1.6	1.0	5.1	0.4	0.5	0.9	0.3	0.0
HIST1H4H	"H4/h, H4FH"	ENSG00000158406	"Histone cluster 1 H4 family member h"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 119.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 6.0;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 17.5"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	6.2	3.6	4.4	10.6	4.4	5.2	23.0	6.4	4.6	7.0	6.6	1.2	5.6	6.5	4.5	6.8	13.9	4.0	5.5	8.3	5.2	5.2	5.2	3.3	5.5	4.1	7.1	2.8	9.4	2.8	1.2	4.0	9.0	2.5	16.7	4.0	3.8	3.9	4.5	30.9	3.7	9.9	7.6	10.9	10.9	3.8	11.0	1.9	119.1	9.5	10.3	23.1	7.3	7.3	1.6	1.1	17.5	1.0	0.2	0.8	4.4	2.4	2.4	0.6	0.3	5.9	0.3	1.5	3.8	0.4	1.1	0.3	2.4	0.7	1.1	6.4	1.0	1.7	0.3	0.4	0.3	3.6	1.1	2.3	4.5	2.3	2.5	0.9	2.0	5.8	0.4	1.2	0.9	2.0	7.2	7.2	2.0	3.0	9.3	6.0	1.1	3.4	6.4	1.4	4.1	0.8	2.5	4.2	0.8	7.7	4.3	2.9	6.3	3.2	0.6	1.4	12.1	1.2	4.2	9.0	36.6	2.2	0.7	8.5	2.0	1.9	0.6	6.0	0.5	1.0	0.3	0.7	0.4	0.6	0.5	1.6	0.4	0.6	17.5	0.2	0.3	1.1	0.8	4.4	4.4	4.4	6.4	4.6	5.2	5.2	7.1	2.8	2.5	1.9
OR52M1	OR52M1P	ENSG00000197790	"Olfactory receptor family 52 subfamily M member 1"	Q8NGK5	11	4545191-4546144	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"blood: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Not detected"	"Not detected"																																			0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
OR8H2		ENSG00000181767	"Olfactory receptor family 8 subfamily H member 2"	Q8N162	11	56103687-56107658	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;bone marrow: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 3.1"																																					0.3	0.1	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.5	0.1			0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.3			0.0		0.0	0.7	0.1	0.2	0.1	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.5	0.0	0.2	0.0	0.1	0.9	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.1	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.9	0.2	0.0	0.1	0.0	0.0										
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.0;HEL: 11.7;RPTEC TERT1: 2.7"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	3500000000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 90.8;TIME: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.7	8.6	15.2	23.3	6.4	7.9	5.4	10.7	9.2	12.6	10.9	11.4	7.7	31.4	21.5	14.7	4.5	6.7	10.4	16.4	5.8	6.1	16.4	6.6	14.8	10.8	3.3	7.7	11.1	4.2	10.5	11.0	90.8	10.0	26.5	17.7	5.9	5.7	4.4	5.5	7.8	4.4	24.4	23.3	21.4	4.7	11.7	9.1	11.8	6.2	6.6	5.2	3.6	56.7	14.3	13.5	7.8	7.6	15.2	11.9	16.5	6.2	3.4	4.2	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffolding protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.8;lung: 16.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.4;HEL: 10.5;HMC-1: 32.0;K-562: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 10.8;neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB034217	Approved					890000	890000			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	3.3	1.7	2.0	13.0	2.2	2.4	1.7	1.3	4.5	1.7	1.4	6.1	0.0	1.8	2.5	0.9	1.4	1.6	3.5	1.6	2.4	1.5	1.6	2.2	16.7	12.1	1.9	3.1	2.4	1.5	0.4	1.3	6.6	3.4	1.4	1.3	2.7	1.8	2.5	1.3	1.5	2.9	1.8	2.9	9.2	1.5	1.1	2.2	4.1	1.3	1.1	4.3	3.0	1.4	0.0	3.4	33.8	1.9	1.4	2.3	1.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.6	0.2	0.1	0.3	0.1	2.2	0.1	0.1	6.4	0.1	0.1	0.0	0.4	0.1	0.1	10.5	0.1	0.6	0.2	0.3	32.0	0.7	0.2	0.1	0.0	0.0	12.9	0.1	0.3	0.1	0.2	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.2	1.9	10.8	0.7	0.4	1.0	0.0	1.2	1.3	3.4	0.0	2.3	2.0	33.8	1.4	0.0	1.2	0.6	1.1	2.0	2.2	1.3	4.5	2.4	1.5	1.9	3.1	3.4	2.2
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 43.1;hTCEpi: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.4	1.7	2.3	37.5	22.0	2.9	34.9	10.2	23.5	9.5	5.9	2.5	0.7	10.2	24.5	0.9	1.6	8.6	11.0	19.1	4.6	0.4	11.9	2.5	43.1	0.2	0.8	21.0	75.3	10.6	17.3	7.3	1.7	13.7	15.1	2.5	1.1	1.0	1.5	1.6	40.5	3.2	6.3	16.7	1.1	7.4	3.1	9.4	16.1	1.2	1.3	0.4	19.2	16.7	8.3	16.2	2.6	2.8	1.6	0.6	14.8	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 49.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB025177	Uncertain				"Secreted to blood"					"CAB025177: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.6	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.3	0.0	0.0	3.9	0.8	0.1	0.1	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	3.0	1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	3.5	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	0.9	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5
MTRNR2L6		ENSG00000270672	"MT-RNR2-like 6"	P0CJ73	7	142666272-142667718	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.7;skeletal muscle: 39.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 49.1;Hep G2: 43.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 81.7"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 81.7"														"Secreted to blood"						"unprognostic (5.34e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.03e-2)"		"unprognostic (2.66e-2)"	"unprognostic (8.07e-3)"	3.4	8.2	1.4	0.8	2.3	0.1	1.1	1.2	5.5	1.1	3.9	1.5	0.8	1.1	1.1	0.8	1.7	1.1	0.8	17.9	6.1	1.4	7.3	4.7	1.1	5.9	2.2	3.9	1.1	2.2	0.0	1.1	0.8	4.5	1.1	2.3	0.8	2.5	0.8	39.1	1.5	2.6	0.8	3.5	1.1	2.2	1.7	1.8	0.8	1.5	0.8	0.8	1.8	1.1	8.4	4.2	81.7	8.2	4.7	3.9	9.5	5.5	9.4	3.2	22.2	3.8	1.9	5.4	5.9	0.5	0.6	1.0	3.1	10.1	4.8	8.1	1.1	19.5	0.1	1.1	0.5	3.0	3.6	6.7	49.1	43.2	1.2	1.4	7.2	3.3	1.4	0.5	1.6	0.5	5.7	7.2	1.7	3.1	2.7	14.9	1.2	1.1	4.4	2.7	3.7	3.8	8.1	2.1	8.0	1.6	3.7	11.3	5.2	9.4	6.8	6.4	6.5	7.7	2.0	2.9	1.3	3.1	3.8	8.5	1.5	20.0	8.2	21.6	2.4	4.9	2.4	8.4	2.9	2.9	4.1	7.7	3.2	3.9	81.7	4.7	4.4	4.2	3.1	9.5	1.4	2.3	1.2	2.9	6.1	1.4	2.2	3.9	4.5	1.8
OR51I2		ENSG00000187918	"Olfactory receptor family 51 subfamily I member 2"	Q9H344	11	5449323-5456518	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.0"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	10	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.3	0.7	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.2		0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.9	24.5	5.4	14.2	9.7	15.3	12.1	17.1	20.7	17.2	18.6	18.3	13.6	17.5	7.2	29.8	15.2	11.1	20.9	17.6	13.0	13.0	5.8	14.8	31.2	18.4	15.3	13.9	22.8	14.9	18.3	16.9	17.5	7.8	17.1	11.4	28.7	15.6	14.1	23.0	15.9	19.9	12.1	34.8	19.1	19.4	10.3	19.5	14.1	31.1	10.2	20.2	13.4	20.3	12.4	14.0	33.4	16.7	21.2	17.7	22.0	10.3	19.3	16.4	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"				Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: "	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	22.7	15.4	13.7	15.5	15.8	24.9	18.1	27.6	15.0	14.2	15.3	17.0	22.6	29.0	20.2	25.2	13.1	18.9	20.7	17.8	28.8	18.3	15.4	14.2	12.7	12.9	45.0	17.8	17.3	20.8	19.8	19.8	23.9	21.9	26.8	22.3	18.0	27.0	19.8	10.6	15.7	36.4	24.5	21.3	19.6	31.7	18.5	15.1	23.9	20.9	12.2	12.9	20.9	28.5	42.1	32.4	29.1	32.7	16.6	16.5	31.4	18.3	21.4	15.9	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1
C7orf25	MGC2821	ENSG00000136197	"Chromosome 7 open reading frame 25"	Q9BPX7	7	42908726-42912305	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 20.9;eosinophil: 12.3;neutrophil: 6.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020120, HPA049635"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020120: AB_1845755, HPA049635: "	"unprognostic (6.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.23e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.05e-3)"	4.8	6.5	7.6	3.8	7.6	2.4	6.1	7.1	11.0	5.0	5.2	6.3	2.6	2.1	5.3	11.0	5.2	6.5	5.9	5.8	9.2	8.6	7.7	5.9	4.8	5.2	10.0	9.1	7.2	5.1	12.6	6.5	5.8	12.2	8.2	3.4	4.0	5.0	9.2	5.7	3.9	5.3	5.8	9.6	5.2	5.3	11.0	5.3	5.8	7.7	4.5	3.8	5.3	4.4	2.1	1.4	20.9	1.9	1.6	2.2	1.1	3.4	9.0	3.2	4.8	4.6	2.5	3.6	6.9	2.6	4.5	4.1	5.9	4.5	9.1	5.3	6.6	5.9	3.4	6.1	5.2	4.3	8.6	4.8	9.2	3.5	8.3	3.6	3.1	5.0	4.1	4.5	4.6	3.5	6.0	2.1	3.8	6.5	1.9	3.5	3.9	11.6	2.2	3.5	3.8	2.6	8.6	4.0	4.6	10.1	3.0	3.6	4.0	3.5	9.2	4.6	5.2	4.9	4.3	4.8	10.7	2.8	4.2	4.6	9.8	20.9	1.9	12.3	1.5	1.8	2.2	2.1	1.1	1.4	1.4	1.7	1.6	1.6	6.4	1.6	1.7	0.6	0.8	1.1	7.6	7.6	7.1	11.0	9.2	8.6	10.0	9.1	12.2	5.3
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.8;NB-4: 14.4;THP-1: 42.2;TIME: 18.8;U-2197: 13.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.1	0.2	0.5	2.6	8.8	0.4	0.0	0.0	0.0	0.0	14.4	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	42.2	18.8	0.0	0.1	13.9	0.1	0.0	0.0	0.0	0.3	7.5	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6
GNG10		ENSG00000242616	"G protein subunit gamma 10"	P50151	9	111661335-111670246	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 75.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.68e-2)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (3.62e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.91e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.42e-1)"	32.3	33.1	36.9	31.0	31.9	25.3	20.1	11.9	30.5	21.4	18.5	17.3	7.7	12.5	21.6	16.8	15.2	16.9	20.6	23.2	29.9	30.4	19.7	24.7	21.5	34.2	27.6	20.1	16.6	17.1	25.9	34.6	28.1	18.6	28.3	16.3	17.4	20.1	15.4	11.1	7.5	18.5	23.5	26.8	32.3	16.4	11.8	18.3	11.8	20.3	11.9	13.8	32.5	15.1	2.1	7.3	75.4	8.7	1.7	4.6	4.7	22.9	11.5	9.7	14.9	36.4	25.8	16.3	23.8	30.1	23.3	21.5	17.6	16.7	1.2	10.0	30.9	17.2	17.8	23.3	27.1	7.9	18.7	2.9	12.9	13.4	23.8	9.2	8.2	23.4	16.8	20.6	27.7	26.8	9.8	6.0	37.7	15.1	6.1	7.5	17.2	27.0	4.6	45.5	1.2	43.4	14.6	15.3	12.9	23.9	11.6	21.9	26.3	14.8	18.6	21.4	17.6	43.3	25.3	3.7	7.3	2.6	31.0	22.4	13.8	3.0	8.7	11.8	2.0	7.8	3.2	1.6	2.7	2.5	7.3	2.1	2.9	2.1	75.4	1.7	6.5	4.6	4.6	4.7	36.9	31.9	11.9	30.5	29.9	30.4	27.6	20.1	18.6	18.3
MTRNR2L10		ENSG00000256045	"MT-RNR2-like 10"	P0CJ77	X	55181391-55182920	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.2"	"Group enriched"	"Detected in many"	4	"A549: 22.2;HeLa: 81.9;Hep G2: 69.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 60.2"														"Secreted to blood"						"unprognostic (4.42e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.97e-4)"	4.2	3.8	3.2	0.6	4.6	0.0	1.0	1.3	4.4	1.2	4.5	1.2	0.6	0.6	1.0	4.7	2.2	1.5	1.5	19.8	4.1	2.2	14.3	8.5	2.0	5.1	2.6	0.6	1.2	2.4	0.0	2.5	1.0	2.7	1.1	8.4	0.6	3.0	0.6	16.9	1.1	1.0	2.6	2.1	1.0	1.1	3.7	1.0	0.6	1.0	1.6	1.7	1.0	1.0	6.1	3.9	60.2	6.9	3.5	3.4	7.4	1.2	22.2	0.2	6.3	0.5	0.2	1.6	2.0	0.1	0.1	0.0	1.3	3.3	3.0	0.4	0.1	4.7	0.0	0.1	0.0	0.8	4.6	1.5	81.9	69.9	0.1	0.5	0.8	0.8	0.3	0.0	0.2	0.0	2.6	1.7	0.2	8.2	0.4	3.6	0.1	1.8	1.1	1.3	1.4	0.5	13.6	0.3	1.3	0.6	0.5	2.1	1.8	2.6	3.3	2.3	0.5	0.8	0.2	0.5	0.3	0.2	1.4	0.6	0.5	16.9	6.9	19.1	1.5	3.8	1.8	5.8	2.4	2.0	3.2	6.1	3.1	3.4	60.2	3.5	3.5	3.9	2.4	7.4	3.2	4.6	1.3	4.4	4.1	2.2	2.6	0.6	2.7	1.0
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812283	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 39.1;hTERT-HME1: 27.0;Karpas-707: 25.6;PC-3: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 135.8;neutrophil: 234.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 234.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol				Cytosol		"HPA013385: AB_2668827"	"prognostic favourable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavourable (2.90e-5)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	22.7	62.0	8.1	39.2	20.1	84.9	23.3	6.0	10.0	20.7	57.5	4.5	50.6	23.2	43.3	34.2	45.5	27.4	35.0	14.2	8.2	13.2	9.4	10.8	24.3	32.6	8.9	6.6	25.1	84.3	1.9	52.6	16.7	16.9	99.8	19.1	44.0	5.0	54.5	4.4	6.4	33.9	135.0	19.0	50.6	22.5	13.0	7.9	3.9	4.2	5.7	6.2	72.1	28.5	0.3	6.2	234.2	26.6	0.1	1.8	12.2	0.0	5.3	7.0	0.6	13.8	2.1	0.4	2.6	3.3	0.8	0.9	4.7	3.2	0.4	0.7	2.4	2.6	4.5	4.7	0.8	0.6	3.3	1.2	3.5	0.1	6.1	3.1	0.7	2.2	39.1	1.8	27.0	6.5	1.1	25.6	2.7	0.0	1.7	4.4	9.3	61.8	1.7	1.6	1.3	4.5	4.3	2.5	13.1	1.8	0.1	2.9	0.2	1.6	1.8	1.3	1.2	1.4	1.3	15.3	0.4	1.3	18.8	0.6	4.7	135.8	26.6	38.0	0.8	10.5	1.8	0.3	0.5	0.5	6.2	0.1	0.3	0.3	234.2	0.1	17.7	0.8	0.3	12.2	8.1	20.1	6.0	10.0	8.2	13.2	8.9	6.6	16.9	7.9
TMEM140	FLJ11000	ENSG00000146859	"Transmembrane protein 140"	Q9NV12	7	135148072-135166215	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 54.0;neutrophil: 75.1"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 75.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.52e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.41e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.20e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	39.1	13.6	4.6	12.4	19.9	6.4	27.9	2.4	14.2	9.0	10.4	15.2	9.2	11.9	13.5	7.3	6.3	6.5	12.9	13.8	6.5	5.0	16.9	32.9	18.8	15.6	30.7	4.8	10.8	10.0	2.5	4.0	22.7	15.4	9.7	5.7	9.9	11.4	7.5	51.6	6.1	11.4	8.0	31.4	17.6	8.3	6.3	22.1	4.4	7.6	3.7	10.7	16.7	14.5	7.7	2.0	75.1	5.1	6.1	8.3	10.1	5.0	12.2	4.4	8.8	36.0	7.1	4.0	3.9	5.9	3.0	7.7	4.7	5.1	6.7	5.1	1.6	5.0	0.0	0.1	0.5	13.1	5.6	4.0	5.1	4.7	7.5	9.2	6.4	1.8	0.2	1.2	0.0	4.7	8.8	22.8	0.9	4.4	8.9	4.2	9.0	7.0	6.3	6.4	14.2	1.8	7.8	4.9	7.8	3.7	5.6	9.6	2.3	8.4	4.8	3.7	2.6	8.1	4.8	25.4	18.9	9.9	11.2	11.1	8.9	54.0	4.8	18.0	8.2	4.0	6.0	6.1	6.8	8.0	2.0	7.7	7.7	8.3	75.1	6.1	5.1	0.3	8.3	10.1	4.6	19.9	2.4	14.2	6.5	5.0	30.7	4.8	15.4	22.1
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618632-152680165	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.3;HMC-1: 28.0;Karpas-707: 21.8;U-266/70: 27.3;U-937: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 75.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	1.4	0.7	0.8	12.5	0.8	8.3	2.0	0.7	0.7	5.0	1.4	1.3	0.9	1.0	1.1	1.2	36.1	1.1	2.4	1.7	0.8	0.8	1.0	4.8	7.9	20.4	1.3	0.1	0.7	0.8	0.1	3.5	3.5	0.8	3.9	1.1	0.5	16.1	2.5	1.3	28.7	3.0	2.2	1.2	16.2	2.7	0.6	0.1	8.2	1.5	26.0	38.0	7.1	6.3	8.3	2.9	75.4	6.0	0.1	3.4	2.2	12.0	0.0	0.1	0.0	0.2	3.5	5.5	3.0	11.3	3.3	6.4	0.1	1.6	12.4	1.3	2.8	8.8	0.0	24.3	6.2	0.0	0.0	0.6	0.1	0.0	3.6	9.5	28.0	3.3	11.7	10.7	9.3	8.3	0.0	21.8	0.2	0.8	3.7	2.9	0.6	2.9	0.4	0.0	0.0	19.2	7.4	0.0	0.5	0.7	2.4	0.4	0.3	6.7	3.3	0.4	2.0	0.3	4.2	27.3	9.2	6.8	4.6	21.7	2.5	49.8	5.8	44.8	0.8	5.9	1.5	8.3	1.8	1.3	2.9	7.2	1.8	1.2	75.4	0.1	6.0	0.3	3.4	2.2	0.8	0.8	0.7	0.7	0.8	0.8	1.3	0.1	0.8	0.1
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.5;ASC TERT1: 39.4;HHSteC: 49.6;HSkMC: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 25.0;eosinophil: 53.0"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favourable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	18.4	11.0	6.0	6.5	10.0	10.5	19.6	7.6	9.6	16.1	15.9	7.8	39.7	5.7	9.0	12.9	8.1	6.7	10.7	34.8	5.3	3.7	20.2	11.5	14.4	12.2	8.5	5.3	6.9	23.9	10.0	10.2	33.5	9.4	8.4	17.9	11.5	30.2	19.3	49.3	11.8	7.7	10.0	7.5	8.9	14.5	4.6	6.5	1.6	10.0	25.2	9.8	10.3	10.3	1.1	2.2	53.0	5.7	2.5	3.1	3.3	1.0	2.1	1.9	2.8	51.5	39.4	10.4	7.5	36.1	3.0	9.8	1.6	1.6	0.5	3.4	16.1	0.8	0.7	4.8	5.4	0.9	0.9	7.4	0.7	9.2	49.6	0.5	10.8	41.4	8.9	12.0	16.5	13.6	0.4	18.8	9.1	6.4	0.1	1.4	0.3	3.2	0.1	6.6	7.3	4.6	3.7	0.5	2.5	1.7	23.6	38.3	12.2	2.1	12.9	15.0	2.2	6.9	1.8	16.5	18.6	2.2	22.6	3.6	6.6	25.0	4.6	53.0	3.1	5.5	1.4	1.1	0.8	3.0	2.2	0.4	0.0	1.5	9.7	2.5	5.7	1.5	0.6	3.3	6.0	10.0	7.6	9.6	5.3	3.7	8.5	5.3	9.4	6.5
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.4	20.4	18.0	19.3	12.5	19.9	20.7	35.2	31.9	41.3	41.8	28.6	20.4	20.2	30.4	32.0	18.6	42.7	27.0	50.2	45.5	26.5	22.1	28.8	31.8	29.6	30.8	24.9	15.6	20.1	36.6	36.3	23.7	40.2	10.2	27.9	31.9	37.0	36.8	30.5	19.5	34.8	21.4	33.5	15.3	14.5	35.2	19.1	17.4	29.1	15.4	20.9	20.4	25.1	34.9	23.4	29.7	29.3	23.9	30.2	30.0	26.6	32.2	29.4	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8
BAZ2B	WALp4	ENSG00000123636	"Bromodomain adjacent to zinc finger domain 2B"	Q9UIF8	2	159318979-159616692	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 24.1;neutrophil: 54.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019819, HPA059292"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA019819: AB_1845282, HPA059292: AB_2683968"	"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.14e-2)"	16.7	20.7	22.1	12.7	37.7	23.5	16.5	30.3	28.5	25.8	18.3	30.0	19.4	12.4	25.4	17.7	16.6	19.2	19.3	13.4	26.1	13.1	13.3	12.3	18.1	9.8	37.2	20.4	33.4	16.4	27.1	45.4	14.9	29.5	17.1	12.4	13.0	19.0	24.6	19.2	12.7	14.5	20.0	42.3	14.4	14.4	18.6	48.9	6.5	19.0	9.1	9.6	18.6	19.2	2.4	5.9	54.6	7.0	4.7	2.7	1.4	3.6	7.3	25.2	15.2	7.6	12.2	4.4	7.8	9.6	4.3	5.1	11.1	10.2	6.3	13.4	7.6	8.5	10.0	10.6	6.8	2.1	5.7	11.5	12.7	1.5	5.0	7.8	8.0	9.5	11.7	10.7	11.8	22.1	12.5	1.2	6.8	4.3	2.7	4.8	8.3	6.4	6.4	8.1	4.3	8.7	13.3	16.7	14.6	15.4	1.9	9.2	2.9	21.6	21.8	7.8	15.8	3.2	5.2	4.7	0.4	7.0	7.2	8.5	4.9	24.1	7.0	8.8	2.7	3.0	2.2	1.5	1.6	2.7	4.4	2.4	1.1	1.7	54.6	4.7	2.6	5.9	1.7	1.4	22.1	37.7	30.3	28.5	26.1	13.1	37.2	20.4	29.5	48.9
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement component 5a receptor 2"	Q9P296	19	47332147-47347327	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.1;lymphoid tissue: 17.3"	"Group enriched"	"Detected in some"	5	"MCF7: 16.7;T-47d: 20.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 9.4;eosinophil: 7.0;neutrophil: 21.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 21.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA016629	Uncertain									"HPA016629: AB_1849312"	"unprognostic (5.00e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.00e-6)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.73e-5)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-3)"	7.2	1.7	1.1	7.4	1.6	9.2	4.7	0.3	3.5	2.0	1.9	1.7	0.0	0.9	1.5	4.1	3.3	2.8	2.9	3.2	3.6	1.0	2.4	3.1	7.5	6.8	1.3	2.2	2.0	1.4	0.4	1.4	3.9	2.9	0.8	0.9	1.9	1.9	0.6	0.8	2.2	2.0	1.8	4.5	17.3	1.6	3.8	0.3	0.0	1.4	4.4	13.6	5.6	2.0	0.3	0.4	21.1	2.7	0.2	0.4	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.1	0.0	0.7	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	16.7	0.0	1.9	0.2	0.0	0.2	0.2	2.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	20.7	0.2	0.1	0.7	0.2	0.4	0.1	0.3	0.2	0.7	0.7	1.2	0.1	9.4	1.7	7.0	0.2	1.5	0.2	0.2	0.1	0.1	0.4	0.3	0.1	0.1	21.1	0.2	2.7	0.2	0.4	0.4	1.1	1.6	0.3	3.5	3.6	1.0	1.3	2.2	2.9	0.3
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067599-19080095	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 45.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	9.1	14.2	13.5	7.8	12.9	4.0	12.6	11.3	18.5	11.2	12.8	12.8	15.2	11.4	14.7	17.4	11.9	15.0	13.9	21.1	12.1	13.0	13.5	11.4	14.6	11.1	12.2	12.0	19.4	12.2	23.7	15.1	9.4	12.9	17.1	12.5	16.5	11.3	14.7	37.3	7.5	12.1	11.1	12.4	8.7	11.8	34.7	10.7	9.4	15.3	24.7	7.6	12.1	10.0	5.1	5.3	45.2	4.0	4.1	4.4	1.8	12.4	13.4	11.6	6.8	6.6	7.0	9.8	7.3	6.0	10.0	10.4	8.5	10.4	9.5	35.6	5.6	13.2	16.2	9.1	7.2	8.0	16.3	5.0	12.3	26.0	8.1	12.0	11.2	5.8	8.1	9.3	6.8	8.1	13.8	8.9	7.0	22.4	12.5	9.7	8.8	7.2	15.3	12.9	12.1	8.7	8.4	16.9	9.7	6.8	15.1	8.5	13.8	16.4	8.8	10.7	6.2	7.7	10.5	8.3	13.4	10.4	11.4	7.0	6.8	10.8	4.0	5.8	3.5	3.5	3.3	5.1	3.2	3.1	4.3	5.0	4.4	3.9	45.2	4.1	3.9	5.3	2.0	1.8	13.5	12.9	11.3	18.5	12.1	13.0	12.2	12.0	12.9	10.7
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 42.3"	"Group enriched"	"Detected in some"	9	"HL-60: 8.8;HMC-1: 20.6;NB-4: 8.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.2"									"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					27000000	27000000			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: , HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	9.0	1.1	0.6	17.0	0.6	5.8	1.5	0.4	0.5	0.6	1.7	0.2	0.0	0.5	0.7	5.6	1.4	2.2	1.1	8.0	0.6	0.5	2.3	3.8	4.0	42.3	0.6	0.0	1.7	1.2	0.0	0.6	5.5	1.0	1.7	0.7	0.5	1.9	0.0	0.8	0.5	5.1	3.6	0.7	42.0	1.1	0.9	0.1	1.3	0.7	0.0	11.1	3.2	1.3	2.8	0.2	23.2	2.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.8	20.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.2	2.3	9.4	0.0	1.4	0.4	2.8	0.6	0.3	0.2	1.4	0.1	0.1	9.1	0.0	1.2	0.0	0.0	0.6	0.6	0.6	0.4	0.5	0.6	0.5	0.6	0.0	1.0	0.1
FRAT2		ENSG00000181274	"FRAT2, WNT signaling pathway regulator"	O75474	10	97332497-97334709	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 29.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.0	3.8	5.7	8.7	7.5	23.8	9.7	8.6	9.4	5.7	18.8	4.8	10.2	21.9	6.0	5.9	13.2	6.4	7.2	7.7	6.1	4.9	5.8	15.6	12.0	22.4	5.6	2.0	3.0	16.5	4.8	3.2	9.6	7.7	8.8	14.0	5.4	22.4	4.9	8.7	17.8	20.3	3.7	5.9	28.0	11.5	14.9	7.3	9.0	8.1	8.3	11.1	7.9	13.2	1.2	1.9	29.3	3.7	0.6	1.1	1.1	5.3	2.1	3.5	15.7	2.5	2.1	13.1	1.2	4.4	1.9	1.9	3.3	6.3	6.5	4.3	1.2	10.1	9.2	4.7	1.5	9.7	14.0	8.7	4.6	7.2	1.5	13.9	10.5	1.6	10.2	1.8	5.9	4.7	7.6	2.1	0.9	8.7	6.0	17.7	21.8	8.8	6.2	1.4	9.2	4.5	4.8	6.4	5.2	1.5	9.6	6.0	14.5	22.1	2.1	1.1	1.4	0.8	3.1	5.8	5.9	3.2	1.3	24.2	0.4	3.3	3.7	7.1	0.6	2.3	0.3	0.5	0.7	0.9	1.9	1.2	1.1	0.7	29.3	0.6	3.5	0.4	0.3	1.1	5.7	7.5	8.6	9.4	6.1	4.9	5.6	2.0	7.7	7.3
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703343	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 50.7"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 50.9"									HPA028660	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	16.1	0.2	0.4	6.4	0.5	13.2	8.3	0.2	0.7	5.8	3.6	0.3	6.2	0.4	0.8	1.6	26.0	0.4	1.1	1.2	0.8	0.2	1.9	1.8	11.3	0.7	3.3	0.2	1.2	0.2	4.4	0.9	8.2	1.0	8.6	0.0	0.3	9.7	10.7	0.7	17.8	0.7	0.4	0.9	16.5	0.8	2.8	1.1	1.1	0.4	13.5	21.5	3.5	8.3	0.0	0.5	50.9	6.6	0.0	0.0	0.3	1.8	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	50.7	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	50.9	0.0	6.6	0.0	0.0	0.3	0.4	0.5	0.2	0.7	0.8	0.2	3.3	0.2	1.0	1.1
MADCAM1	MACAM1	ENSG00000099866	"Mucosal vascular addressin cell adhesion molecule 1"	Q13477	19	489176-505342	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.9;lymphoid tissue: 27.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.6;Hep G2: 4.3;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.3"									CAB075699	Enhanced					41000000	41000000			"CAB075699: "	"unprognostic (2.30e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.17e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.42e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.07e-2)"	1.4	0.9	4.6	27.2	5.2	0.9	1.1	6.8	6.3	0.7	5.6	0.9	1.2	5.1	0.9	3.3	1.6	0.6	19.9	0.7	3.6	2.9	0.7	0.9	0.8	3.2	2.4	3.1	0.7	3.3	2.9	2.9	0.9	2.7	0.9	5.0	0.5	1.3	0.7	1.5	0.9	12.1	0.8	2.4	13.7	5.0	1.6	3.2	1.0	2.3	0.0	0.8	0.7	1.5	1.0	0.4	10.3	0.4	0.4	1.2	0.1	0.8	0.1	0.3	1.2	1.1	0.1	1.4	0.3	0.2	0.4	0.1	0.8	0.5	0.5	2.4	0.2	1.3	0.2	0.0	0.1	2.8	3.6	0.0	2.2	4.3	0.1	0.1	2.7	1.2	0.2	0.3	0.0	0.0	0.7	1.9	0.4	2.6	0.2	1.3	0.4	2.0	0.7	0.0	0.2	0.0	0.6	1.7	0.4	0.2	0.3	0.1	0.1	0.0	0.0	1.4	0.3	1.0	0.2	4.8	1.7	0.9	0.2	1.2	0.1	0.0	0.4	1.0	0.5	0.4	0.6	0.6	0.4	0.3	0.1	1.0	1.2	1.2	10.3	0.4	0.3	0.4	0.0	0.1	4.6	5.2	6.8	6.3	3.6	2.9	2.4	3.1	2.7	3.2
MTRNR2L8		ENSG00000255823	"MT-RNR2-like 8"	P0CJ75	11	10507887-10509189	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"blood: 329.5;skeletal muscle: 107.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 188.8;Hep G2: 138.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 329.5"														"Secreted to blood"						"unprognostic (6.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-2)"	35.7	33.4	22.5	4.2	22.8	6.6	4.3	7.3	17.5	6.5	15.6	3.6	19.3	10.2	3.8	6.1	12.7	4.6	14.1	73.2	20.1	14.7	30.7	21.7	6.3	4.0	22.0	7.3	7.0	10.9	1.9	6.9	7.0	9.0	7.7	15.5	3.3	12.3	14.8	107.4	12.0	12.9	8.8	16.1	9.7	10.2	28.4	6.5	2.2	4.4	32.3	4.3	10.0	5.8	35.3	24.5	329.5	42.7	16.6	19.0	36.2	30.2	54.5	21.4	96.0	21.5	11.8	29.5	28.6	4.2	4.0	5.1	33.1	46.6	42.5	33.6	6.1	85.7	0.6	6.5	4.4	18.1	47.2	39.6	188.8	138.0	8.3	7.3	38.3	20.9	10.2	3.3	9.8	3.9	33.4	22.1	12.3	19.3	11.1	54.7	7.0	15.2	19.1	18.3	20.4	24.4	30.6	12.1	27.5	14.3	21.0	43.6	24.6	55.0	25.6	28.3	25.1	29.8	11.1	12.4	5.9	22.6	18.5	64.9	6.7	89.7	42.7	97.5	11.6	21.0	14.3	33.7	14.8	13.0	16.3	35.3	19.0	17.5	329.5	16.6	20.1	24.5	14.9	36.2	22.5	22.8	7.3	16.7	20.1	14.7	22.0	7.3	9.0	6.5
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 100.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	15.1	10.0	10.7	16.1	10.2	22.1	21.6	10.9	13.9	12.3	12.3	7.0	9.0	12.4	13.9	9.9	13.9	10.0	13.2	13.6	10.9	9.5	10.6	50.2	19.1	29.4	13.1	8.9	9.2	10.3	6.9	11.5	21.3	11.7	8.7	12.8	6.0	14.8	11.0	46.2	14.6	15.0	10.8	11.7	22.9	10.5	10.0	8.9	16.4	14.2	13.9	14.6	14.6	13.5	7.0	10.0	100.9	13.3	4.3	5.7	7.2	8.7	8.0	8.0	7.3	19.2	29.6	8.0	12.6	21.6	10.1	14.4	16.9	9.4	11.4	6.2	14.1	6.9	7.7	10.6	13.8	10.2	7.8	8.4	4.2	13.5	24.6	11.1	9.9	27.4	22.9	16.4	40.4	10.3	8.5	13.3	12.8	6.5	9.4	19.8	9.3	33.3	9.2	7.2	6.6	11.6	5.0	4.6	7.9	7.5	14.6	21.9	9.1	11.1	10.5	7.0	10.4	10.9	13.3	16.8	12.8	13.8	19.6	17.9	5.6	13.8	11.8	22.8	4.5	13.3	4.7	7.0	4.6	4.9	10.0	5.9	5.7	5.3	100.9	4.3	12.5	4.9	5.1	7.2	10.7	10.2	10.9	13.9	10.9	9.5	13.1	8.9	11.7	8.9
PIGX	FLJ20522	ENSG00000163964	"Phosphatidylinositol glycan anchor biosynthesis class X"	Q8TBF5	3	196639775-196736007	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029409	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA029409: AB_10610280"	"unprognostic (8.83e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.25e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.45e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.01e-1)"	19.1	13.7	25.1	12.7	25.5	9.3	19.2	16.9	25.8	13.1	15.5	13.1	7.8	12.3	15.2	18.5	16.6	12.6	12.7	13.9	23.2	25.4	18.1	12.5	15.6	27.0	24.8	13.4	10.9	16.0	28.1	18.2	17.7	14.5	18.6	17.1	16.3	12.9	18.5	18.6	12.3	11.8	17.1	21.7	18.4	10.6	9.0	14.2	24.6	15.5	10.6	14.7	13.6	10.7	1.7	3.2	34.5	4.4	3.6	2.1	1.5	21.9	10.0	13.1	9.2	13.9	10.6	7.5	9.9	12.0	12.2	12.7	9.7	14.3	10.8	33.3	9.9	12.1	11.2	9.4	15.1	9.8	10.4	8.9	6.9	6.5	12.9	10.0	16.7	7.9	14.8	9.8	9.3	6.6	6.1	21.7	11.1	19.9	25.8	13.0	5.9	11.3	14.0	15.5	15.6	12.6	7.4	12.7	14.1	16.7	11.5	13.6	39.8	9.4	3.4	11.7	5.1	12.8	15.2	27.4	31.5	20.4	10.6	12.3	12.0	15.5	3.0	34.5	1.5	4.4	1.3	1.7	1.4	2.1	3.2	1.7	1.6	1.4	8.6	3.6	4.4	1.4	1.7	1.5	25.1	25.5	16.9	25.8	23.2	25.4	24.8	13.4	14.5	14.2
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 23.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"									HPA005563	Uncertain				"Intracellular and membrane"					"HPA005563: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6
ADAM8	"CD156, CD156a, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262403-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3"	"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BEWO: 32.2;CAPAN-2: 27.3;HaCaT: 26.8;HDLM-2: 17.2;U-87 MG: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"					"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	4.8	1.0	0.7	18.0	1.6	37.1	3.1	1.7	1.2	3.8	4.8	0.9	0.2	3.5	1.8	1.6	2.8	3.6	10.1	4.1	0.8	1.1	2.8	4.3	13.0	25.0	1.0	0.2	1.7	2.4	0.1	2.0	7.5	1.6	2.9	0.9	2.9	5.5	0.7	1.5	1.9	6.0	1.6	1.5	28.3	6.9	2.3	0.5	6.6	2.0	1.8	19.7	12.0	2.8	2.5	8.6	56.8	5.4	5.5	5.5	4.6	22.3	0.6	0.2	0.3	0.1	0.0	32.2	0.2	0.5	0.1	0.1	1.7	27.3	0.4	0.6	0.0	26.8	0.0	4.6	0.0	17.2	0.3	0.3	0.1	0.0	0.2	1.3	6.3	0.1	0.4	0.2	0.4	0.0	1.2	0.9	0.0	1.8	0.0	7.6	0.1	0.6	0.1	0.2	2.4	0.3	0.5	0.0	0.3	0.1	0.1	0.4	0.4	0.7	0.6	0.0	0.6	0.2	0.3	1.3	0.8	0.2	13.7	0.7	0.1	20.7	5.4	56.8	5.5	2.1	4.0	2.5	3.7	5.2	8.6	1.5	1.4	2.0	32.9	5.5	2.0	0.1	3.8	4.6	0.7	1.6	1.7	1.2	0.8	1.1	1.0	0.2	1.6	0.5
ARL6IP6	MGC33864	ENSG00000177917	"ADP ribosylation factor like GTPase 6 interacting protein 6"	Q8N6S5	2	152717893-152761253	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.7;eosinophil: 45.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014743	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane"	Cytosol	"HPA014743: AB_1845030"	"unprognostic (4.41e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.86e-3)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (5.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.57e-1)"	"unprognostic (7.39e-2)"	6.1	5.1	8.4	4.2	10.1	14.5	9.4	6.6	11.4	4.7	5.7	10.1	7.9	6.5	5.6	2.5	7.8	5.1	5.6	3.2	11.4	4.9	3.3	2.3	7.2	7.2	15.9	7.4	6.9	3.3	2.6	8.3	10.2	12.9	4.6	4.1	3.4	4.9	4.8	9.7	8.2	6.1	4.7	12.4	8.7	6.0	7.3	13.5	2.5	4.1	4.6	5.4	6.3	18.9	5.7	7.4	50.7	3.5	2.6	5.6	3.6	8.3	5.2	12.6	3.5	3.1	3.8	19.5	10.3	4.2	8.6	10.8	13.6	12.3	14.8	10.3	4.4	9.6	6.6	4.5	9.0	23.1	14.1	12.1	5.2	12.0	4.2	9.9	11.3	2.8	5.3	9.3	7.5	6.4	13.4	9.5	6.6	6.0	10.2	10.7	12.2	11.6	11.8	12.5	11.9	3.6	6.2	11.0	11.9	9.4	0.9	8.2	4.2	7.5	8.9	13.8	9.4	9.6	9.0	9.1	9.1	11.9	6.6	8.5	11.3	50.7	2.8	45.4	4.1	3.0	4.2	5.7	4.2	4.1	3.2	4.9	4.3	3.7	7.5	2.6	3.5	7.4	5.6	3.6	8.4	10.1	6.6	11.4	11.4	4.9	15.9	7.4	12.9	13.5
C10orf128	Em:AC084727.5	ENSG00000204161	"Chromosome 10 open reading frame 128"	Q5T292	10	49154725-49188585	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 61.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 59.8;HEL: 14.4;K-562: 27.9;U-87 MG: 30.1;U-937: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 61.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 61.0"	"Low region specificity"	"Detected in many"							HPA058166	Approved									"HPA058166: AB_2683627"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (9.13e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (2.86e-5)"	"unprognostic (2.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.24e-1)"	21.6	2.6	5.9	12.9	15.0	2.8	19.4	1.7	9.2	13.1	9.9	19.2	4.6	7.0	11.0	10.0	8.6	9.4	14.7	14.2	9.2	6.7	4.1	7.3	21.1	18.7	27.6	6.5	3.7	3.3	10.1	3.0	8.6	15.0	6.8	11.8	9.6	7.6	6.6	6.7	5.6	17.4	16.8	33.7	23.3	6.7	4.7	20.6	1.5	8.0	9.7	18.0	15.3	13.7	9.1	4.6	61.0	0.9	0.0	9.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	59.8	0.0	14.4	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.4	27.9	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	30.1	25.9	0.0	6.0	0.9	61.0	5.5	0.3	9.1	9.1	3.5	5.4	4.6	2.8	0.2	1.6	4.5	0.0	0.1	0.1	2.7	2.3	5.9	15.0	1.7	9.2	9.2	6.7	27.6	6.5	15.0	20.6
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Supported	Nucleoplasm,Mitochondria		310000	310000	"Nucleoplasm, Mitochondria"		"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.2	4.6	18.3	8.7	11.4	15.2	10.6	24.8	18.8	17.4	10.1	8.3	6.9	11.5	3.9	12.1	7.0	14.5	8.8	19.9	29.4	7.9	18.3	3.6	19.3	13.6	14.9	17.5	20.7	10.8	11.0	9.0	21.5	15.1	72.7	17.9	3.5	23.5	13.9	18.1	5.8	17.0	8.6	11.0	15.0	13.5	10.5	11.4	10.7	9.8	13.9	5.3	9.7	14.6	8.0	7.3	5.9	11.4	33.8	31.7	7.9	9.7	10.4	11.3	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.8;bone marrow: 18.7;lung: 15.2"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HMC-1: 8.0;U-266/70: 12.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in many"	7	"eosinophil: 41.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.8"														"Secreted to blood"						"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	0.8	2.4	0.0	4.5	0.6	18.7	8.0	0.3	4.6	0.9	0.4	2.3	0.0	0.6	0.3	0.3	0.1	0.0	4.5	2.1	0.0		0.7	5.0	15.2	8.1	0.6	0.3	0.1	0.1	1.0	0.0	1.0	0.5	0.7	0.8	1.0	1.6	0.0	0.0	0.0	0.5	0.5	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.9	1.8	1.9	0.0	0.0	0.0	41.8	0.1	0.3	5.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	1.9	1.0	0.0	0.1	0.0	0.2	0.1	41.8	5.6	0.0	1.3	0.0	0.2	3.2	0.0	0.0	0.0	3.3	6.3	0.3	0.0	0.0	0.0	1.5										
CD300LD	"CD300D, CMRF35A4"	ENSG00000204345	"CD300 molecule like family member d"	Q6UXZ3	17	74579365-74592283	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.5;bone marrow: 3.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;RPMI-8226: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	7	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.5"									HPA027756	Uncertain									"HPA027756: AB_10601097"			"unprognostic (8.03e-2)"											"unprognostic (3.30e-1)"				0.3	0.2	0.1	2.2	0.1	3.2	0.2	0.2	0.3	0.4	0.2			0.0	0.2	0.0	0.2	0.4	0.3	0.3	0.1	0.1	0.1	0.2	0.9	0.7	0.1		0.1	0.1	0.0	0.1	0.1		0.1	0.0		1.1	0.0	0.1	1.6	0.9	0.1	0.1	1.4	0.2	1.7			0.1		0.6	0.4	0.1	0.5	0.7	8.5	0.7	0.8	1.3	0.2	0.4	0.3	0.5	1.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.4	0.5	0.3	0.5	0.5	0.3	0.5	0.0	0.5	0.2	0.2	1.5	0.7	0.0	1.1	4.4	0.6	0.4	0.3	0.5	0.0	0.5	1.7	0.2	1.4	0.2	0.6	0.5	0.6	0.4	0.6	2.7	0.5	0.8	0.5	0.5	0.7	0.4	0.0	0.6	0.1	0.5	0.6	0.5	1.1	0.0	0.8	0.3	0.6	0.2	0.3	0.3	0.8	0.4	0.4	0.4	0.7	0.2	0.3	0.3	0.2	0.7	0.5	0.5	0.4	8.5	0.8	0.4	0.5	1.3	0.2										
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"Carcinoembryonic antigen related cell adhesion molecule 3"	P40198	19	41796437-41811553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.0;bone marrow: 35.4"	"Cell line enhanced"	"Detected in single"		"PC-3: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 60.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 60.0"									HPA011041	Approved									"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"	0.9	0.3	0.3	3.6	0.8	35.4	0.7	0.2	0.8	0.6	1.0	0.0	0.0	0.2	0.4	0.2	1.2	0.7	0.4	5.1	0.4	0.3	0.4	1.1	14.0	11.5	1.8	0.1	0.7	1.0	0.2	0.3	4.6	0.5	0.3	0.3	1.4	0.8	0.2	1.5	0.2	0.6	0.4	0.3	10.7	0.4	0.9	0.2	1.6	0.5	0.3	2.7	0.8	0.6	0.0	0.8	60.0	8.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	60.0	0.0	8.9	0.0	0.0	0.6	0.3	0.8	0.2	0.8	0.4	0.3	1.8	0.1	0.5	0.2
CEP63	FLJ13386	ENSG00000182923	"Centrosomal protein 63"	Q96MT8	3	134485743-134575017	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 54.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058154, HPA058313"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA058154: AB_2683624, HPA058313: "	"unprognostic (1.80e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	21.6	15.4	17.7	17.1	18.1	25.3	16.5	19.7	22.6	13.8	15.4	14.5	18.8	9.1	13.7	17.6	15.1	12.2	12.3	25.6	17.2	15.0	15.2	20.5	12.4	15.7	20.4	15.7	16.7	17.8	21.8	23.1	13.5	20.0	16.7	14.5	11.1	15.5	17.4	38.1	15.0	11.3	20.2	20.2	15.3	13.9	37.2	21.5	21.7	18.3	14.9	16.3	17.3	19.9	6.1	7.2	54.1	8.2	5.9	5.6	3.5	17.2	7.7	14.6	9.5	21.3	18.0	13.7	18.7	15.4	15.0	12.7	6.1	7.4	19.6	12.0	13.5	10.3	7.5	10.4	18.2	21.8	4.0	25.3	8.3	8.6	14.7	16.0	11.8	15.7	13.8	8.0	26.7	14.8	7.5	17.1	17.6	11.6	19.0	19.1	10.4	9.1	12.4	21.6	28.0	12.7	10.8	8.6	8.2	16.8	6.6	25.2	13.5	21.8	16.8	17.0	10.1	16.1	13.8	15.8	10.9	25.1	18.2	17.1	21.5	18.1	6.0	9.9	4.0	6.2	5.4	4.8	3.9	5.1	7.2	6.1	5.6	4.2	54.1	5.9	8.2	4.8	4.8	3.5	17.7	18.1	19.7	22.6	17.2	15.0	20.4	15.7	20.0	21.5
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859175	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 95.0;eosinophil: 27.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 95.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		340000	340000	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (3.56e-1)"	22.0	23.3	12.6	27.1	18.8	38.1	18.8	13.6	14.7	22.0	27.9	10.0	43.8	28.8	19.1	30.3	56.4	17.1	40.3	23.4	14.0	12.7	40.8	48.6	22.3	19.2	11.7	11.7	20.1	25.3	47.9	25.9	30.1	14.3	21.5	23.7	11.3	39.9	47.1	38.7	26.0	34.6	30.9	13.0	19.0	29.4	12.1	13.0	23.6	30.3	23.3	32.8	37.1	33.8	7.8	9.9	95.0	7.8	8.8	12.7	7.5	22.7	32.9	23.5	21.8	32.7	27.6	33.7	32.1	33.3	31.8	44.9	45.8	36.0	42.9	36.9	30.5	34.4	31.8	37.1	45.4	20.2	25.7	28.6	29.6	22.9	33.4	39.0	38.8	20.5	27.9	35.6	40.2	29.7	24.4	23.9	25.5	20.0	30.6	21.7	24.6	34.1	27.6	35.2	36.2	31.8	41.0	20.7	22.5	23.2	40.2	31.6	27.7	27.6	29.8	27.8	20.6	25.3	31.4	27.9	26.5	55.0	22.5	44.7	24.3	95.0	7.4	27.6	7.4	7.8	12.7	7.8	7.1	7.3	9.9	7.0	6.2	6.6	2.8	8.8	7.8	7.8	10.1	7.5	12.6	18.8	13.6	14.7	14.0	12.7	11.7	11.7	14.3	13.0
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.3;brain: 38.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 53.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 53.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	20.0	3.6	12.1	15.4	19.5	11.5	9.0	10.4	17.8	4.6	5.6	38.0	0.9	2.8	16.3	6.9	7.7	4.7	23.1	10.4	16.7	8.7	6.6	4.6	9.5	6.1	17.9	12.1	2.4	7.0	1.5	2.8	19.5	18.3	3.1	4.3	1.1	6.5	3.0	6.2	5.5	4.2	9.8	14.6	12.6	3.2	2.3	22.7	0.0	3.8	7.0	2.5	5.5	5.0	0.3	4.8	53.3	7.8	0.0	0.0	1.5	0.0	0.3	3.9	0.2	0.2	5.6	0.1	0.3	0.8	2.3	3.5	2.2	1.4	9.7	0.7	0.9	0.4	0.1	3.3	7.4	0.0	2.6	10.5	2.0	0.2	0.2	31.6	0.4	0.7	0.7	10.0	10.8	1.5	1.2	13.2	0.8	0.0	0.0	0.0	4.8	3.9	0.2	3.6	0.2	4.8	1.0	0.4	2.8	0.1	0.2	1.1	0.1	0.7	0.4	4.6	13.9	15.2	4.4	0.8	2.2	0.1	5.1	0.2	7.8	0.0	7.8	0.0	0.0	2.7	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	53.3	0.0	0.8	0.0	0.0	1.5	12.1	19.5	10.4	15.6	16.7	8.7	17.9	12.1	18.3	22.7
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 105.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HMC-1: 19.5;NB-4: 4.2;U-937: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 105.1"					"Low region specificity"	"Detected in many"			HPA035644	Approved					260000000	260000000			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	7.8	0.9	1.3	7.1	2.4	13.0	3.5	0.7	2.5	1.5	2.6	2.4	1.1	1.7	4.1	4.1	1.8	2.0	6.8	2.4	1.6	1.3	2.0	2.0	11.4	10.4	2.1	2.0	0.7	0.9	0.1	0.9	19.4	2.7	2.4	2.4	5.1	2.8	0.4	1.6	1.2	10.1	2.3	3.3	26.4	1.6	2.5	1.6	3.5	2.5	3.8	11.1	6.3	1.5	5.0	4.3	105.1	15.3	5.6	4.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.3	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	4.3	0.0	0.1	0.0	0.1	19.5	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	4.2	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	6.5	0.0	43.5	10.7	105.1	2.3	13.0	2.7	4.1	4.0	1.9	4.3	5.0	4.9	2.5	47.3	5.6	15.3	0.6	4.0	5.7	1.3	2.4	0.7	2.5	1.6	1.3	2.1	2.0	2.7	1.6
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.0;HMC-1: 28.2;K-562: 8.3;NB-4: 7.9;THP-1: 30.0;U-937: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		55000000	55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.2	0.0	0.3	4.0	28.2	0.3	0.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.2	7.9	0.0	0.6	0.1	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.9	3.5	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2
LTC4S	MGC33147	ENSG00000213316	"Leukotriene C4 synthase"	Q16873	5	179793980-179796647	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.3"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 50.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 8.5;eosinophil: 31.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044688			Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				Nucleoplasm	"Endoplasmic reticulum, Cytosol"	"HPA044688: "	"unprognostic (8.94e-2)"	"unprognostic (2.40e-2)"			"unprognostic (9.35e-3)"		"unprognostic (3.57e-2)"	"unprognostic (1.24e-2)"		"unprognostic (9.40e-2)"	"unprognostic (4.53e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.62e-1)"	9.0	6.7	3.5	2.8	3.5	8.6	4.6	1.7	5.0	6.9	5.0	9.4	5.4	3.6	8.7	10.4	4.2	13.0	15.7	11.3	3.9	3.1	6.2	2.3	28.3	8.0	6.8	4.2	5.8	2.4	2.0	3.2	2.9	4.3	5.6	1.9	3.3	7.4	11.6	2.7	3.5	5.7	4.5	6.3	6.7	5.0	3.3	3.9	0.8	5.3	5.6	3.2	3.6	3.9	0.1	4.5	31.3	0.3	2.2	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	5.1	0.0	0.2	0.2	0.3	50.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	8.5	0.2	31.3	0.5	0.3	1.7	0.1	1.2	0.8	4.5	0.1	0.2	0.5	0.1	2.2	0.0	0.2	0.1	0.3	3.5	3.5	1.7	5.0	3.9	3.1	6.8	4.2	4.3	3.9
MPPE1	PGAP5	ENSG00000154889	"Metallophosphoesterase 1"	Q53F39	18	11882622-11909223	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 22.1;neutrophil: 66.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 66.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"basal ganglia: 104.4"	HPA012639	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA012639: AB_1854088"	"unprognostic (9.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavourable (1.35e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.61e-1)"	"prognostic favourable (6.45e-7)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-2)"	"unprognostic (6.15e-2)"	15.0	13.7	11.8	16.5	16.0	19.9	15.2	11.4	20.9	14.1	16.4	20.1	18.2	13.5	18.7	22.1	13.4	15.8	23.6	17.2	11.5	14.4	23.7	20.8	24.7	29.0	19.8	12.2	11.7	24.6	22.2	16.5	15.2	14.1	13.1	17.2	14.8	16.8	26.6	19.3	22.4	19.7	14.0	15.1	17.5	17.7	6.7	14.8	22.7	37.1	14.6	17.6	14.9	13.9	4.5	8.5	66.2	9.5	6.3	6.0	6.7	4.3	6.2	4.7	11.5	13.7	16.2	4.5	10.3	14.9	6.1	9.7	11.6	12.3	8.6	22.8	9.9	4.7	3.3	5.8	5.8	9.4	5.6	2.4	12.5	2.6	19.2	11.0	17.8	23.9	7.7	5.4	3.9	3.6	3.1	8.3	10.2	10.1	8.1	7.4	3.3	1.7	3.3	3.0	10.4	10.0	6.6	6.7	3.8	9.6	7.6	9.0	5.6	14.4	7.4	12.4	4.8	11.9	5.7	13.0	11.4	10.8	9.3	5.8	12.2	4.1	9.5	22.1	6.0	7.7	4.3	4.0	3.7	5.6	8.5	4.5	4.5	5.7	66.2	6.3	5.2	6.7	5.8	6.7	11.8	16.0	11.4	20.9	11.5	14.4	19.8	12.2	14.1	14.8
MS4A4E		ENSG00000214787	"Membrane spanning 4-domains A4E"	Q96PG1	11	60201253-60243088	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 17.1"	"Cell line enhanced"	"Detected in some"		"K-562: 5.1;NB-4: 1.7;THP-1: 7.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in some"	7	"basophil: 17.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 17.1"									HPA040075	Uncertain									"HPA040075: AB_10793915"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.16e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.97e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.05e-2)"	4.7	2.2	0.2	1.2	0.2	7.1	3.4	0.1	0.2	0.5	1.6			1.0	0.8	1.1	1.2	0.9	2.9	1.2	0.3	0.3	1.0	0.8	1.9	1.6	0.2		0.8	0.8	0.8	0.7	1.0		0.9	1.2		1.9	0.1	0.6	1.0	2.8	3.3	0.5	3.1	1.6	0.5			0.7		0.4	2.1	0.9	0.0	2.4	17.1	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	17.1	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	1.3	1.0	0.0	0.2										
MT-ND2	"MTND2, NAD2, ND2"	ENSG00000198763	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2"	P03891	MT	4470-5511	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 432.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 601.0"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in all"	5	"basophil: 432.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 432.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.77e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.35e-2)"	93.0	57.2	116.0	16.9	169.9	15.6	33.9	40.1	73.5	22.6	53.7			50.1	21.5	59.8	29.0	22.1	19.3	262.4	112.2	85.2	125.9	128.9	20.9	14.7	113.0		25.1	62.0	24.3	20.3	37.0		28.1	59.0		85.3	41.0	263.4	72.7	39.2	24.6	72.4	15.2	49.2	27.3			18.2		17.7	23.8	13.1	66.1	43.5	432.3	54.8	43.0	57.9	21.8	92.8	102.3	91.6	154.4	330.8	59.0	86.6	86.7	21.7	23.2	29.3	128.7	125.5	133.3	82.5	62.2	166.7	14.4	108.4	50.2	116.0	74.5	153.8	601.0	207.5	67.8	149.2	179.0	97.6	198.2	57.0	56.5	34.0	112.1	130.7	55.7	109.8	84.6	241.4	45.9	67.0	74.4	51.3	111.8	171.8	143.7	57.3	68.7	37.5	115.2	138.2	177.3	172.5	107.5	87.2	108.0	122.6	109.8	85.5	73.2	112.2	56.6	128.8	39.0	432.3	54.8	93.1	34.1	39.7	54.7	58.6	39.5	42.5	23.0	66.1	48.5	57.9	88.6	43.0	45.7	43.5	25.9	21.8										
MTRNR2L7		ENSG00000256892	"MT-RNR2-like 7"	P0CJ74	10	37601440-37602974	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.1;Hep G2: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.1"														"Secreted - unknown location"															"unprognostic (2.28e-1)"				"unprognostic (5.87e-2)"				0.3	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.1	0.1	0.9	0.4	0.1	0.0	0.1		0.1	0.1	0.0	0.3	0.0		0.1	0.5		0.1	0.0	1.9	0.1	0.1	0.0	0.1	0.1	0.2	0.2			0.1		0.0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.3	0.0	0.3	0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	3.1	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.5	0.4	0.3	0.0	0.2	0.8	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.8	0.0	1.2	0.2	0.6	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2										
OR6K3		ENSG00000203757	"Olfactory receptor family 6 subfamily K member 3"	Q8NGY3	1	158716327-158720720	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 10.4;bone marrow: 4.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055949	Uncertain									"HPA055949: AB_2682982"																		0.1	0.1	0.0	0.0	0.1	4.8	0.1	0.1	0.1	0.2	0.1			0.3	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	2.2	0.3	0.1		0.2	0.1	0.1	0.1	0.1		0.1	0.0		0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.1	0.4			0.1		0.0	0.2	0.1	1.3	1.0	10.4	0.9	0.9	1.5	0.3	0.2	0.3	0.1	0.9	0.6	0.2	0.5	0.2	0.4	0.4	0.2	0.6	0.7	1.1	0.3	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.5	0.2	0.8	0.3	0.8	0.6	0.3	1.8	0.3	0.5	2.7	0.1	0.6	0.3	1.0	0.1	0.0	0.4	0.2	0.4	0.2	0.6	0.4	0.0	0.0	0.3	0.1	0.2	0.0	1.6	0.6	0.5	0.4	0.1	0.6	0.6	0.6	0.0	0.6	0.7	10.4	0.9	0.9	1.3	0.8	1.4	1.1	1.3	1.0	0.4	1.3	1.4	1.5	1.7	0.9	0.7	1.0	0.9	0.3										
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274622-2282176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;lymphoid tissue: 19.1"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 16.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.5"					"Group enriched"	"Detected in some"	5	"basal ganglia: 6.4;cerebellum: 6.0"	HPA057806	Uncertain									"HPA057806: AB_2683534"	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	1.9	1.3	1.4	4.7	3.3	8.2	0.9	0.8	2.0	1.3	1.7	2.1	0.1	1.1	0.7	1.0	0.8	1.6	0.9	2.1	2.0	0.9	3.8	2.0	4.4	14.3	3.3	0.9	1.0	0.8	0.6	1.2	0.8	2.3	1.0	1.1	0.7	0.8	0.6	1.5	1.0	2.5	0.9	4.0	19.1	1.1	0.6	1.7	0.6	0.8	0.0	2.7	0.9	1.9	0.2	1.1	24.5	3.4	2.8	1.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.2	0.5	0.1	16.5	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	5.3	2.7	6.6	1.0	3.4	0.1	0.1	0.1	0.1	1.1	0.2	0.0	0.2	24.5	2.8	1.1	0.1	0.0	0.5	1.4	3.3	0.8	2.0	2.0	0.9	3.3	0.9	2.3	1.7
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 57.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	7.3	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4										
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850940-60855971	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;lymphoid tissue: 28.1"	"Cell line enhanced"	"Detected in some"		"HEL: 10.3;Hep G2: 5.0;HMC-1: 6.5;K-562: 4.2;NB-4: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 35.1;eosinophil: 51.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain									"HPA014259: "	"unprognostic (9.77e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.45e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.30e-4)"	"unprognostic (2.61e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.99e-2)"	1.2	0.3	3.9	2.3	8.0	0.4	2.8	2.3	8.2	1.7	10.7	4.0	0.3	7.5	0.9	0.6	1.4	1.5	1.6	5.1	4.3	2.8	0.5	0.7	1.4	1.9	4.9	5.9	0.5	1.1	5.9	0.6	1.9	5.7	0.9	7.4	0.6	0.5	0.5	11.3	1.0	10.8	0.9	2.2	1.1	13.3	0.5	0.8	28.1	0.4	5.6	0.6	1.1	0.4	0.0	1.2	51.8	7.8	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.4	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	10.3	0.0	5.0	1.2	0.0	6.5	2.2	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.1	3.3	14.8	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.1	0.0	51.8	0.0	2.5	0.0	0.0	0.3	0.2	1.2	0.0	0.0	0.0	0.1	0.0	7.8	0.2	0.3	0.4	3.9	8.0	2.3	8.2	4.3	2.8	4.9	5.9	5.7	0.8
SDR42E2		ENSG00000183921	"Short chain dehydrogenase/reductase family 42E, member 2"	A6NKP2	16	22165583-22191754	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;fallopian tube: 5.0;testis: 3.3"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 3.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.03e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.72e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.32e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.61e-2)"	0.1	0.1	1.0	0.2	2.1	0.1	0.0	0.0	1.1	0.5	0.0			0.6	0.1	0.1	0.0	5.0	0.2	0.0	1.7	2.4	0.2	0.0	0.4	0.3	0.0		0.3	0.5	0.1	2.2	0.2		0.2	0.1		0.2	0.0	1.5	0.6	0.2	0.0	0.3	0.5	0.1	3.3			0.1		0.0	0.1	0.0	0.8	0.3	6.0	0.8	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.3	0.4	0.5	0.3	0.4	0.1	0.8	0.3	0.4	6.0	0.3	0.1	0.3	0.3	0.2										
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294443-132344206	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.4;U-138 MG: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 23.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.0"	"Region enhanced"	"Detected in all"		"cerebellum: 72.4"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria				Mitochondria		"CAB015468: , HPA036974: "	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	2.7	4.1	3.5	3.8	5.0	22.4	3.1	3.1	4.7	2.4	5.9	4.4	1.8	4.6	2.1	3.2	0.8	14.7	2.6	3.0	3.9	4.9	15.4	1.6	7.2	3.8	3.2	2.0	5.0	1.0	7.7	6.9	6.8	12.6	5.4	3.1	13.8	2.6	4.1	9.2	1.7	18.1	1.5	9.9	7.7	2.2	0.9	2.7	0.5	1.0	2.7	0.8	2.5	2.2	0.0	1.7	23.0	3.5	0.0	0.0	0.6	1.1	1.7	0.1	0.4	0.7	0.6	0.5	7.4	34.4	5.7	6.0	0.6	1.9	0.3	2.1	4.3	1.8	0.0	1.2	4.0	1.4	0.2	0.1	3.2	0.1	0.6	2.3	0.0	1.4	0.2	3.1	2.9	2.5	2.9	3.9	4.4	0.6	0.0	5.3	0.2	1.9	0.0	0.4	0.2	0.9	0.1	0.4	0.2	8.1	0.5	0.2	0.3	1.4	3.0	14.6	1.4	5.7	1.9	0.0	1.5	0.0	4.3	2.7	1.7	0.0	3.5	3.5	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	23.0	0.0	0.2	0.2	0.0	0.6	3.5	5.0	3.1	4.7	3.9	4.9	3.2	2.0	12.6	2.7
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649977-24667033	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.3;intestine: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.6;neutrophil: 57.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: "	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favourable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.47e-5)"	6.8	4.8	8.2	15.4	9.2	3.7	5.6	10.8	7.5	6.1	36.0	3.7	4.9	25.8	4.9	5.2	4.9	4.5	6.2	8.1	6.8	6.9	16.4	10.4	6.5	7.1	7.7	6.3	5.7	5.9	4.4	9.4	5.7	6.5	12.3	27.9	3.6	4.9	4.8	5.0	4.8	55.7	6.1	5.8	6.3	5.1	21.1	5.7	8.2	5.3	4.1	7.3	9.6	7.0	5.3	3.3	57.3	3.9	6.9	8.3	5.7	17.7	14.1	16.1	18.6	25.0	25.6	12.6	15.8	20.3	15.1	20.4	19.3	10.1	21.4	27.8	16.5	13.1	19.6	18.0	20.7	27.3	20.5	20.0	15.0	31.5	15.9	30.6	19.3	17.1	17.0	15.8	14.3	24.4	17.8	9.2	22.7	12.6	23.8	19.6	14.4	12.2	20.7	17.0	22.9	26.0	25.2	20.4	11.7	12.9	32.7	25.8	15.0	17.8	18.2	14.8	12.3	11.0	23.0	13.3	39.1	29.2	10.2	40.4	23.6	15.6	3.5	7.1	6.9	3.7	8.3	5.3	8.0	7.5	3.3	3.5	6.6	7.2	57.3	6.9	3.9	3.1	7.9	5.7	8.2	9.2	10.8	7.5	6.8	6.9	7.7	6.3	6.5	5.7
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826820-36945098	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;HMC-1: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 42.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 42.3"	"Low region specificity"	"Detected in all"							HPA035508	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	4.1	3.6	4.5	10.4	11.2	6.9	4.7	21.5	12.0	8.5	14.2	1.7	3.1	8.6	12.3	4.5	3.1	19.3	7.3	4.1	3.3	3.9	3.2	7.9	6.2	13.9	2.9	6.6	9.0	2.8	5.0	3.8	3.7	6.0	7.9	10.9	4.4	4.9	5.0	2.6	2.9	23.1	10.5	3.2	9.9	6.0	2.9	1.7	15.1	5.8	1.1	16.2	9.8	6.0	5.2	0.5	42.3	1.3	2.8	5.7	0.9	0.7	0.9	0.2	0.0	2.4	9.5	0.0	0.7	5.0	2.3	4.4	0.0	3.9	38.1	1.5	2.8	0.2	0.1	0.5	0.4	1.9	0.0	6.2	2.5	0.0	3.1	1.7	15.3	3.1	1.9	1.7	0.1	2.8	4.9	5.5	1.6	0.0	4.8	0.7	0.2	1.0	1.3	0.1	0.7	0.7	1.7	0.3	0.0	3.8	1.0	0.3	0.6	2.1	1.9	1.8	0.7	0.1	0.6	5.4	1.1	8.4	0.3	1.3	0.2	2.5	0.6	3.9	5.6	0.9	4.2	4.0	4.8	5.7	0.5	5.2	4.4	4.2	42.3	2.8	1.3	0.0	4.0	0.9	4.5	11.2	21.5	12.0	3.3	3.9	2.9	6.6	6.0	1.7
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell line enhanced"	"Detected in many"		"A-431: 41.9;CAPAN-2: 28.0;HeLa: 39.7;PC-3: 20.0;SiHa: 49.8;U-937: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA064202	Enhanced		Approved	Nucleoplasm		3700000	3700000	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	41.9	4.1	0.0	0.0	0.0	1.2	0.0	3.2	0.8	0.8	3.3	0.2	28.0	0.0	1.6	6.7	14.7	0.8	11.0	2.2	0.0	0.8	0.0	39.7	5.3	0.3	0.0	0.0	1.8	1.8	7.9	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	20.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	49.8	0.0	0.0	0.0	1.2	0.7	0.0	1.7	3.8	0.2	0.0	0.0	0.0	0.5	17.6	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 36.7;RT4: 29.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	6	"basophil: 24.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 24.6"	"Group enriched"	"Detected in some"	5	"olfactory region: 0.7;thalamus: 0.8"	"Low region specificity"	"Detected in many"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.9	0.4	0.5	2.4	0.5	0.2	5.8	0.3	0.4	1.1	1.1	0.1	13.7	0.2	0.9	13.0	7.2	1.0	1.3	2.2	0.4	0.4	2.5	0.6	1.7	1.2	0.5	0.0	0.7	5.5	0.0	0.4	6.4	0.1	11.3	0.2	1.7	3.6	16.6	0.3	5.7	0.7	3.6	0.4	2.9	6.4	4.0	0.2	4.5	6.4	5.3	6.8	15.6	9.9	0.1	0.3	24.6	0.2	2.9	4.0	1.1	0.0	1.7	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.1	4.1	3.0	4.4	0.7	5.9	3.5	0.0	0.0	0.6	0.0	0.1	36.7	0.0	1.3	0.5	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.8	0.0	1.5	0.0	0.0	0.0	29.7	0.2	0.1	0.0	0.6	0.1	7.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.6	0.2	0.0	2.1	0.2	2.7	0.1	3.2	4.0	0.3	0.1	0.3	2.1	0.2	2.9	0.1	0.0	2.9	1.1	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.0	0.1	0.2
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.3;lymphoid tissue: 64.4"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 34.2"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 213.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 213.3"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	22.6	3.7	5.2	52.2	12.4	54.5	2.9	1.1	6.3	2.6	2.4	5.9	0.0	1.1	2.3	2.3	3.3	8.4	9.6	11.2	15.7	4.3	6.0	7.5	28.8	58.4	15.5	0.8	1.9	3.5	0.8	2.3	13.0	9.7	1.8	1.2	2.4	2.4	0.9	3.2	1.1	2.2	12.8	14.3	64.4	3.2	2.9	10.1	0.9	2.7	0.7	3.2	7.9	4.6	0.0	8.9	213.3	36.3	0.0	0.0	16.9	0.3	0.5	0.2	0.3	0.4	1.1	0.3	0.2	0.0	0.3	1.0	0.2	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.6	2.7	0.2	0.4	2.4	0.1	0.8	0.8	0.0	0.1	0.3	6.9	0.5	0.1	0.2	0.2	0.4	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.4	0.0	0.3	0.6	0.6	0.5	1.1	0.2	0.0	1.6	0.1	0.0	0.3	34.2	0.8	0.1	13.0	36.3	10.0	0.0	15.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	213.3	0.0	9.5	0.3	0.0	16.9	5.2	12.4	1.1	6.3	15.7	4.3	15.5	0.8	9.7	10.1
GP1BB	"CD42c, GPIbbeta"	ENSG00000203618	"Glycoprotein Ib platelet beta subunit"	P13224	22	19722945-19724771	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.7;brain: 19.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.6;K-562: 10.1;NB-4: 8.4;REH: 10.2;SH-SY5Y: 4.9;U-2 OS: 10.2"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"basophil: 6.3;neutrophil: 11.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									110000000	110000000																					0.9	0.5	16.7	1.2	19.6	0.5	0.5	7.3	9.0	0.5	1.7			1.2	0.7	0.5	1.8	0.5	0.7	2.9	15.0	4.1	0.5	0.9	0.6	0.6	2.7		0.5	0.5	0.5	2.5	0.6		1.3	0.7		1.9	0.5	1.2	10.4	0.5	1.0	0.2	1.8	1.9	0.5			0.7		0.7	0.5	0.2	0.1	1.7	11.0	1.2	0.1	0.3	61.7	0.0	0.9	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	1.7	5.6	2.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	10.1	0.1	0.1	0.4	0.4	8.4	0.4	3.1	10.2	0.0	0.1	0.0	0.0	3.7	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	6.3	1.2	1.1	0.2	0.3	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.1	11.0	0.1	0.0	1.7	0.3	61.7										
H3F3B	H3.3B	ENSG00000132475	"H3 histone family member 3B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 570.8;bone marrow: 441.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 570.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 570.8"									"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	57.2	41.2	38.1	58.9	48.6	441.9	71.4	60.2	47.0	86.6	44.6	65.9	42.7	37.9	60.5	77.7	93.2	70.2	75.8	35.1	38.5	33.9	42.8	48.1	64.2	62.3	50.4	41.2	141.0	90.9	33.0	41.5	58.5	42.7	60.5	26.6	65.8	58.4	55.4	71.1	114.0	58.0	63.7	51.8	65.9	45.1	66.9	46.2	78.6	58.9	69.1	55.7	78.5	71.9	78.9	88.1	570.8	98.4	80.0	77.2	203.5	118.3	105.1	43.9	43.3	25.1	39.4	60.7	56.1	49.7	68.9	55.3	112.5	84.2	59.3	53.6	32.6	46.6	34.7	77.5	39.3	32.3	78.2	52.9	56.1	95.2	56.7	87.8	68.1	42.9	48.0	70.6	91.1	51.7	74.8	106.6	35.4	174.1	126.0	73.7	35.2	117.5	93.8	80.4	64.6	54.4	70.3	89.1	99.0	56.9	83.5	120.3	65.4	94.8	48.2	123.7	109.4	53.3	148.4	129.0	76.3	71.2	65.4	83.8	67.4	182.8	98.4	259.3	74.4	86.9	70.2	78.9	71.8	70.5	86.7	65.3	77.2	64.5	570.8	80.0	78.9	88.1	76.0	203.5	38.1	48.6	60.2	47.0	38.5	33.9	50.4	41.2	42.7	46.2
HEATR5A	"C14orf125, DKFZP434I1735"	ENSG00000129493	"HEAT repeat containing 5A"	Q86XA9	14	31291791-31420582	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 35.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049539	Uncertain									"HPA049539: AB_2680809"	"unprognostic (2.63e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.47e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.11e-6)"	"unprognostic (1.00e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.00e-2)"	14.4	20.0	13.5	11.4	13.4	8.5	11.7	8.3	13.0	14.2	18.2	21.6	7.7	13.7	16.8	8.2	14.3	12.3	10.1	20.9	15.9	9.7	14.1	19.9	14.8	6.9	17.8	9.3	11.3	9.7	16.0	26.8	23.9	18.2	9.4	15.8	15.8	15.0	8.3	20.8	7.3	17.7	19.6	17.1	12.4	10.9	13.2	17.1	3.6	10.4	8.6	10.2	13.2	11.4	1.9	3.0	35.9	6.2	1.2	1.1	1.5	11.3	17.9	5.1	6.5	12.5	11.9	10.6	13.9	11.8	7.6	7.8	7.1	8.7	6.1	13.4	20.9	7.7	9.6	4.2	10.9	4.6	8.9	4.6	25.1	29.7	7.3	8.7	6.7	5.5	2.3	6.5	6.2	9.5	9.3	6.3	8.8	10.1	3.2	3.8	3.9	10.6	1.9	10.2	3.5	5.0	7.2	2.1	6.5	32.1	14.8	31.5	8.4	2.5	14.7	5.6	8.4	9.5	5.5	6.3	16.3	9.4	1.6	4.9	8.1	35.9	4.5	16.8	1.1	4.4	0.6	1.9	0.7	0.9	3.0	1.4	0.7	1.1	14.5	1.2	6.2	1.4	0.7	1.5	13.5	13.4	8.3	12.2	15.9	9.7	17.8	9.3	18.2	17.1
HIST1H4B	"H4/I, H4FI"	ENSG00000278705	"Histone cluster 1 H4 family member b"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 102.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	6	"neutrophil: 25.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.8"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	2.6	1.0	0.3	6.2	0.4	11.3	2.3	6.2	1.0	4.0	3.2	0.0	4.2	1.8	5.7	1.8	5.7	3.3	2.0	1.6	0.2		5.0	1.7	3.0	4.7	0.2	0.0	8.6	19.9	1.0	0.5	2.4	0.4	3.6	1.4	6.0	4.0	3.5	2.3	1.6	2.7	2.0	0.0	6.3	2.2	10.5	0.2	102.5	8.0	3.0	8.9	3.5	4.3	4.3	1.3	25.8	1.2	0.2	1.0	0.3	1.7	0.0	0.2	3.7	0.0	0.0	0.0	2.7	0.3	1.7	1.1	0.7	0.5	1.4	0.6	0.5	0.5	0.8	0.0	1.0	0.6	3.8	4.7	1.8	2.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	5.3	0.5	2.8	4.7	3.7	0.8	0.6	3.4	1.7	2.9	0.0	1.3	1.0	0.7	0.4	2.0	0.0	0.5	2.4	0.0	1.1	2.5	2.0	3.6	3.0	2.8	2.2	1.4	1.4	1.9	0.0	0.5	0.7	0.9	0.6	0.9	1.7	1.0	0.8	0.4	4.3	0.8	0.4	25.8	0.2	1.2	1.3	0.7	0.3										
LY96	MD-2	ENSG00000154589	"Lymphocyte antigen 96"	Q9Y6Y9	8	73991352-74029087	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.9;Karpas-707: 52.0;RPMI-8226: 25.1;U-87 MG: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 92.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053060			Approved	Vesicles	"Secreted to blood"	95000	95000	Vesicles		"HPA053060: AB_2682029"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.38e-11)"	"unprognostic (2.87e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.90e-2)"	23.4	9.6	5.7	20.9	9.6	7.3	12.6	1.6	7.8	7.5	10.3	2.5	2.7	6.0	6.2	12.3	9.6	7.6	17.1	18.8	11.2	5.8	7.4	10.9	17.3	36.3	11.6	1.9	12.7	3.2	0.7	7.2	21.8	9.2	9.6	7.4	3.9	9.0	3.4	6.0	3.5	7.0	10.0	19.6	47.3	4.9	7.2	6.6	5.3	6.5	5.2	18.4	15.3	16.1	4.0	6.8	92.6	14.2	0.0	3.1	4.6	0.4	0.0	0.1	0.0	10.0	20.9	0.0	13.9	16.9	3.7	8.7	0.0	0.1	4.3	4.8	8.9	0.1	0.0	0.2	9.7	4.6	0.1	0.1	0.0	0.4	5.0	0.7	0.2	6.1	0.1	6.1	1.2	18.5	0.0	52.0	13.4	0.0	1.7	0.5	0.0	0.3	1.7	0.0	25.1	0.7	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.9	14.3	9.7	0.7	5.1	3.3	13.7	6.3	2.6	26.8	0.2	4.1	1.6	14.2	0.0	0.0	12.3	0.2	4.0	2.0	0.3	6.8	1.8	1.3	0.4	92.6	0.0	9.8	5.6	3.1	4.6	5.7	9.6	1.6	7.8	11.2	5.8	11.6	1.9	9.2	6.6
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720452	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.3;eosinophil: 62.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA049781: AB_2680879"	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favourable (9.14e-4)"	"prognostic favourable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	13.5	7.4	24.3	14.4	28.5	11.1	25.2	16.4	32.2	26.6	10.0	45.0	9.4	7.9	25.1	22.8	18.3	24.9	13.3	7.7	31.3	23.9	16.7	5.1	22.0	14.7	29.7	21.9	15.6	24.6	15.6	15.5	8.5	38.2	21.7	12.7	9.5	32.2	14.0	3.3	24.5	8.5	17.0	59.9	9.6	30.4	8.1	25.5	14.7	10.3	11.0	24.6	16.5	13.7	8.5	9.2	62.2	10.2	4.6	6.8	5.8	10.5	9.6	16.3	20.4	20.2	25.5	13.1	13.4	25.4	13.2	17.7	14.7	15.3	16.5	8.6	24.7	13.3	15.4	26.6	17.0	38.7	11.7	19.2	20.9	32.9	11.1	29.1	33.3	21.1	13.8	15.2	12.5	29.2	4.2	32.1	36.9	16.1	23.4	9.0	17.5	10.7	19.7	25.9	4.7	19.8	14.7	18.6	26.9	13.9	21.1	16.4	12.5	4.5	17.2	16.5	17.0	11.0	11.3	25.8	17.1	15.4	20.1	22.3	25.9	50.3	8.9	62.2	3.0	9.6	3.5	8.5	4.0	3.4	9.2	4.1	2.5	2.9	9.4	4.6	10.2	1.8	6.8	5.8	24.3	28.5	16.4	32.2	31.3	23.9	29.7	21.9	38.2	25.5
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993796-91041064	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 36.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					57000	57000			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.54e-4)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	15.8	18.6	18.7	9.1	19.5	35.2	11.7	21.4	31.7	14.2	16.5	11.1	7.3	4.4	15.0	7.1	8.5	8.6	15.5	26.0	18.2	23.5	13.7	5.7	8.1	11.8	22.8	20.0	16.1	4.8	14.6	13.4	12.2	25.5	12.3	7.2	17.4	10.1	18.6	16.7	8.0	6.6	18.6	25.4	11.2	9.6	9.7	21.1	7.1	9.4	6.9	7.7	13.3	10.5	1.5	5.3	36.2	5.6	1.2	2.4	2.9	2.6	1.6	9.4	5.9	15.3	18.1	1.9	11.4	13.5	5.8	8.6	1.0	4.4	5.1	1.5	10.9	0.6	2.2	3.7	7.6	4.7	4.6	8.1	1.7	0.8	13.8	1.9	7.3	10.0	2.4	7.3	5.4	5.5	4.0	17.0	20.1	1.8	5.4	4.8	4.9	5.9	2.2	3.8	6.1	8.1	1.6	1.0	5.3	0.7	3.6	13.9	0.1	3.3	8.3	10.4	4.3	6.0	4.8	6.8	4.1	3.1	18.0	3.4	13.9	0.3	5.6	5.3	0.8	2.6	1.3	1.5	1.8	0.9	5.3	1.1	2.4	1.0	36.2	1.2	1.0	3.1	1.5	2.9	18.7	19.5	21.4	31.7	18.2	23.5	22.8	20.0	25.5	21.1
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		490000	490000	"Endoplasmic reticulum, Cytosol"		"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	13.9	43.2	28.0	44.0	77.9	37.1	21.3	34.7	35.4	25.2	28.9	8.2	15.8	6.1	36.4	30.1	6.5	6.7	13.6	11.0	22.6	24.6	6.5	14.8	10.3	53.2	2.7	75.0	70.6	28.5	19.2	13.2	21.1	23.0	24.6	18.1	18.3	4.7	13.0	18.2	8.9	6.0	21.3	24.9	12.9	10.5	20.1	33.4	16.6	10.3	18.5	14.2	47.0	37.2	21.3	10.2	18.0	7.7	25.6	27.3	6.3	34.2	10.9	13.1	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.6	5.7	4.3	5.5	16.3	16.4	25.5	12.0	15.8	16.2	18.3	14.4	25.6	2.8	14.5	11.8	19.7	6.1	12.2	15.1	8.4	8.4	6.0	5.1	24.3	21.8	6.4	9.7	15.0	20.1	19.2	12.7	29.5	5.2	9.0	16.2	8.2	8.6	6.5	3.0	10.4	5.6	7.2	11.1	19.1	23.7	5.7	4.2	7.2	17.9	17.3	4.8	8.7	19.5	8.2	4.7	12.2	2.6	18.3	10.7	0.1	2.6	9.0	6.0	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45544411	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	9.0	7.8	7.1	8.2	13.5	10.5	12.5	9.6	8.9	5.0	9.7	6.0	9.4	31.2	4.3	4.6	2.3	4.6	3.5	3.2	7.1	6.1	4.7	14.1	13.9	14.1	8.7	4.4	8.1	5.4	1.8	3.5	32.9	11.5	4.7	2.0	17.8	6.0	3.5	3.5	6.1	16.5	2.3	5.9	11.7	5.7	3.4	3.4	11.8	9.6	2.8	4.1	3.1	3.1	0.9	4.9	37.6	6.4	0.4	1.1	2.4	10.4	9.5	1.9	7.8	0.6	0.8	15.6	4.9	0.8	4.5	2.9	22.0	9.7	9.7	9.8	1.2	5.4	3.9	3.6	1.1	8.9	19.0	20.5	5.2	15.3	2.7	13.3	3.2	1.0	2.7	4.9	1.6	3.7	24.4	4.3	1.6	11.7	18.1	12.4	11.2	11.2	24.6	2.2	28.3	2.0	6.3	11.7	10.3	5.5	9.1	4.2	6.9	15.8	4.5	5.9	7.4	1.6	8.0	1.8	6.5	8.8	2.6	21.8	4.7	0.6	6.4	8.5	0.3	6.0	1.1	0.9	0.5	0.7	4.9	0.3	0.8	0.5	37.6	0.4	3.7	1.5	1.0	2.4	7.1	13.5	9.6	8.9	7.1	6.1	8.7	4.4	11.5	3.4
ST20-MTHFS		ENSG00000259332	"ST20-MTHFS readthrough"		15	79845150-79923754	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 52.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 52.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 52.3"									HPA008067	Uncertain									"HPA008067: AB_1078882"	"unprognostic (9.84e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.75e-3)"	"unprognostic (6.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-4)"	"unprognostic (2.38e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-1)"	5.4	7.7	9.2	12.1	8.4	9.1	5.4	12.5	7.2	5.9	6.4	4.9	3.3	5.0	6.3	7.3	4.4	7.2	8.1	7.2	7.4	8.3	14.1	18.8	10.3	7.6	8.6	4.1	5.1	4.1	11.5	10.2	6.3	7.9	9.8	5.4	6.6	7.8	6.5	4.8	4.0	8.3	4.5	8.4	9.3	8.8	8.3	4.7	7.0	9.6	4.3	7.4	6.7	7.8	5.8	3.9	52.3	9.2	7.3	5.0	4.6	4.4	10.4	4.1	4.5	12.9	6.0	9.8	6.2	6.4	6.1	6.5	4.9	8.1	7.5	3.6	3.4	9.5	11.1	5.2	5.2	9.2	11.3	8.0	9.0	4.3	5.9	5.0	3.4	7.1	0.9	2.1	11.2	2.1	9.5	3.9	2.7	9.2	3.5	7.6	6.1	7.1	9.5	2.4	3.1	2.5	4.8	10.7	8.5	10.6	5.6	14.5	6.7	7.3	5.9	5.3	6.5	0.2	5.3	5.9	15.2	6.5	3.8	17.1	5.5	8.2	6.2	17.4	3.2	4.7	3.3	4.5	3.7	3.4	3.9	5.8	4.4	5.0	52.3	7.3	9.2	3.6	4.2	4.6	9.2	8.4	12.5	7.2	7.4	8.3	8.6	4.1	7.9	4.7
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107407-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.3;skeletal muscle: 37.8"	"Cell line enhanced"	"Detected in some"		"HEL: 9.4;HHSteC: 22.3;HUVEC TERT2: 11.7;THP-1: 6.5;TIME: 30.6;U-698: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 44.3;neutrophil: 26.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain									"HPA016051: AB_2203924, HPA056857: "	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	9.6	3.4	4.9	4.9	6.8	4.7	11.2	4.4	13.9	4.0	3.0	6.8	0.9	2.3	3.2	4.1	2.4	3.4	3.9	9.2	7.2	6.7	2.9	2.5	10.6	9.0	8.0	7.1	2.1	1.5	1.8	1.7	7.2	10.0	2.5	2.9	3.4	3.2	1.9	37.8	1.7	2.6	3.8	12.5	5.2	2.1	4.1	3.7	0.6	9.9	3.5	3.0	4.9	2.4	0.2	4.6	44.3	7.8	1.0	1.2	2.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.2	9.4	0.0	0.0	22.3	0.5	0.0	0.1	0.0	0.0	0.0	11.7	0.4	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.8	0.0	6.5	30.6	0.3	0.4	0.0	0.1	0.9	0.0	7.0	0.0	1.2	0.0	14.1	7.8	44.3	1.2	3.3	0.0	0.0	0.1	0.1	4.6	0.2	0.0	0.1	26.4	1.0	1.4	0.6	0.0	2.8	4.9	6.8	4.4	13.9	7.2	6.7	8.0	7.1	10.0	3.7
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.6	18.9	18.4	22.8	6.8	11.6	24.9	13.5	14.3	22.9	12.6	26.6	11.9	23.7	15.7	14.1	15.7	25.5	21.5	30.5	9.6	13.4	13.6	8.9	17.6	9.0	20.2	8.3	7.3	16.6	23.9	27.7	17.5	37.1	5.2	15.8	28.6	20.9	9.8	22.1	12.8	27.2	10.1	11.2	14.4	11.1	17.2	10.1	32.3	10.5	9.1	24.1	12.9	12.8	15.9	12.7	8.0	12.8	8.7	12.1	60.1	10.3	13.0	16.3	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2
Z84488.2		ENSG00000285446			6	116399395-116463696	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.5;lymphoid tissue: 3.0"	"Cell line enhanced"	"Detected in some"		"BJ: 3.4;HDLM-2: 3.7;hTEC/SVTERT24-B: 2.8;Karpas-707: 4.3;RPMI-8226: 3.2;SiHa: 2.4"									"Cell type enriched"	"Detected in single"	6	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.5"																																					0.5	0.0		0.0		0.4	0.0		0.1	0.1	0.0			0.0	0.0	0.0	0.2	0.8	1.5	0.0			0.0	0.4	0.2	0.1			0.2	0.0	0.0		0.1		0.0	0.1		0.7	0.0	0.0	0.0	0.4	0.0		3.0	1.1	0.0			0.0		0.5	0.0		0.5	0.1	3.5	0.3	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	1.2	0.0	0.0	0.0	0.8	0.0	1.4	0.2	1.8	0.9	3.7	0.0	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.8	0.0	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	3.2	0.0	0.6	0.0	0.0	2.4	0.2	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.5	0.0	0.1	0.2	0.8	0.0	3.5	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
ZFP36L1	"Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B"	ENSG00000185650	"ZFP36 ring finger protein like 1"	Q07352	14	68787660-68796253	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 212.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 212.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001301	Uncertain									"HPA001301: AB_1080644"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.68e-2)"	59.0	22.4	40.2	42.4	35.0	14.2	89.9	16.3	31.0	91.5	60.2	49.6	24.8	26.0	90.6	37.5	66.8	59.9	36.5	36.2	45.1	15.3	34.6	46.0	45.6	39.0	32.7	16.7	121.7	47.1	63.4	14.8	62.7	44.9	65.3	21.9	29.9	60.3	43.7	31.6	90.2	28.5	91.2	47.3	33.9	42.2	26.9	39.4	22.1	43.3	22.7	57.1	81.2	93.2	37.0	8.7	212.7	17.7	10.4	16.1	14.4	38.8	37.3	15.5	22.4	39.3	31.6	34.3	16.5	27.4	9.6	12.1	16.3	25.8	9.4	10.0	28.4	18.0	1.4	51.0	11.8	4.4	2.2	3.4	18.7	11.5	22.4	0.5	4.3	26.6	65.5	11.7	76.7	19.3	9.6	18.5	51.1	9.2	1.4	1.7	12.9	5.4	24.9	20.8	2.8	35.3	28.0	0.1	0.4	18.6	26.8	13.8	24.6	0.4	44.1	28.6	21.0	22.6	15.7	10.4	5.2	6.5	35.5	0.2	10.8	14.2	17.7	0.2	16.1	17.2	15.0	19.7	12.9	11.2	8.7	37.0	14.1	12.4	212.7	10.4	11.4	1.1	12.0	14.4	40.2	35.0	16.3	31.0	45.1	15.3	32.7	16.7	44.9	39.4
AL096870.1		ENSG00000258973			14	24332310-24337382	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 4.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;HUVEC TERT2: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.1;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.1"																				"unprognostic (2.50e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.34e-1)"		"unprognostic (4.64e-1)"			"unprognostic (2.53e-1)"			"unprognostic (1.04e-1)"		"unprognostic (3.25e-1)"	"unprognostic (6.48e-2)"	2.7	0.0	0.0	0.9	0.0	1.4	2.0	0.0	0.0	0.9	0.9			1.2	0.7	0.0	0.6	0.2	0.6	0.8	0.0	0.0	0.5	0.1	1.7	0.6	0.0		0.0	0.2	0.0	0.0	1.4		0.6	0.7		0.8	0.1	0.9	1.6	1.3	0.3	0.0	1.1	1.8	0.1			1.2		0.3	0.6	1.1	0.1	0.3	4.1	0.8	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.1	0.7	0.0	0.0	0.0	0.2	2.4	0.0	0.4	0.4	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	4.1	0.8	0.1	0.1	0.3	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.1	2.5	0.2	0.1	0.3	0.7	0.2										
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;esophagus: 21.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.8;HUVEC TERT2: 5.3;K-562: 4.3;THP-1: 4.9;U-937: 7.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"eosinophil: 29.9;neutrophil: 43.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 43.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043669	Enhanced				"Intracellular and membrane"	43000000	43000000			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favourable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	0.7	0.2	0.0	0.9	0.0	2.7	0.7	0.0	0.0	5.0	7.3			13.0	0.9	0.0	21.5	0.4	0.0	1.9	0.0	0.0	1.5	0.0	4.6	0.1	0.0		0.0	0.6	0.0	0.6	0.1		1.3	2.0		2.8	2.2	0.1	2.2	12.5	0.3	0.0	4.3	1.0	0.0			0.3		0.9	1.2	8.4	0.0	1.6	43.3	6.7	0.4	8.1	1.7	0.3	0.0	0.3	0.1	0.5	2.1	0.5	0.6	0.2	0.0	0.1	3.1	0.0	0.1	0.8	1.5	2.1	0.0	0.5	0.0	0.1	0.4	0.0	0.1	1.6	0.7	0.7	9.8	2.6	1.8	0.1	0.1	5.3	4.3	0.3	0.0	0.7	0.0	2.8	0.7	0.1	0.2	0.6	0.0	0.2	1.1	1.3	0.9	0.0	0.2	0.0	0.0	4.9	1.9	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	7.9	0.0	21.7	4.3	29.9	0.7	3.3	8.1	0.0	0.3	1.5	1.6	0.0	0.0	0.1	43.3	0.4	6.7	0.1	0.1	1.7										
GJD4	"CX40.1, FLJ90023"	ENSG00000177291	"Gap junction protein delta 4"	Q96KN9	10	35605410-35608935	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;brain: 3.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.4"	"Not detected"	"Not detected"							HPA038266	Uncertain									"HPA038266: AB_10672741"	"unprognostic (2.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.74e-6)"	"unprognostic (2.00e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"		"unprognostic (8.49e-2)"		"unprognostic (7.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.19e-10)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-1)"	0.2	0.2	0.7	0.2	1.0	2.5	0.2	0.2	3.5	0.5	0.2	0.2	0.2	1.0	0.7	0.2	0.3	0.2	1.3	0.3	0.6	1.3	0.2	0.3	0.2	0.4	0.8	0.2	0.2	0.4	0.3	0.5	0.4	0.2	0.3	0.3	0.2	0.8	0.2	1.5	2.6	0.8	0.2	0.3	0.4	0.8	0.9	0.2	0.2	0.9	0.2	0.2	0.4	0.2	0.7	0.9	5.4	0.6	0.6	0.8	0.2	0.9	0.9	0.5	1.5	0.2	0.0	1.4	0.2	0.0	0.0	0.3	0.7	1.4	1.0	0.5	0.1	1.5	0.1	0.3	0.3	1.1	0.8	0.9	0.4	0.6	0.0	0.2	0.8	0.3	0.3	0.3	0.1	0.2	1.8	1.9	0.2	1.3	1.3	1.0	0.9	2.4	0.8	5.8	0.4	0.1	1.6	1.2	0.8	0.8	0.6	1.3	1.0	1.3	1.4	1.0	2.0	0.8	0.6	1.0	0.6	0.3	0.9	0.8	1.0	1.8	0.6	0.7	0.5	0.2	0.4	0.6	0.5	0.4	0.4	0.7	0.8	0.7	5.4	0.6	0.2	0.9	0.2	0.2	0.7	1.0	0.2	3.3	0.6	1.3	0.8	0.2	0.2	0.2
H3F3A	"H3.3A, H3F3"	ENSG00000163041	"H3 histone family member 3A"	P84243	1	226061851-226072001	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 258.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 258.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011481, CAB037178, HPA042570"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (3.66e-2)"	"unprognostic (8.03e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.03e-2)"	39.0	43.4	37.2	83.4	33.4	126.8	67.9	45.0	42.8	44.6	54.0	31.6	62.9	47.9	43.4	60.6	66.3	42.4	49.6	59.4	36.1	31.2	45.9	59.2	73.2	217.9	37.8	23.2	44.4	79.7	30.8	34.8	59.1	29.2	38.4	59.4	42.7	49.0	49.7	37.0	47.1	50.0	42.0	48.6	71.9	41.4	87.6	31.7	148.9	38.5	71.0	84.1	43.5	47.6	39.2	44.6	258.7	56.9	23.6	34.9	60.5	53.7	30.7	119.8	67.6	33.3	38.8	90.0	25.5	31.0	41.4	32.8	32.0	89.7	51.8	56.8	31.3	51.6	59.2	46.5	40.8	32.0	102.3	64.0	45.5	42.8	33.0	65.7	77.8	35.5	53.9	29.0	38.2	61.3	90.1	88.6	47.1	31.1	136.4	122.3	162.5	60.9	92.4	87.5	133.4	85.8	57.5	117.0	174.0	72.8	92.1	63.1	104.4	154.2	34.5	30.2	42.1	40.7	73.9	39.5	50.5	90.4	28.8	62.8	64.5	40.0	56.9	80.8	23.1	44.9	23.6	39.2	25.0	24.9	44.6	36.0	23.7	25.7	258.7	23.6	50.8	36.6	34.9	60.5	37.2	33.4	45.0	42.8	36.1	31.2	37.8	23.2	29.2	31.7
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol				Cytosol		"HPA004775: "	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.0	9.6	10.0	16.3	7.8	21.9	9.0	13.9	10.8	10.1	6.6	12.8	13.4	28.3	46.2	12.6	13.1	2.3	10.8	3.7	13.2	4.8	9.6	9.4	2.9	8.5	3.0	0.4	14.3	3.8	10.0	5.4	20.8	10.2	11.6	6.4	6.1	27.8	7.5	14.0	10.7	21.4	5.3	10.2	4.3	9.2	2.8	6.8	10.6	4.9	5.0	4.6	4.1	23.5	20.7	22.5	16.8	9.8	26.2	19.0	22.5	8.5	14.3	6.7	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell line enhanced"	"Detected in many"		"K-562: 48.9;SiHa: 46.5;U-2 OS: 91.7;U-266/70: 101.7;U-266/84: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	Nucleoplasm,Nucleoli		1800000	1800000	"Nucleoplasm, Nucleoli"		"CAB011507: AB_2117984, HPA055907: "	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.7	4.2	3.1	3.3	8.0	1.6	0.1	2.9	4.8	13.8	14.7	2.2	4.2	0.4	16.8	3.8	2.5	1.0	2.2	3.9	5.6	3.6	2.4	4.6	2.5	2.3	1.1	5.8	11.2	3.1	1.8	3.0	2.1	48.9	36.8	6.8	2.6	2.9	2.6	1.7	6.4	1.5	1.4	18.7	8.1	4.2	8.0	2.7	46.5	8.0	3.2	9.9	1.7	0.9	6.3	91.7	1.8	1.3	101.7	96.6	4.4	4.6	38.1	2.1	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4
HIST2H2BE	"H2B, H2B.1, H2B/q, H2BFQ"	ENSG00000184678	"Histone cluster 2 H2B family member e"	Q16778	1	149884459-149886652	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;U-266/70: 39.7;U-266/84: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: "	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-3)"	14.3	16.2	9.8	22.2	10.0	19.4	16.9	17.2	14.0	31.3	9.0	11.2	10.5	6.4	18.5	24.9	25.5	13.3	9.6	51.1	13.1	10.1	12.5	10.2	27.5	24.5	12.4	8.7	28.0	13.4	5.8	15.4	17.2	8.5	72.8	7.6	19.4	24.1	15.3	43.1	33.5	8.6	18.8	18.2	22.0	17.5	9.3	11.6	198.1	12.1	12.4	25.3	27.2	33.8	2.3	4.5	29.9	5.5	0.7	1.2	5.1	1.1	1.1	1.9	0.4	10.1	2.7	0.9	4.0	2.7	1.7	0.5	0.4	1.8	0.2	1.1	3.5	4.5	1.5	0.7	0.9	1.4	1.2	0.3	4.5	0.8	3.2	0.3	5.3	9.2	3.3	0.7	2.8	0.5	4.8	23.8	2.1	6.8	1.2	2.0	1.2	2.4	1.4	0.7	5.4	1.6	0.9	12.8	2.0	13.8	1.9	1.0	9.8	0.9	0.7	1.3	14.4	0.9	0.3	39.7	21.2	1.0	1.7	1.4	0.7	8.4	2.1	3.8	0.7	3.2	1.2	0.8	0.9	1.1	1.6	2.3	1.2	1.1	29.9	0.7	5.5	4.5	1.0	5.1	9.8	10.0	17.2	8.5	13.1	10.1	12.4	8.7	8.5	11.6
IFIT2	"cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K"	ENSG00000119922	"Interferon induced protein with tetratricopeptide repeats 2"	P09913	10	89283694-89309276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 93.4"	"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 49.6;BJ hTERT+ SV40 Large T+ RasG12V: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 93.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003408	Approved		Approved	Vesicles				Vesicles		"HPA003408: AB_1079100"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.46e-2)"	15.5	7.7	10.2	8.9	11.9	31.9	5.5	8.1	10.5	4.5	3.7	15.6	2.1	4.7	3.5	7.4	2.3	6.7	9.7	4.8	10.4	9.2	10.5	14.9	14.4	6.5	23.7	6.7	6.9	2.4	4.5	3.3	11.3	20.4	3.9	3.1	5.2	5.8	4.7	1.8	2.5	4.1	4.6	29.4	18.0	2.6	1.3	17.9	3.9	4.2	0.4	3.7	7.3	3.5	4.0	2.9	93.4	17.0	1.7	2.2	3.4	9.8	0.3	0.1	4.6	4.7	5.2	1.4	3.7	10.4	49.6	39.4	0.0	7.2	1.1	2.1	2.6	10.4	0.2	0.5	5.3	4.1	0.0	1.8	5.3	0.0	8.1	0.2	0.8	2.9	0.2	3.7	0.5	0.2	0.0	0.2	0.7	0.0	1.2	2.3	0.1	2.0	0.7	1.2	0.2	1.6	2.0	0.0	0.0	1.1	0.2	8.9	0.2	0.5	0.3	0.5	0.1	1.4	0.3	0.3	1.7	0.1	0.8	0.8	1.0	17.9	7.0	21.8	2.2	15.1	1.2	4.0	1.7	1.5	2.3	3.5	1.8	1.6	93.4	1.7	17.0	2.9	0.9	3.4	10.2	11.9	8.1	10.5	10.4	9.2	23.7	6.7	20.4	17.9
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	21.0	8.9	3.7	12.2	4.6	3.6	13.6	1.1	4.0	17.0	12.3	1.7	6.0	3.3	9.5	10.2	8.5	7.3	11.0	23.6	4.0	3.7	17.0	25.3	16.1	14.0	4.2	1.7	12.8	5.8	4.1	12.6	22.1	6.3	12.2	6.1	3.6	7.6	6.7	10.0	3.2	6.2	13.3	5.2	30.6	5.3	5.8	3.8	15.2	19.8	6.2	7.8	15.1	26.2	3.3	3.7	19.8	4.3	3.7	2.4	1.1	3.2	10.1	11.5	7.1	27.7	29.3	10.1	53.2	32.7	14.1	18.0	2.1	3.2	10.7	9.1	32.7	7.0	4.4	20.4	23.9	3.1	6.8	4.1	6.5	15.1	10.6	7.5	8.2	21.9	4.4	16.2	14.6	19.8	6.2	4.2	34.6	2.9	3.4	17.5	4.3	8.7	3.0	16.6	5.4	23.2	3.7	1.7	5.5	15.2	1.0	8.4	3.3	9.5	18.5	30.1	10.7	13.2	13.6	4.6	4.8	8.0	8.9	7.0	21.6	6.0	4.3	12.6	2.1	3.3	2.4	3.3	1.3	2.1	3.7	2.2	1.4	1.5	19.8	3.7	3.7	2.6	1.6	1.1	3.7	4.6	1.1	4.0	4.0	3.7	4.2	1.7	6.3	3.8
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 202.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 202.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 202.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	55.0	14.1	18.0	49.2	42.4	53.3	65.7	5.0	18.5	50.4	36.4	45.2	20.2	13.9	42.7	28.8	19.6	34.0	35.3	31.5	20.7	15.7	48.9	66.3	73.0	80.6	28.6	13.2	43.1	26.3	15.9	17.1	46.2	42.8	36.2	36.7	26.0	57.3	32.2	18.6	28.5	24.1	41.6	52.1	57.9	26.3	11.0	19.0	18.7	53.3	18.8	36.4	47.4	41.6	14.1	16.9	202.5	10.3	20.2	37.6	35.6	13.7	25.6	16.2	7.8	2.5	1.9	16.4	17.9	55.1	17.0	25.4	10.6	37.1	6.9	22.9	15.1	17.0	6.8	30.0	16.3	52.7	7.1	0.5	22.3	53.7	38.0	2.1	2.3	5.7	58.3	13.9	38.2	0.0	4.2	26.8	0.2	13.1	0.3	31.8	26.4	0.1	2.1	3.5	39.6	14.3	19.4	4.0	12.2	30.9	39.5	31.8	22.1	11.7	0.1	7.1	12.0	4.1	4.1	10.5	23.1	17.7	8.1	16.8	40.5	32.2	10.3	20.8	37.6	9.8	22.8	14.1	23.5	33.5	13.6	13.9	26.8	31.7	202.5	20.2	5.7	16.9	26.2	35.6	18.0	42.4	5.0	18.5	20.7	15.7	28.6	13.2	42.8	19.0
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.5;HaCaT: 25.7;HL-60: 28.7;HMC-1: 47.8;WM-115: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (3.43e-4)"	"prognostic favourable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	9.4	1.2	1.0	0.1	3.3	1.2	1.7	4.0	3.9	2.0	2.0	2.1	33.5	0.0	13.8	5.7	25.7	0.6	5.5	3.2	2.5	2.8	9.6	3.1	4.9	1.2	28.7	47.8	0.6	5.6	2.2	1.8	15.4	0.4	0.1	3.3	0.6	0.0	11.6	1.5	0.1	2.9	1.1	1.4	1.9	3.7	0.6	7.4	7.7	3.1	5.6	1.3	7.3	17.3	0.3	0.0	2.0	2.7	0.1	0.0	0.0	0.8	14.0	34.0	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706885-31710595	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3"	"Cell line enriched"	"Detected in single"	138	"HEL: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"									HPA008053	Uncertain					12000000	12000000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	1.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MED13L	"KIAA1025, THRAP2, TRAP240L"	ENSG00000123066	"Mediator complex subunit 13 like"	Q71F56	12	115953872-116277338	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039445	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA039445: AB_10673532"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.64e-1)"	21.3	7.9	9.8	14.7	10.6	39.1	22.0	29.7	11.1	17.3	13.6	12.1	12.3	7.8	21.6	11.1	13.2	13.9	12.2	9.4	11.0	7.0	9.0	7.3	15.2	16.7	11.5	9.1	20.5	15.6	14.3	13.6	13.4	9.6	14.6	10.9	11.7	14.2	14.2	18.1	21.9	13.1	15.3	11.9	14.3	12.8	14.9	11.2	55.9	14.0	10.8	15.4	13.8	22.7	2.5	1.9	13.1	1.1	1.4	1.1	0.7	6.3	15.2	7.1	8.0	9.6	15.8	7.6	6.7	8.9	9.3	6.6	15.1	2.3	4.4	5.6	12.1	4.7	8.1	5.3	12.3	9.9	5.2	8.9	4.5	5.6	10.6	8.0	12.0	12.7	9.2	10.2	15.6	6.7	9.8	4.3	8.0	14.3	15.7	16.8	4.0	3.6	11.1	7.7	10.5	6.0	5.8	7.3	6.3	6.0	3.2	5.9	50.1	17.7	8.3	10.6	7.0	7.7	8.0	8.3	3.8	8.0	4.9	8.8	5.6	13.1	1.1	3.6	1.0	0.9	1.1	2.5	1.0	1.1	1.5	1.3	0.8	0.9	4.1	1.4	1.1	1.9	0.7	0.7	9.8	10.6	29.7	11.1	11.0	7.0	11.5	9.1	9.6	11.2
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in some"	15	"NB-4: 35.9;THP-1: 67.7;U-937: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	Nucleoplasm,Nucleoli		110000	110000	"Nucleoplasm, Nucleoli"		"HPA034532: AB_10669677, HPA073215: "	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3
MPL	"CD110, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337849-43352772	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.6"	"Cell line enriched"	"Detected in single"	78	"HEL: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Low region specificity"	"Detected in all"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"				"Plasma membrane"	"Nuclear membrane"	"HPA007619: "	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	1.1	0.3	0.9	0.5	0.8	2.0	0.9	0.5	2.2	0.6	0.6	0.5	0.5	0.3	0.9	1.7	0.9	2.1	0.5	3.9	0.8	0.6	0.5	0.5	2.0	0.5	0.9	0.5	6.6	1.1	0.6	0.6	2.2	0.5	1.5	0.7	0.5	0.5	0.7	0.6	0.4	1.2	2.1	2.5	8.6	0.5	2.1	0.5	0.5	2.2	2.4	0.5	0.9	0.5	0.0	0.0	1.6	0.3	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	40.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.0	0.9	0.8	0.5	2.2	0.8	0.6	0.9	0.5	0.5	0.5
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361943-41409390	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.2;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.2;BJ hTERT+ SV40 Large T+ RasG12V: 41.2;MOLT-4: 26.3;U-266/84: 43.8;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 61.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.2"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain									"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	21.6	1.4	1.6	14.3	7.6	12.5	11.5	0.7	2.3	9.2	4.7	3.0	2.5	5.5	9.2	7.4	5.7	5.6	12.4	7.1	2.3	2.2	4.9	3.0	6.1	34.7	2.2	2.8	3.9	2.8	0.2	1.7	5.7	6.1	4.4	2.8	5.7	6.7	1.8	4.5	4.8	8.9	4.9	5.5	24.3	11.2	3.9	2.1	35.9	4.6	2.4	14.9	12.3	6.7	5.2	7.4	61.2	11.7	2.5	8.3	6.3	0.2	0.0	0.0	0.0	0.9	2.3	0.0	0.0	5.8	42.2	41.2	0.0	14.3	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.5	0.0	17.4	0.0	7.5	0.3	0.3	0.0	3.4	0.0	0.8	0.0	0.0	0.7	8.9	0.0	0.0	26.3	10.5	16.5	0.2	3.8	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.6	1.3	45.2	4.5	2.3	10.5	9.0	4.4	11.7	5.7	5.2	7.1	5.2	7.4	4.7	8.3	5.4	61.2	2.5	10.3	4.2	4.8	6.3	1.6	7.6	0.7	2.3	2.3	2.2	2.2	2.8	6.1	2.1
NINJ1	NIN1	ENSG00000131669	"Ninjurin 1"	Q92982	9	93121489-93134288	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 48.1;HHSteC: 43.8;MCF7: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 149.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045063	Uncertain									"HPA045063: AB_10964133"	"unprognostic (1.23e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.46e-3)"	20.7	42.5	14.8	15.2	15.5	92.9	30.5	7.5	14.7	14.9	19.9	20.4	9.6	10.6	12.9	27.0	14.7	14.9	16.5	27.1	14.3	14.6	39.0	51.7	24.3	28.1	17.1	7.2	16.9	17.9	39.3	20.2	37.3	15.6	18.9	7.3	24.6	31.9	25.7	16.9	30.7	15.4	17.2	20.7	34.7	13.5	21.7	12.9	11.4	43.8	13.7	13.4	25.4	14.3	0.6	6.7	149.2	29.5	3.9	9.0	15.3	10.5	16.5	3.4	7.2	12.6	5.0	13.3	7.7	21.9	11.2	6.9	7.2	3.6	0.1	3.7	7.4	11.0	3.8	21.3	2.4	24.4	7.3	1.6	4.2	48.1	43.8	1.1	3.4	16.7	20.9	10.7	5.7	10.6	1.1	12.0	2.5	46.8	3.3	3.4	4.6	13.6	5.9	2.5	18.9	9.0	4.5	1.0	4.7	16.2	25.6	9.9	19.8	7.4	7.5	3.9	11.5	8.1	5.3	6.8	2.6	0.2	11.9	3.5	3.0	9.8	27.1	69.4	6.6	27.3	9.0	0.6	6.1	5.6	6.7	0.2	7.5	5.2	149.2	3.9	29.5	0.9	6.3	15.3	14.8	15.5	7.5	14.7	14.3	14.6	17.1	7.2	15.6	12.9
OR4F15		ENSG00000182854	"Olfactory receptor family 4 subfamily F member 15"	Q8NGB8	15	101812202-101820197	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"basophil: 2.7;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.7"	"Not detected"	"Not detected"																																			0.1	0.1	0.1	0.8	0.1	0.7	0.1	0.1	0.3	0.7	0.1			0.5	0.3	0.2	0.4	0.4	0.4	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.3		0.2	0.1	0.0	0.1	0.0		0.1	0.0		0.2	0.0	0.1	1.1	0.4	0.0	0.1	0.8	0.1	0.4			0.4		0.0	0.3	0.2	0.5	0.3	2.7	0.3	0.5	0.2	0.1	0.1	0.0	0.9	0.9	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.5	1.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.7	1.1	0.4	0.0	0.2	1.0	0.5	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.7	0.1	0.6	0.5	0.5	0.3	0.1	0.3	0.5	0.3	0.3	0.0	0.2	0.3	0.0	0.5	0.6	0.0	1.5	0.4	1.2	0.7	0.8	0.3	0.4	1.4	0.3	0.8	2.7	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.2	0.2	1.9	0.5	0.1	0.3	0.1	0.1										
OR5H14		ENSG00000236032	"Olfactory receptor family 5 subfamily H member 14"	A6NHG9	3	98147479-98156614	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.1;placenta: 2.1"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"																																					0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.4	0.1			0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.2	0.1		0.2	0.1	0.0	0.1	2.1		0.1	0.0		0.3	0.0	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5			0.1		0.0	0.2	0.1	0.4	0.4	2.1	0.4	0.4	0.4	0.0	0.6	0.6	0.6	0.6	0.3	0.1	0.5	0.8	0.5	0.1	0.0	0.9	0.5	0.3	0.4	0.0	0.9	0.1	0.3	0.0	0.5	0.6	0.6	1.0	0.7	0.2	0.4	0.5	0.1	0.7	0.2	0.0	0.0	0.3	1.4	0.0	1.0	0.4	0.7	0.7	1.1	0.7	0.2	0.4	0.1	1.0	0.3	0.5	0.4	0.4	0.5	0.6	0.3	0.1	0.7	1.1	0.9	0.4	0.8	0.9	0.7	0.5	0.3	0.5	2.1	0.4	0.4	0.4	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.4	0.2	0.4	0.3	0.0										
PCDHB13	PCDH-BETA13	ENSG00000187372	"Protocadherin beta 13"	Q9Y5F0	5	141213919-141218979	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.7;T-47d: 14.8;U-2197: 12.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"																				"unprognostic (9.91e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.55e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.93e-3)"	2.1	2.9	1.0	0.6	1.4	0.0	2.1	1.7	2.3	3.2	1.8			0.0	3.4	2.6	1.4	2.0	3.3	2.8	1.0	1.0	1.6	0.9	1.5	0.2	0.7		3.1	4.2	1.5	3.3	2.5		2.4	1.0		2.8	2.3	0.5	3.8	0.4	2.7	1.2	1.4	1.4	1.8			1.7		0.1	1.5	1.6	1.2	0.5	6.7	0.5	0.4	0.6	0.0	0.0	0.2	1.9	1.4	4.9	5.3	0.4	0.3	2.5	0.7	1.5	0.0	2.0	0.0	7.7	1.8	0.5	1.7	0.0	0.5	0.0	0.1	0.0	0.9	0.3	0.1	0.0	0.9	0.4	1.3	0.1	0.1	0.7	0.3	1.9	2.4	0.3	0.2	0.1	0.4	0.2	5.5	0.9	0.0	0.1	0.1	1.8	0.6	2.4	0.2	0.7	14.8	0.1	2.2	0.6	1.4	12.1	0.0	0.0	0.1	0.0	3.4	0.1	3.7	1.8	0.5	1.7	0.4	0.4	0.3	0.7	0.4	0.4	0.1	1.2	0.6	0.6	6.7	0.4	0.3	0.5	0.4	0.0										
POLM	Tdt-N	ENSG00000122678	"DNA polymerase mu"	Q9NP87	7	44072247-44082540	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058900, HPA066007"			Supported	Nucleoplasm				Nucleoplasm		"HPA058900: AB_2683848, HPA066007: AB_2685595"	"unprognostic (2.44e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-3)"	10.7	8.7	7.0	18.0	7.1	7.6	12.2	11.9	8.8	13.8	11.2	11.1	11.7	12.2	10.1	12.0	11.7	11.8	11.8	10.8	6.8	4.4	13.0	12.5	10.1	20.9	9.9	7.0	13.8	12.3	10.0	9.0	8.1	8.2	11.8	7.1	12.4	13.5	14.3	11.2	12.0	12.6	8.9	9.0	18.7	12.0	6.8	8.1	30.1	15.4	8.3	17.6	12.4	10.7	5.9	4.8	31.6	2.1	3.5	4.2	1.3	1.0	1.5	1.5	3.4	2.2	2.5	4.9	3.5	3.9	2.7	1.6	1.9	2.6	11.1	3.5	2.9	3.3	1.6	37.7	1.5	3.9	3.5	1.3	1.6	0.7	3.1	3.4	5.0	4.0	3.6	2.2	2.8	4.8	1.6	5.4	2.3	2.5	7.0	3.0	3.3	8.1	5.6	0.9	4.4	3.0	1.8	1.6	2.9	1.7	7.2	3.6	4.6	6.0	3.3	1.9	2.8	1.9	5.1	8.9	4.4	8.7	3.5	3.1	4.6	8.6	1.8	5.1	3.3	2.1	3.3	4.0	2.9	3.0	1.6	5.9	4.2	3.4	31.6	3.5	1.6	4.8	2.7	1.3	7.0	7.1	11.9	8.8	6.8	4.4	9.9	7.0	8.2	8.1
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 34.6;U-937: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"eosinophil: 54.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	17.2	7.1	5.6	24.7	7.9	34.0	16.1	1.7	4.7	12.6	15.9	6.2	4.6	5.3	17.5	7.3	11.5	10.9	13.9	10.1	6.5	3.4	6.1	8.3	20.2	44.9	7.2	1.8	14.9	4.0	2.3	2.9	13.3	6.0	11.2	3.7	7.3	7.9	6.1	6.6	9.5	11.3	13.9	9.8	37.4	9.1	4.9	6.2	48.2	7.8	7.8	23.6	18.2	18.0	4.2	3.4	54.5	4.1	10.2	11.9	5.2	9.9	1.6	5.9	7.2	4.3	11.5	0.2	5.9	6.9	5.3	3.6	1.2	2.0	9.7	5.4	10.4	6.6	2.9	6.5	2.7	8.1	0.6	23.3	2.9	1.2	3.4	6.1	34.6	7.0	7.6	13.0	11.7	4.2	4.3	4.9	6.2	1.0	8.6	12.0	0.0	0.4	27.5	5.2	7.9	3.1	0.6	0.4	2.0	5.5	2.1	11.0	1.6	8.3	14.1	20.8	5.3	0.0	14.7	1.8	9.5	12.0	6.0	36.0	24.2	8.1	2.8	54.5	11.7	4.1	8.5	3.1	5.7	11.9	1.8	4.2	4.7	9.0	13.2	10.2	3.0	3.4	9.4	5.2	5.6	7.9	1.7	4.7	6.5	3.4	7.2	1.8	6.0	6.2
PYROXD2	"C10orf33, FLJ23849"	ENSG00000119943	"Pyridine nucleotide-disulphide oxidoreductase domain 2"	Q8N2H3	10	98383565-98415184	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.8"	"Cell line enhanced"	"Detected in many"		"U-937: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037566, HPA037567, HPA067394"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832"	"unprognostic (2.35e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic favourable (3.37e-4)"	11.0	15.5	5.1	9.0	7.0	2.7	9.2	2.6	6.3	12.2	6.5	12.0	14.2	2.5	8.3	15.5	4.1	11.6	13.1	9.5	5.3	3.8	6.7	11.7	8.6	2.9	12.6	3.0	11.5	4.3	7.5	6.0	5.0	9.6	12.9	5.8	12.5	26.9	11.3	9.6	3.2	4.1	12.2	8.1	5.2	5.5	3.7	10.7	4.3	9.2	2.3	3.0	11.9	6.9	0.0	0.5	50.8	0.0	11.3	1.8	0.4	2.4	6.1	3.4	0.1	5.4	10.9	1.3	4.0	12.4	2.3	4.3	0.0	8.5	0.0	7.2	4.2	1.2	1.0	1.3	2.3	0.2	1.0	4.9	10.0	0.5	7.0	0.0	11.4	6.4	1.8	1.8	2.2	1.7	0.1	0.1	3.4	7.5	0.1	11.6	1.0	2.1	1.5	1.3	0.1	3.3	3.7	0.2	0.1	4.3	0.5	3.0	3.5	5.5	2.3	0.0	2.6	0.7	3.9	0.8	0.5	0.0	4.1	21.4	0.3	1.1	0.0	50.8	1.8	0.0	0.4	0.0	0.6	1.5	0.5	0.0	0.3	1.1	0.1	11.3	0.0	0.1	0.1	0.4	5.1	7.0	2.6	6.3	5.3	3.8	12.6	3.0	9.6	10.7
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;SCLC-21H: 23.8;SK-MEL-30: 80.0;U-266/84: 62.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	7.9	0.0	0.0	1.0	2.6	0.0	1.0	17.5	1.3	2.1	0.5	1.4	0.0	0.6	5.9	0.0	0.5	0.0	2.1	0.1	15.3	3.5	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.7	0.0	5.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.1	8.6	2.1	23.8	0.0	1.3	0.0	80.0	0.1	0.5	3.7	0.0	0.0	0.0	0.1	3.0	62.5	0.0	5.3	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3;bone marrow: 55.8"	"Group enriched"	"Detected in many"	5	"MOLT-4: 14.8;U-937: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"neutrophil: 81.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 81.3"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	1.6	1.0	0.5	9.8	0.6	55.8	0.6	1.0	0.8	0.4	1.0	0.2	0.0	1.3	1.0	1.0	1.1	1.2	1.8	10.8	0.5	0.5	0.8	1.5	6.7	19.9	0.6	0.0	1.4	1.0	0.0	0.7	0.8	0.5	0.5	0.2	0.4	2.2	0.0	0.8	1.9	4.1	0.0	0.6	21.6	0.9	18.4	0.3	11.1	1.0	0.3	8.9	1.1	3.6	0.9	0.8	81.3	12.0	4.8	17.8	5.8	0.9	0.3	3.4	1.5	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.6	1.1	0.2	0.0	1.6	0.0	0.0	0.0	1.1	2.1	0.5	1.2	0.2	0.0	1.9	2.3	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.5	14.8	2.1	0.2	0.4	5.3	1.2	0.8	0.0	1.0	1.0	1.6	1.0	2.2	0.3	0.7	1.1	1.4	1.9	1.2	1.3	0.6	3.1	0.5	0.7	1.1	34.8	0.9	11.8	0.4	58.6	9.5	2.9	9.8	0.9	12.4	10.9	0.8	0.7	17.8	15.9	81.3	4.8	12.0	0.1	17.0	5.8	0.5	0.6	1.0	0.5	0.5	0.5	0.6	0.0	0.5	0.3
RIPOR2	"C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP"	ENSG00000111913	"RHO family interacting cell polarization regulator 2"	Q9Y4F9	6	24804281-25042170	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 125.3;lymphoid tissue: 49.7"	"Cell line enhanced"	"Detected in some"		"AF22: 14.0;Daudi: 32.9;fHDF/TERT166: 32.1;U-266/70: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 125.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 125.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.05e-3)"	"unprognostic (1.34e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.89e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	8.2	2.5	6.7	38.0	14.9	14.7	4.7	1.8	11.4	8.6	2.5	1.9	1.4	1.9	33.8	4.2	3.4	8.8	5.5	7.3	6.1	6.2	2.7	2.8	13.2	49.7	3.6	9.1	2.5	1.8	0.8	16.9	17.8	2.9	4.4	2.7	3.3	12.5	3.0	12.9	4.0	11.9	10.7	2.2	39.1	3.8	4.1	2.4	21.5	2.5	1.2	42.7	7.7	5.4	25.8	9.1	125.3	21.1	15.8	24.6	18.1	0.4	0.0	14.0	0.2	0.1	0.1	5.1	3.6	6.9	1.6	2.4	0.1	0.2	32.9	0.9	32.1	0.3	0.0	0.0	0.3	3.3	0.1	7.9	0.5	0.1	0.2	0.1	0.6	1.4	0.1	0.0	0.1	0.0	0.4	5.6	0.1	0.1	7.3	0.3	1.0	0.9	7.8	1.3	0.3	0.0	0.1	0.7	0.1	0.2	0.1	2.5	0.1	0.2	0.1	0.3	1.5	0.3	0.4	11.9	0.2	1.0	0.3	0.4	2.2	43.1	12.9	41.8	18.1	16.7	19.1	25.8	18.5	18.9	9.1	25.0	24.6	19.1	125.3	15.8	21.1	7.5	15.9	18.1	6.7	14.9	1.8	11.4	6.1	6.2	3.6	9.1	2.9	2.4
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4, Y-linked 2"	Q8TD47	Y	20756164-20781032	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3"	"Cell line enriched"	"Detected in single"	7	"U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"					"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.7"									HPA000857	Uncertain									"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.1	0.0	10.7	0.0	0.0	0.0	0.0	0.0										
SCARF1	"KIAA0149, SREC, SREC1"	ENSG00000074660	"Scavenger receptor class F member 1"	Q14162	17	1633858-1645747	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.9"	"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HUVEC TERT2: 15.5;REH: 7.9;TIME: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 8.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072936	Enhanced				"Intracellular and membrane"	940000	940000			"HPA072936: AB_2686559"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.39e-2)"	15.3	3.4	2.3	6.8	2.8	3.7	15.6	3.5	2.4	6.7	3.8	2.4	2.3	3.9	8.7	5.7	2.9	4.1	4.8	10.1	2.1	2.2	5.4	6.1	12.6	8.5	2.9	3.1	4.5	3.1	2.5	2.8	7.6	3.4	5.0	1.8	5.3	2.7	3.4	5.7	2.4	3.8	3.6	2.4	28.9	3.4	3.4	1.3	1.5	13.5	4.6	2.5	4.7	12.4	0.0	1.1	8.3	1.7	0.0	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.5	2.3	2.8	3.5	2.4	2.1	2.2	2.9	3.1	3.4	1.3
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884410-53891988	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 78.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 78.6"	"Low region specificity"	"Detected in all"							HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favourable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favourable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	20.4	33.5	29.2	19.0	30.2	38.8	24.1	19.7	21.7	18.9	20.5	20.9	28.3	17.3	15.8	49.4	15.0	16.3	17.1	43.2	25.3	26.2	27.6	38.5	18.0	15.1	32.8	16.8	24.8	72.6	20.0	33.0	18.4	27.9	19.3	22.1	27.3	34.2	20.6	41.0	11.5	20.4	16.7	30.1	16.9	18.4	16.8	27.4	8.7	37.7	18.6	20.3	20.2	18.7	12.4	13.4	78.6	10.9	9.9	15.2	15.4	8.6	5.9	12.9	9.6	19.9	12.2	15.2	12.5	14.6	14.8	18.3	13.2	13.3	13.1	5.6	8.1	5.4	14.4	8.3	13.6	22.9	20.4	8.1	26.5	31.2	17.7	10.7	19.7	7.0	14.8	10.7	14.6	13.3	7.9	35.5	14.3	9.8	6.9	13.1	13.4	22.2	4.5	8.1	24.4	18.5	15.1	7.0	20.2	8.0	11.9	12.4	7.8	17.6	8.4	10.1	11.6	25.0	17.6	24.5	28.7	11.5	15.2	14.1	15.1	78.6	8.9	21.9	15.2	9.4	14.6	12.4	14.1	15.1	7.5	9.9	12.3	14.1	19.6	9.9	10.9	13.4	14.3	15.4	29.2	30.2	19.7	21.6	25.3	26.2	32.8	16.8	27.9	27.4
STMP1	"C7orf73, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 71.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 71.6"									HPA065565			Approved	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favourable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.6	32.2	22.5	19.7	24.3	33.5	27.3	13.8	20.4	20.1	19.0	25.0	20.3	17.4	16.5	26.7	51.4	16.2	19.3	29.5	19.3	20.6	28.4	34.7	19.7	28.1	22.3	13.5	16.5	25.4	14.6	25.4	28.1	20.4	20.7	22.5	31.2	23.0	18.5	40.7	21.1	23.2	21.3	22.0	18.7	19.5	38.7	17.0	38.4	31.9	42.6	34.9	18.2	28.0	5.3	12.5	71.6	13.1	7.6	6.6	9.2	14.9	6.9	17.0	15.8	20.1	28.6	10.3	16.6	16.2	13.8	14.4	4.3	16.5	13.6	14.8	25.0	6.2	16.2	20.8	18.8	17.0	13.4	21.4	8.0	10.4	19.8	21.7	13.9	17.6	23.9	16.4	15.4	11.3	23.0	12.3	30.3	18.5	30.9	25.1	33.3	17.8	15.7	18.1	22.5	38.3	7.8	21.4	20.7	22.0	15.4	15.3	6.2	24.0	18.5	13.5	10.9	23.9	23.0	14.3	20.6	26.5	41.6	22.7	24.4	71.6	12.0	25.0	5.3	12.3	5.0	5.3	5.1	5.3	12.5	4.5	4.9	5.4	9.3	7.6	13.1	7.1	6.6	9.2	22.5	24.3	13.8	20.4	19.3	20.6	22.3	13.5	20.4	17.0
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.4;U-138 MG: 12.5;U-2 OS: 13.6;U-266/70: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"basophil: 55.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 55.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favourable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	8.3	1.5	2.3	9.0	3.7	9.4	3.8	0.8	2.4	5.1	7.4	7.1	0.6	2.9	4.6	5.5	3.6	11.6	7.3	5.3	3.4	2.0	4.7	2.2	20.2	26.7	3.5	1.3	2.5	2.3	0.9	2.1	1.3	5.5	5.3	1.8	4.8	12.4	4.8	11.4	3.0	12.0	3.5	10.4	21.9	5.8	3.2	3.9	2.3	21.7	1.2	24.5	18.8	3.6	0.2	1.3	55.6	4.5	10.9	10.2	4.4	4.8	0.7	0.0	0.3	0.7	0.7	0.2	1.9	1.3	0.5	1.4	0.4	3.9	0.0	0.4	3.4	0.5	0.1	0.6	1.9	9.5	0.2	3.7	0.1	0.0	1.2	1.0	16.4	2.2	1.4	4.1	0.7	0.9	0.2	3.7	4.9	0.2	0.1	1.3	0.1	0.7	0.0	4.0	0.4	1.9	0.2	10.9	0.8	0.7	6.9	0.5	1.3	0.2	5.7	12.5	13.6	0.3	0.4	19.2	4.3	0.4	8.1	5.3	0.4	55.6	4.5	0.2	10.2	0.8	6.0	0.2	4.1	6.8	1.3	0.0	4.5	5.5	9.2	10.9	0.3	0.3	4.1	4.4	2.3	3.7	0.8	2.4	3.4	2.0	3.5	1.3	5.5	3.9
TARM1		ENSG00000248385	"T cell-interacting, activating receptor on myeloid cells 1"	B6A8C7	19	54069895-54081365	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;lymphoid tissue: 2.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"basophil: 2.8;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"									"HPA051022, HPA054401"	Uncertain									"HPA051022: AB_2681315, HPA054401: AB_2682476"														"unprognostic (1.56e-1)"				0.1	0.7	0.1	0.0	0.1	1.2	0.2	0.1	0.4	0.0	0.1			0.0	0.4	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.1	0.2	0.6	0.0	0.1		0.1	0.5	0.0	0.1	0.0		0.1	0.0		0.4	0.1	0.1	0.1	0.1	0.0	0.1	2.4	0.2	0.7			0.7		0.1	0.0	0.1	0.5	0.3	3.1	0.5	0.6	0.3	0.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.3	0.3	0.0	0.0	0.6	1.1	0.4	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.4	0.8	0.7	1.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	1.0	0.2	0.8	0.4	0.4	0.2	0.0	0.0	0.6	0.2	1.4	0.4	1.1	0.2	0.0	0.6	0.0	0.9	0.2	0.1	1.1	0.1	1.1	0.4	0.3	0.0	0.9	0.2	2.8	0.5	0.6	0.3	0.4	0.2	0.1	0.2	0.1	0.2	0.5	0.1	0.3	3.1	0.6	0.3	0.3	0.1	0.2										
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347015	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 32.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	9.1	12.0	8.1	6.2	18.2	22.3	9.0	10.4	13.0	9.7	8.6	31.5	3.3	6.2	10.3	7.1	20.1	11.6	8.1	18.9	8.3	5.8	6.1	5.6	14.4	12.9	22.2	9.4	9.7	8.6	11.1	7.2	12.3	16.2	7.5	7.9	9.5	15.9	5.9	18.0	14.0	10.3	10.2	14.6	10.2	10.2	8.7	18.4	16.4	12.2	6.3	14.0	11.3	11.8	6.2	0.8	32.1	3.2	1.9	6.3	1.7	2.6	6.6	1.0	1.9	9.2	10.7	4.2	1.7	8.6	1.1	2.8	1.0	3.6	0.9	2.7	6.7	12.6	0.8	3.7	2.0	1.4	2.8	0.5	2.5	4.0	9.0	0.3	1.8	13.4	8.7	1.3	6.5	6.2	1.6	1.3	1.5	1.9	1.6	1.4	1.2	4.2	0.8	0.2	3.0	8.7	12.5	4.2	3.1	4.5	1.4	5.2	3.9	0.3	4.7	1.6	1.4	2.4	0.4	8.4	0.6	3.2	4.6	0.2	0.8	10.8	3.2	4.9	2.4	1.4	1.8	6.2	4.9	2.7	0.8	5.7	6.3	4.1	32.1	1.9	2.2	0.6	5.6	1.7	8.1	18.2	10.4	13.0	8.3	5.8	22.2	9.4	16.2	18.4
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.0;RPMI-8226: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.5	6.0	0.2	0.1	0.3	6.9	0.0	1.6	7.1	0.7	2.4	0.0	13.0	7.1	2.8	0.3	0.7	0.1	1.3	1.1	0.0	0.5	3.3	7.2	0.2	0.5	3.6	5.4	2.9	1.3	2.9	1.6	1.4	3.6	2.3	3.3	0.0	0.0	6.3	0.2	1.0	3.5	3.2	10.2	0.4	0.1	0.0	0.1	0.2	0.0	1.0	0.3	1.9	2.0	2.3	7.8	0.9	2.5	0.1	0.0	6.0	5.3	4.3	1.7	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.0	7.5	10.3	9.0	12.6	11.4	6.5	10.3	9.7	8.6	10.0	4.6	4.1	13.1	5.9	10.2	5.4	12.1	11.7	12.1	10.9	6.6	44.2	13.0	5.8	7.8	12.5	12.2	9.2	13.1	12.4	8.8	10.4	7.6	6.8	13.9	4.3	11.2	23.1	13.7	7.6	11.6	9.2	5.9	11.4	8.5	5.1	8.2	10.3	5.6	6.7	5.7	7.2	10.9	9.4	9.6	4.9	7.6	4.8	7.7	14.2	8.7	7.2	4.2	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773479	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.7;EFO-21: 10.9;HMC-1: 12.6;MCF7: 10.5;SK-BR-3: 9.8;T-47d: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 27.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria				Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favourable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.6	8.2	10.5	8.8	16.5	20.1	15.2	3.5	7.4	7.9	6.7	3.2	22.1	2.9	8.5	6.4	4.2	10.0	7.5	11.6	10.1	4.6	14.9	9.2	15.8	24.2	6.3	2.9	8.9	10.8	3.5	11.0	6.2	5.8	5.1	3.7	20.4	12.3	18.4	4.3	11.8	5.2	7.0	9.9	21.4	10.4	2.3	11.0	9.6	11.8	4.0	5.6	4.6	13.3	0.0	3.5	27.7	5.4	0.1	0.4	1.4	0.0	2.7	3.1	21.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	6.7	0.1	10.9	0.1	0.3	1.6	0.0	0.1	0.1	0.3	1.1	0.0	0.0	6.7	0.0	12.6	4.5	1.1	0.0	0.1	2.3	2.0	0.5	0.0	10.5	0.4	1.1	0.3	6.8	1.6	0.0	8.0	1.5	0.0	1.2	1.0	0.0	9.8	0.0	12.2	1.3	5.3	0.1	3.6	0.0	0.0	0.5	0.0	0.1	0.1	3.7	0.1	0.0	5.4	2.2	0.2	2.2	0.1	0.0	0.2	0.2	3.5	0.0	0.4	0.1	27.7	0.1	0.7	1.6	0.0	1.4	10.5	16.5	3.5	7.4	10.1	4.6	6.3	2.9	5.8	11.0
ARGFX		ENSG00000186103	"Arginine-fifty homeobox"	A6NJG6	3	121570704-121586634	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.6;testis: 2.2"	"Cell line enhanced"	"Detected in some"		"K-562: 1.7;Karpas-707: 1.5;U-698: 1.9"	"Cancer enriched"	"Detected in single"	119	"testis cancer: 6.4"					"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.6"									HPA043049	Uncertain									"HPA043049: AB_2678288"															"unprognostic (6.00e-2)"			0.3	0.1	0.2	0.5	0.2	0.9	0.2	0.1	0.2	0.1	0.1			0.0	0.2	0.1	0.0	0.1	0.3	0.3	0.2	0.2	0.0	0.4	0.1	0.1	0.1		0.1	0.5	0.0	0.1	0.0		0.1	0.0		0.2	0.1	1.1	0.8	0.4	0.0	0.1	0.5	0.1	2.2			0.1		0.0	0.2	0.1	0.4	0.2	3.6	0.8	0.7	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.2	0.0	0.2	0.3	0.0	0.0	0.2	1.0	0.5	0.7	0.0	0.4	0.0	1.1	0.0	0.3	0.4	0.0	0.0	1.7	1.5	0.4	0.0	0.0	0.1	0.4	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.6	0.0	0.4	0.5	0.0	0.2	0.5	0.0	0.5	1.2	0.5	1.9	0.0	0.2	0.2	0.8	0.3	0.4	0.2	0.4	0.2	0.4	0.1	0.1	0.2	0.4	0.2	0.3	3.6	0.7	0.8	0.2	0.1	0.2										
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472255-57488814	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in some"		"HEL: 11.0;HMC-1: 49.0;THP-1: 14.1;U-937: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 76.9"					"Low region specificity"	"Detected in many"														"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favourable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	5.1	2.5	5.1	33.0	8.0	48.1	4.4	3.7	4.8	1.8	5.4	2.5	0.5	3.6	1.6	1.7	2.7	4.4	4.8	2.4	4.2	1.8	3.5	3.8	11.2	24.1	8.1	0.6	1.2	2.2	0.3	1.5	2.3	5.8	2.5	5.1	2.4	6.0	1.3	0.9	1.4	18.6	2.6	8.5	50.4	3.9	8.8	6.4	19.0	2.6	3.2	28.5	4.7	2.2	8.9	18.9	76.9	17.0	13.1	13.3	11.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.8	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	11.0	0.0	0.0	0.4	6.4	49.0	0.2	0.0	0.0	0.1	0.0	0.2	3.2	0.0	0.0	8.7	8.7	0.4	0.0	3.6	4.2	1.7	0.0	0.0	1.6	1.3	0.0	0.0	0.1	0.0	14.1	0.3	0.0	0.1	0.0	0.0	4.0	2.6	5.3	0.1	11.1	0.2	8.4	16.6	45.1	9.0	17.0	6.2	7.1	9.9	8.1	13.9	8.9	13.3	9.6	76.9	13.1	12.8	18.9	12.1	11.8	5.1	8.0	3.7	4.8	4.2	1.8	8.1	0.6	5.8	6.4
CIR1	CIR	ENSG00000138433	"Corepressor interacting with RBPJ, 1"	Q86X95	2	174348022-174395715	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 56.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015784, HPA061442"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA015784: , HPA061442: AB_2732664"	"unprognostic (3.17e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.56e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.00e-2)"	"unprognostic (4.39e-2)"	"prognostic favourable (9.80e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (1.04e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-3)"	"prognostic favourable (2.04e-5)"	24.1	20.8	27.0	21.9	38.1	48.4	31.0	41.0	34.8	33.6	22.8	19.8	27.2	21.4	23.9	38.6	23.8	24.7	19.8	23.1	25.1	24.7	28.4	22.3	22.2	23.4	26.2	28.3	30.0	24.4	22.5	54.0	36.9	32.3	31.6	22.8	14.0	21.2	23.5	30.8	27.5	34.3	20.3	27.6	32.4	21.0	26.9	30.7	35.8	35.8	21.4	23.7	37.8	22.2	12.0	11.9	56.9	10.1	13.3	10.9	7.6	10.3	5.9	14.1	11.2	19.7	27.7	20.9	17.2	24.4	17.2	21.3	11.0	16.1	7.2	16.2	16.8	12.6	11.6	12.2	20.8	13.3	15.3	15.0	9.4	17.8	19.2	17.8	13.9	22.7	22.3	18.9	14.2	17.0	15.4	16.2	16.3	9.9	22.1	28.2	12.9	16.7	12.6	20.3	21.3	20.3	16.6	16.4	19.3	11.8	15.2	26.0	11.4	26.5	17.4	14.1	10.2	13.2	8.8	18.5	15.7	2.7	20.1	9.3	12.2	17.8	10.1	15.8	9.1	9.2	9.0	12.0	10.3	9.6	6.4	11.8	10.9	10.0	56.9	13.3	9.4	11.9	10.5	7.6	27.0	38.1	41.0	34.8	25.1	24.7	26.2	28.3	32.3	30.7
COP1	"FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1, E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207493	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	22.4	15.8	14.8	20.1	16.7	19.1	19.3	24.6	19.7	21.4	23.9	15.3	17.7	16.1	23.5	16.5	22.3	14.9	15.5	14.5	12.8	11.6	17.2	22.9	17.8	24.1	13.1	11.3	14.4	20.8	15.6	24.5	17.2	15.7	15.4	26.1	18.1	20.2	21.4	19.2	25.4	22.1	19.7	10.9	27.1	17.5	23.4	15.0	39.3	18.3	15.8	25.0	22.6	17.6	1.5	2.0	13.7	3.4	0.5	2.7	1.0	14.1	7.6	12.4	6.7	12.5	12.8	23.5	11.0	13.5	11.8	11.2	12.9	15.0	29.0	10.8	12.5	13.4	11.4	16.7	10.6	9.0	7.0	12.3	9.4	12.7	13.2	22.1	14.3	11.3	14.0	11.5	14.7	16.7	17.9	11.4	14.0	17.7	13.0	11.7	21.3	0.8	11.3	10.8	16.9	16.2	43.8	10.0	17.6	12.9	20.6	14.0	14.6	29.6	16.0	10.0	7.0	13.4	9.4	14.7	25.1	26.4	8.4	13.1	11.5	6.1	2.7	10.1	1.8	3.4	1.4	1.4	2.1	1.4	2.0	1.5	2.7	2.0	13.7	0.5	3.1	1.1	1.5	1.0	14.8	16.7	24.6	19.7	12.8	11.6	13.1	11.3	15.7	15.0
FAM240B		ENSG00000283329	"Family with sequence similarity 240 member B"	A0A1B0GVZ2	9	38694263-38720428	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.9;tongue: 6.0"	"Low cell line specificity"	"Detected in some"											"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 0.8"																																	0.1	0.0	0.1	0.1	0.1	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.0	0.4	0.1	0.1		0.1	0.1	0.1	0.6	0.1	0.1	0.1	2.6	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	1.5	0.3	0.1	0.1	0.8	0.0	1.6	0.1	0.1	0.2	6.0	0.1	0.1	0.1	1.5	1.6	6.9	0.8	1.2	0.7	0.5	1.0	0.7	0.5	0.7	0.0	1.0	0.5	0.0	0.2	0.2	0.0	1.9	0.7	0.2	0.3	0.0	1.6	0.0	0.4	0.3	1.0	0.5	0.8	1.7	0.4	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.4	0.2	0.9	0.4	0.9	0.0	1.2	0.0	0.0	0.3	1.1	0.3	0.4	0.2	1.7	1.2	0.2	0.0	0.4	0.1	1.2	0.8	0.8	1.5	0.4	0.0	0.6	0.0	6.9	0.8	1.5	0.6	0.7	0.5	1.1	0.6	0.6	0.3	1.5	0.6	0.7	3.9	1.2	0.6	1.6	0.4	0.5										
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;lymphoid tissue: 66.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 25.9;NB-4: 14.3;THP-1: 15.0;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									160000	160000				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favourable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"	7.1	3.3	3.4	28.8	5.3	20.6	4.4	1.3	3.6	2.3	3.9	5.2	0.4	3.4	2.2	4.2	4.1	4.2	5.5	4.7	3.6	3.0	5.2	5.1	17.3	32.2	5.3	1.0	2.1	1.9	0.8	2.5	6.1	4.7	4.0	4.0	4.7	7.2	1.8	1.2	2.5	18.4	2.2	9.1	66.2	4.8	2.0	4.6	53.0	3.4	1.5	33.3	8.1	3.4	5.7	6.3	29.9	6.6	3.4	7.4	4.6	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	1.6	0.6	0.9	0.1	0.6	4.3	2.0	0.7	0.1	0.0	1.1	0.7	5.4	0.1	6.1	0.0	0.2	1.8	0.0	25.9	0.4	0.0	0.2	0.9	3.0	2.9	7.2	0.1	0.0	3.0	14.3	0.0	0.0	2.5	0.3	6.6	0.3	0.0	0.0	0.2	0.0	0.0	0.9	0.1	15.0	2.8	0.3	1.2	0.0	0.3	0.3	0.3	4.7	0.1	8.8	1.6	4.6	6.5	19.2	5.2	6.6	4.8	5.7	6.9	6.0	6.3	5.3	7.4	5.6	29.9	3.4	6.4	4.4	4.7	4.6	3.4	5.3	1.3	3.6	3.6	3.0	5.3	1.0	4.7	4.6
HIST1H4J	"H4/e, H4F2iv, H4FE"	ENSG00000197238	"Histone cluster 1 H4 family member j"	P62805	6	27824108-27824480	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.9;lymphoid tissue: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 31.4;MCF7: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 58.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.9"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.9	9.4	2.9	15.6	4.1	25.9	4.0	3.7	15.5	5.3	9.9	0.2	6.8	7.9	4.4	4.7	7.6	5.6	6.2	7.5	5.9	1.9	4.0	18.1	8.3	26.7	2.2	7.1	5.2	4.1	0.6	4.5	3.2	2.3	8.0	4.6	0.7	2.0	3.7	0.7	2.7	7.6	3.8	6.0	13.9	7.5	19.3	0.8	68.3	8.6	8.0	10.8	5.4	4.9	12.0	7.7	58.9	10.8	10.6	13.2	10.8	3.8	4.7	10.6	17.9	6.4	2.7	6.2	4.4	2.3	4.4	2.8	8.7	1.3	6.2	7.9	1.8	9.2	0.2	6.6	1.4	8.8	1.6	4.1	9.4	31.4	3.8	6.0	5.3	8.4	1.8	2.8	1.5	4.1	7.8	13.1	0.0	31.5	10.7	6.1	6.7	10.4	4.4	0.7	4.4	0.6	1.7	5.8	8.0	7.5	4.4	7.0	5.7	3.0	3.9	2.1	10.6	1.1	0.0	8.4	8.0	10.8	2.7	7.6	4.2	58.9	3.4	14.8	11.7	8.5	8.9	11.0	11.5	12.7	5.2	12.0	6.6	8.3	6.9	10.6	10.8	7.7	13.2	10.8	2.9	4.1	3.7	15.5	5.9	1.9	2.2	7.1	2.3	0.8
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		370000000	370000000	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: "	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.6	1.3	0.9	2.9	1.6	1.3	1.6	1.6	1.1	1.4	1.2	1.1	1.8	0.0	5.7	1.4	1.1	0.0	1.2	0.4	19.8	0.8	5.0	1.2	5.0	0.8	18.3	20.7	1.1	1.0	1.6	0.5	0.6	2.7	64.3	1.5	5.4	2.4	41.4	0.7	9.0	1.5	0.6	48.2	1.4	2.3	0.3	1.2	1.4	4.5	3.6	3.9	5.2	1.1	6.3	0.5	7.0	1.6	3.1	34.1	7.6	4.5	33.8	4.9	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327894-89340971	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 80.0"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 34.4;BJ hTERT+ SV40 Large T+: 80.5;BJ hTERT+ SV40 Large T+ RasG12V: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 80.0"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA059914: AB_2684159"	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	50.5	15.7	14.9	11.3	17.3	22.1	10.6	6.9	17.0	6.8	9.7	7.6	4.1	14.5	8.8	16.8	6.2	10.9	15.1	8.9	14.2	12.9	19.3	17.0	25.9	10.0	13.5	12.4	11.3	4.3	3.8	5.5	22.9	23.0	9.7	5.4	9.2	19.6	8.1	8.1	5.0	11.3	11.1	18.4	26.0	7.2	5.1	12.1	14.3	14.9	5.5	2.9	11.0	5.9	1.6	2.5	80.0	18.4	0.3	2.6	3.2	6.2	0.4	0.1	1.7	7.3	7.9	0.0	4.0	34.4	80.5	93.5	0.3	9.1	0.5	1.7	6.4	5.6	0.1	0.8	5.9	0.9	0.0	2.4	1.8	0.2	4.2	0.7	2.0	4.9	0.1	7.0	0.5	0.4	0.1	1.4	2.0	0.0	1.5	1.9	0.1	2.0	1.5	0.5	0.4	2.3	3.0	0.0	0.0	0.7	0.1	15.8	0.2	0.8	0.6	1.3	0.2	2.2	1.0	2.2	1.8	0.1	1.8	3.0	1.3	15.2	7.5	26.6	0.7	16.0	0.1	1.6	1.1	0.5	2.5	1.4	0.7	0.8	80.0	0.3	18.4	0.5	2.6	3.2	14.9	17.3	6.9	17.0	14.2	12.9	13.5	12.4	23.0	12.1
IRGM	"IFI1, IRGM1, LRG-47, LRG47"	ENSG00000237693	"Immunity related GTPase M"	A1A4Y4	5	150846523-150900736	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.0;NB-4: 5.5;THP-1: 3.0;U-937: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.5"																				"unprognostic (8.73e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.12e-10)"	"unprognostic (5.93e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.11e-1)"	0.6	0.1	0.4	1.1	0.4	1.6	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.8	0.4	0.4	0.1	2.7	0.4	0.8	0.9	0.4	0.4	0.5	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.8	0.4	0.4	1.3	0.8	3.3	0.4	0.4	0.6	0.4	0.4	0.7	0.4	0.8	0.4	5.5	0.3	0.7	1.3	0.5	0.2	0.1	0.2	0.2	0.2	0.0	0.7	0.0	0.0	0.4	0.1	0.7	0.1	0.1	0.3	0.0	0.3	0.2	0.2	0.1	1.3	0.4	0.3	0.8	0.2	0.0	3.0	0.9	0.2	0.2	0.0	0.2	0.0	0.3	1.8	0.0	0.6	1.0	5.5	2.5	0.4	1.1	0.1	0.1	0.1	0.0	0.3	0.4	0.3	0.7	0.6	0.4	3.0	0.0	0.4	0.9	0.6	0.3	0.6	0.5	0.6	0.5	7.0	0.1	5.5	0.3	0.2	0.6	0.2	1.3	0.3	0.6	0.7	0.1	0.8	0.6	0.7	1.3	0.7	0.2	0.4	0.2	0.5	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: , HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.4	1.4	2.5	18.9	4.9	0.4	3.4	2.9	2.6	1.7	0.1	0.8	0.1	0.8	2.0	0.8	1.5	2.1	1.9	26.7	0.5	54.8	2.9	0.7	3.9	3.7	2.8	4.0	0.9	1.1	1.8	2.4	3.9	6.4	4.7	0.9	0.9	5.2	1.3	1.7	1.9	2.7	0.7	2.0	1.3	1.6	0.9	1.0	1.5	1.0	0.7	6.5	5.0	4.0	1.3	4.1	2.4	1.2	2.2	0.5	5.2	1.8	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Intermediate filaments,Cytosol"				Nucleoli	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.9	5.3	9.2	3.5	4.2	5.0	13.7	3.6	3.6	2.6	2.8	20.0	19.6	14.3	9.0	3.0	4.0	12.6	2.4	3.7	10.5	1.7	20.0	2.6	2.6	8.2	14.4	32.4	2.7	3.7	2.9	4.8	20.2	11.4	22.8	2.7	1.4	20.2	6.0	19.6	2.2	9.4	8.8	6.2	2.6	5.5	3.7	3.3	4.7	2.4	2.5	8.4	16.0	12.7	2.7	4.4	4.7	3.8	13.9	14.7	17.6	1.5	8.1	3.0	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9
MBTD1	"FLJ20055, SA49P01"	ENSG00000011258	"Mbt domain containing 1"	Q05BQ5	17	51177425-51260163	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021876	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021876: AB_2140367"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-3)"	9.0	6.8	8.8	10.6	14.2	11.0	13.5	21.2	12.0	10.7	8.8	13.2	8.6	9.2	14.3	9.6	9.3	8.3	7.1	5.8	9.9	5.8	7.4	11.2	7.2	9.3	12.6	8.1	15.4	11.0	8.8	9.6	10.0	8.8	8.9	9.3	8.3	9.0	8.8	7.9	16.7	9.8	11.9	7.7	11.7	9.5	27.9	11.7	32.4	10.1	4.8	9.0	9.5	10.5	0.9	1.1	5.1	0.4	0.4	0.9	0.1	3.8	3.5	19.0	7.7	4.6	5.4	10.1	2.9	3.6	3.1	3.9	4.2	4.9	14.8	6.9	2.1	3.7	8.7	2.1	5.9	4.1	7.9	15.3	4.1	6.4	3.1	10.3	4.6	4.6	4.2	2.3	4.3	5.5	11.8	3.7	2.4	3.8	13.9	10.8	10.8	3.3	16.2	11.5	7.4	4.8	7.2	12.2	18.5	2.6	5.1	6.1	7.3	20.3	3.3	3.4	3.5	2.5	3.1	9.3	5.8	13.3	2.0	6.8	1.9	5.1	0.4	1.9	0.7	0.3	0.2	0.9	0.7	0.5	0.7	0.6	0.4	0.9	0.9	0.4	0.4	1.1	0.8	0.1	8.8	14.2	21.2	12.0	9.9	5.8	12.6	8.1	8.8	11.7
NANOGNB		ENSG00000205857	"NANOG neighbor homeobox"	Q7Z5D8	12	7765216-7774121	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.0;testis: 2.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.0;HL-60: 1.7;HSkMC: 1.6;U-2197: 2.9"	"Cancer enriched"	"Detected in single"	18	"testis cancer: 1.2"					"Group enriched"	"Detected in some"	4	"basophil: 1.8;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"									HPA060371	Uncertain									"HPA060371: AB_2684266"															"unprognostic (2.76e-1)"			0.1	0.3	0.1	0.7	0.1	1.4	0.1	0.1	0.1	0.9	0.1			0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1		0.1	1.2	0.6	0.1	0.0		0.1	0.0		0.1	0.3	0.9	0.5	0.1	0.0	0.1	0.2	0.1	2.0			0.1		0.0	0.1	0.1	0.4	0.2	2.0	0.4	0.3	0.4	0.1	0.1	2.0	0.2	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.5	0.4	1.0	0.0	0.0	1.7	0.0	1.6	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.1	0.4	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.4	1.3	2.9	0.2	0.9	0.5	0.1	0.8	0.2	0.0	1.8	0.3	0.3	0.4	0.4	0.4	0.2	0.3	0.3	0.0	0.4	0.4	0.3	2.0	0.3	0.3	0.2	0.1	0.1										
OR10A3	"HSHTPCRX12, HTPCRX12"	ENSG00000170683	"Olfactory receptor family 10 subfamily A member 3"	P58181	11	7937171-7941708	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;bone marrow: 1.4;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HMC-1: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.2"																																		"unprognostic (2.53e-2)"		"unprognostic (3.24e-3)"	0.1	0.1	0.0	0.2	0.0	1.4	0.4	0.0	0.1	0.2	0.0			0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.2	0.1	0.0	0.0	0.0		0.3	0.1		0.2	0.0	0.0	1.8	0.2	0.0	0.0	0.4	0.3	0.2			0.1		0.0	0.9	0.1	0.5	0.4	2.2	0.3	0.2	0.3	0.1	2.1	0.2	0.0	0.4	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.8	0.2	0.0	0.2	0.0	0.1	0.2	0.8	0.3	0.4	0.2	0.5	0.2	0.2	0.3	0.2	0.1	0.0	0.3	0.3	0.2	0.6	0.5	0.0	0.1	0.0	0.3	0.1	0.2	0.3	0.3	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	1.7	0.2	0.1	0.4	0.2	0.1										
OR7D4	"hg105, OR19-B, OR7D4P"	ENSG00000174667	"Olfactory receptor family 7 subfamily D member 4"	Q8NG98	19	9210276-9219589	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.8;testis: 2.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"																																		"unprognostic (1.30e-1)"			0.1	0.2	0.1	0.3	0.1	2.0	0.2	0.2	0.7	0.4	0.2			0.2	0.2	0.6	0.4	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.1		0.1	0.2	0.0	0.1	0.2		0.2	0.3		0.2	0.0	0.5	1.1	0.5	0.0	0.1	0.6	0.2	2.1			0.3		0.4	0.2	0.2	0.7	0.7	3.8	0.4	0.9	0.4	0.0	0.3	0.2	0.7	1.2	0.4	0.1	0.8	0.2	0.0	0.4	0.0	0.5	0.3	1.0	0.3	0.1	1.1	0.5	0.1	0.3	2.5	1.1	0.8	1.3	0.9	0.1	0.8	1.2	0.4	0.1	0.5	0.2	0.0	0.4	1.4	0.0	0.9	1.0	0.6	0.9	0.1	0.6	0.6	0.2	0.2	0.6	0.6	0.4	0.7	0.4	0.5	0.9	0.3	1.1	0.9	0.5	1.0	0.4	1.1	0.3	0.6	0.5	0.6	0.9	3.8	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.2	0.1	0.7	0.4	0.3	2.3	0.9	0.2	0.7	0.1	0.0										
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158457-192185815	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 66.0;lymphoid tissue: 37.3"	"Group enriched"	"Detected in some"	5	"HEL: 28.6;HL-60: 21.9;NB-4: 20.6;U-937: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 66.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 66.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		380000	380000	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	3.9	1.9	4.8	11.4	4.6	9.9	1.8	0.9	3.1	2.0	2.2	1.0	0.0	2.3	1.1	2.3	2.0	2.2	4.5	7.5	3.6	2.5	2.7	4.2	16.1	23.0	4.9	0.8	1.6	1.2	0.0	1.2	3.8	4.2	1.8	2.3	0.6	1.6	0.8	0.9	0.9	4.8	2.3	9.2	37.3	1.4	1.3	4.4	3.0	1.3	0.4	3.5	4.6	1.3	0.0	9.8	66.0	14.9	0.1	1.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	27.4	9.8	66.0	0.1	12.9	1.3	0.0	0.1	0.2	9.8	0.0	0.0	0.0	32.4	0.1	14.9	2.3	0.0	16.4	4.8	4.6	0.9	3.1	3.6	2.5	4.9	0.8	4.2	4.4
RSBN1L	"FLJ42526, FLJ45813, MGC71764"	ENSG00000187257	"Round spermatid basic protein 1 like"	Q6PCB5	7	77696443-77783022	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 31.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020406, HPA020413"	Approved		Supported	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA020406: AB_1856488, HPA020413: AB_2253910"	"unprognostic (2.02e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.53e-3)"	12.9	10.6	15.0	22.1	14.6	9.5	15.5	28.7	17.0	22.8	23.5	8.9	12.1	11.1	17.2	13.6	15.0	14.2	13.4	10.6	12.4	10.3	12.0	14.9	15.7	18.2	11.1	11.0	19.2	14.9	19.5	16.2	12.2	11.8	18.8	15.1	13.9	14.0	15.4	13.6	11.7	14.9	18.0	11.0	20.7	14.3	29.8	13.8	34.5	21.1	6.7	18.0	23.6	28.2	7.2	7.0	31.5	4.0	3.0	5.2	1.2	8.8	6.8	11.4	20.0	8.0	10.3	5.6	6.6	7.1	9.4	10.8	8.4	15.9	18.2	2.6	6.8	7.7	15.5	8.5	13.5	9.8	8.3	14.5	10.8	8.3	6.8	17.8	13.7	7.3	6.2	8.6	9.5	7.7	19.6	19.2	9.7	10.2	15.2	17.9	8.1	6.1	15.9	11.4	19.1	5.9	11.7	13.5	14.1	10.0	18.2	7.2	11.1	9.5	7.4	14.1	13.0	8.4	10.0	8.6	9.1	29.3	6.7	16.5	9.2	9.1	4.0	6.4	5.2	2.9	3.9	5.4	4.5	3.8	2.2	7.2	4.3	4.7	31.5	3.0	3.2	7.0	4.5	1.2	15.0	14.6	28.7	17.0	12.4	10.3	11.1	11.0	11.8	13.8
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452203-121633693	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 44.1;Daudi: 20.7;RT4: 31.2;U-698: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"					"CAB011500: AB_443414, HPA031321: "	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	5.6	5.0	17.3	17.0	24.9	30.7	10.5	28.3	40.8	34.8	12.7	36.0	9.9	8.6	4.5	7.2	5.7	29.4	5.8	3.0	22.4	18.7	15.0	41.4	10.0	14.8	28.6	21.9	7.3	6.1	19.9	17.7	2.1	24.0	16.0	12.7	6.4	14.7	20.0	1.5	3.9	13.0	3.8	27.8	21.3	7.9	4.1	23.4	11.1	10.3	0.2	16.3	15.8	6.7	2.0	5.6	43.8	5.4	6.7	10.8	6.1	0.4	2.4	2.3	0.3	0.0	0.0	2.3	0.1	0.7	0.1	0.0	3.6	44.1	20.7	2.7	0.5	14.6	2.8	2.1	0.0	0.0	0.8	0.0	3.3	5.0	0.0	8.8	0.0	0.0	2.4	0.0	8.2	0.0	0.0	0.2	0.0	2.9	2.1	4.5	2.7	3.3	2.3	0.1	0.4	4.9	31.2	1.6	0.4	4.6	6.7	0.0	6.5	2.8	0.1	0.0	1.6	0.3	0.0	0.0	0.0	43.0	0.0	11.8	0.1	13.0	5.4	19.1	8.0	2.3	10.8	0.7	9.0	7.2	2.2	2.0	8.6	7.6	43.8	6.7	2.8	5.6	6.3	6.1	17.3	24.9	28.3	40.8	22.4	18.7	28.6	21.9	24.0	23.4
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806935-100903266	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.1;lymphoid tissue: 34.7"	"Cell line enhanced"	"Detected in many"		"AF22: 18.7;HDLM-2: 30.2;Karpas-707: 26.0;NB-4: 12.2;RPMI-8226: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	580000	580000	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	11.7	2.7	4.3	16.7	4.3	8.2	6.5	1.3	4.2	3.4	5.3	2.6	0.3	4.0	2.3	4.2	4.3	3.5	6.5	4.7	4.0	8.0	2.6	3.3	17.5	27.9	5.1	1.7	2.5	2.1	1.5	2.4	13.7	11.6	3.4	5.6	2.7	4.0	1.3	2.0	2.1	7.7	3.6	8.0	31.6	3.7	1.6	4.3	34.7	4.9	0.8	13.8	7.4	3.5	4.7	4.9	37.1	8.9	4.0	6.9	4.4	0.0	2.7	18.7	0.0	1.2	1.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	30.2	0.0	1.1	0.2	0.0	0.0	5.6	2.3	1.5	0.0	0.0	0.0	3.4	0.0	26.0	1.1	0.2	7.9	12.2	0.1	0.1	4.5	0.3	19.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.1	1.2	0.2	0.1	0.0	0.2	8.5	8.7	1.7	0.4	7.0	2.3	18.8	7.5	8.9	5.7	8.8	4.3	4.7	3.8	4.7	4.9	3.6	2.4	4.5	37.1	4.0	8.9	1.5	6.9	4.4	4.3	4.3	1.3	4.2	4.0	8.0	5.1	1.7	11.6	4.3
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;HDLM-2: 32.3;Karpas-707: 6.9;U-937: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria				Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.7	8.0	0.3	0.5	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.2	0.9	32.3	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	1.2	0.6	0.0	6.9	1.4	0.0	1.6	1.2	0.7	0.2	0.1	1.1	0.4	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.3	0.5	0.7	3.3	0.0	1.6	0.0	5.7	19.1	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.1;HSkMC: 16.2;TIME: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain									"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favourable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.1	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.6	2.2	0.7	1.1	1.9	2.3	1.6	2.5	15.1	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	6.9	2.8	4.5	1.6	5.0	1.4	4.5	1.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	0.7	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7
